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Abstract 
 Solid-state nuclear magnetic resonance (SSNMR) is an important tool for the study of 
structure, function and dynamics of many chemical and biological systems. By using this 
technique we are able to study molecules that are insoluble or would not be in their native 
state when dissolved in solution. This is of particular importance in the study of membrane 
proteins, whose structures have been difficult to analyze through the use of traditional x-ray 
crystallography or solution NMR techniques. In this thesis, we have studied the 
transmembrane segment of the M2 proton channel of the influenza A virus. The M2 proton 
channel is essential to virus replication, as it acidifies the viral interior allowing for the 
uncoating and release of viral RNA. The M2 transmembrane peptide (M2TMP) is a 25-
residue α-helical transmembrane segment that spontaneously forms tetramers in the lipid 
bilayer. We are interested in the structure and dynamics of M2TMP, and the interaction of 
the peptide with an anti-influenza drug, amantadine.  
 We determine the orientation of M2TMP relative to the bilayer normal in model 
phosphocholine lipid bilayers such as DLPC and POPC, with and without the amantadine 
drug. This is achieved through the measurement of 15N-1H dipolar coupling and 15N chemical 
shift anistropy, which are directly related to tensor orientation for a uniaxially rotationally 
diffusing molecule. From this information we show that the orientation of M2TMP is 
dependent on lipid bilayer thickness. We also observe that the addition of amantadine affects 
the orientation of the peptide. We have measured the orientation of both singly and multiply 
15N labeled M2TMP. 
 In order to observe the effects of drug binding on M2TMP secondary structure, we 
measure the 13C and 15N chemical shifts for 11 sites along the channel, including several 
proposed binding sites. Chemical shift is known to be very sensitive to local torsion angle 
perturbations. The largest drug-induced chemical shift change is observed at Serine 31, one 
of the proposed binding sites. The chemical shifts are used to simulate backbone torsion 
angles, and an amantadine-bound M2TMP structure is deposited in the Protein Data Bank 
with accession code 2KAD. We also establish a relationship between 13C chemical shift of 
sidechain methyl carbons and sidechain torsion angles. Here we show that sidechain rotamer 
 ix 
can be predicted from 13C methyl chemical shift and direct measurement of Val χ1correlates 
with the predicted rotamer.  
 Finally, we have measured the 13C T2 and 1H T1ρ relaxation rates and 13C linewidths of 
M2TMP in DLPC bilayers with and without amantadine. Substantial 13C line narrowing 
occurs when amantadine is bound to the peptide, and the line-narrowing mechanism is 
attributed to faster peptide motion and a more homogeneous peptide conformation. We 
observe an increase in 13C T2 relaxation time for the amantadine-bound peptide relative to the 
apo state, with the most significant increases occurring near Serine 31. From 1H T1ρ 
measurements, we are able to calculate the relative activation energies and motional 
correlation times for uniaxial rotational diffusion of the apo- and amantadine bound peptides. 
An increase in Ea and a reduction in τC was observed for the amantadine-bound state. We 
propose that the addition of amantadine to the sample results in a more tightly packed and 
homogeneous tetramer bundle that is able to diffuse faster in the lipid bilayer.  
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Chapter 1 
Nuclear Magnetic Resonance Methodology 
 
1.1 Introduction 
Magnetic resonance is an extremely useful physical property that can be measured 
through the use of nuclear magnetic resonance (NMR) spectroscopy. Magnetic resonance 
was first discovered by I. I. Rabi in 1938 (1) and in the subsequent years was refined for 
applications to liquids, solids, and for imaging of three-dimensional objects.  
Although the applications of magnetic resonance have become wide and varied since 
the technique was discovered, most chemists today know NMR as the best tool for chemical 
structure elucidation that is currently available. Solution NMR has many advantages for 
organic chemists. The spectra have sharp, narrow lines, the technique is extremely sensitive 
to atomic environment, requires low sample concentrations, and is non-destructive with short 
measuring times. However, a great deal of important and interesting information is lost when 
a molecule is solvated and consequently undergoes fast isotropic tumbling in solution. 
Moreover, many samples cannot be solubilized. Solid-state NMR allows for the study of 
disordered solids that cannot be studied by other structural techniques such as x-ray 
crystallography or solution NMR. These include biological solids such as amyloid fibrils and 
membrane proteins, in addition to natural organic matter and polymers. In the case of 
membrane proteins, the molecule can be studied in native lipid bilayers that are too large to 
undergo fast isotropic tumbling. The focus of this work is the application of solid-state NMR 
to the elucidation of membrane protein structure and dynamics, specifically the M2 
transmembrane peptide (M2TMP) of the influenza A virus.  
This chapter is intended to provide an overview of the theory and techniques used to 
conduct NMR experiments in subsequent chapters. This work focuses on two main areas of 
solid-state NMR experiments. First, we are interested in the motional rate and amplitude of a 
uniaxially rotating peptide in the lipid bilayer. To observe motional rates we have measured 
relaxation times such as 13C T2 and 1H T1ρ. By measuring the rate of peptide rotational 
diffusion, we are able to observe how temperature, membrane environment and drug binding 
affect peptide motion. To determine motional amplitude we have measured the coupling 
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strengths of a variety of NMR tensors such as 2H quadrupolar coupling, 1H-13C and 1H-15N 
dipolar coupling and 15N and 13C chemical shift anisotropy. By measuring motional 
amplitudes, we are able to extract peptide orientation relative to the lipid bilayer normal. 
Second, we focus on the determination of protein secondary structure from isotropic 
chemical shifts. Here we use several chemical shift correlation experiments such as 13C-13C 
spin diffusion under magic angle spinning, 13C-13C double-quantum filtered single-quantum 
correlation and 13C-15N heteronuclear correlation. From these experiments we are able to 
observe chemical shift changes in the protein due to drug binding. 
 
1.2 Relaxation Measurements and Motional Rate 
 Nuclear spin relaxation in NMR is necessary for pulsed experiments, since without it 
we would only be able to apply a single pulse to a nucleus and it would remain in an excited 
state forever. Relaxation can also be a hindrance if it occurs too quickly – the complicated 
spin gymnastics of many modern pulse sequences require sufficiently long relaxation times 
in order to complete a series of pulses and have enough remaining signal for acquisition. 
Relaxation can also be a useful tool for determining motional rates in samples, since the rate 
of molecular motion is inversely proportional to the locking or decoupling field used in the 
pulse sequence (2, 3). The phenomena described above are due to three types of nuclear spin 
relaxation – longitudinal or T1 relaxation, transverse or T2 relaxation, and T1 relaxation in the 
rotating frame or T1ρ relaxation. Nuclear spin relaxation requires randomly fluctuating 
magnetic fields (4). These arise from random molecular motions that cause fluctuations in 
local interactions such as dipolar coupling or chemical shift anisotropy. These fluctuating 
local processes produce the randomly fluctuating fields that drive relaxation. 
When component of the randomly fluctuating field perpendicular to the static 
magnetic field fluctuates at the Larmor frequency, it induces nuclear spin transitions similar 
to those induced by radiofrequency irradiation (4). This will occur until the populations 
return to the initial Bolzmann distribution, and is referred to as T1 or longitudinal relaxation. 
T1 is typically shorter than 1 second for amorphous membrane samples, but can be as long as 
several minutes to hours in the case of well-ordered crystalline systems.  
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T2 relaxation occurs when the fluctuating fields cause the NMR signals from the 
nuclear spins to become out of phase with one another (5). Since the sample contains many 
spins, the respective signals are no longer in coherence and the detected signal will become 
progressively lower with increasing time after the initial pulse. T2 is also inversely 
proportional to spectral linewidth. This incoherent line broadening is not due to multiple 
molecular conformations having overlapping isotropic chemical shifts or interactions such as 
1H-13C dipolar coupling (6). Incoherent relaxation-induced broadening cannot be reduced by 
pulse effects such as stronger 1H decoupling or through faster magic angle spinning.  
Finally, T1ρ is defined as T1 relaxation in the rotating frame. In this experiment, the 
magnetization is in the transverse plane after a 90° pulse, and is then spin-locked by applying 
a radiofrequency (rf) field to the nucleus of interest for varying lengths of time. Thus, the 
magnetization will not undergo precession in the rotating frame, and will decay as a function 
of spin-lock time.  
These three relaxation times are similar in that they are sensitive to molecular motion 
at a characteristic frequency ωi = γBi (6-8).  For each relaxation time, the origin and strength 
of the Br field is different. For T1 it is B0, the static magnetic field; for T1ρ it is the applied 
spin-locking field with rf strength B1; and for 1H decoupled 13C T2 it is B1, the 1H decoupling 
field (2).  The rate of relaxation is inversely proportional to the spectral density function, 
J(ω), near the characteristic frequency ωi (9): 
 
€ 
J(ω i) =
τC
1+ω i2τC 2
 (1.1) 
 
The spectral density function is the Fourier transform of the correlation function C(t) 
(4), where the correlation function describes the variation in a spatial function at time τ 
relative to time 0. The more random variation in the correlation function, the faster C(t) will 
decay. The characteristic rate of decay of C(t) is the correlation time, τC. Motional correlation 
times are obtained experimentally by measuring the relaxation time at several different 
temperatures or field strengths. Here we will consider the temperature-dependent case. 
Figure 1.1 shows the relationship between relaxation time and correlation time/temperature. 
Three motional regimes can be observed – fast motion and short correlation times where ωiτc 
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<< 1, the intermediate time-scale region where ωiτc ≈ 1, and ωiτc >> 1, the “slow” or long 
correlation time limit.   
 
 
Figure 1.1. Relaxation time versus molecular correlation time/inverse temperature. The correlation 
time is temperature dependent, and relaxation time will be short when the molecule is moving at a 
rate inversely proportional to the locking field or decoupling field. Figure adapted from Harris (4). 
 
Although the individual derivations for T1, T2 and T1ρ relaxation mechanisms are more 
complex, we will consider a general case for Ti. As stated above, relaxation time is inversely 
proportional to the spectral density function: 
 
€ 
Ti−1 = Ci
τ c
1+ω i2τ c2
 (1.2) 
where Ci is a constant obtained from the various prefactors that arise from the different 
derivations of relaxation functions. For the short correlation limit, ωiτC is negligible and the 
equation simplifies to: 
 
€ 
ω iτ c <<1,      Ti-1 = Ciτ c  (1.3) 
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Likewise, for the long correlation limit, ωiτC is much larger than 1, and the expression for the 
relaxation rate can be simplified again:  
 
€ 
ω iτ c >>1,      Ti−1 = Ci
1
ω i
2τ c
 (1.4) 
For the intermediate case, the relaxation rate reaches the maximum value, and the correlation 
time is at a minimum (Figure 1.1): 
 
€ 
ω iτ c =1,      Ti−1 = Ci 12 τ c  (1.5) 
Since we are studying peptides in a lipid membrane, the minimum in T1ρ and T2 occurs near 
the lipid phase transition temperature. Therefore, at high temperatures (fast motion) and low 
temperatures (slow motion) the relaxation time will be long.  
Finally, the correlation time is a function of the activation energy for the motional 
process. For a simple activated process, the Arrhenius equation can be used to obtain Ea: 
 
€ 
τ c = τ 0eEa /RT  (1.6) 
 The relationship between motional correlation time and activation energy will be explored in 
detail in Chapter 8 through measurement of T1ρ relaxation for the uniaxially mobile M2TMP 
in DLPC lipid membranes.  
In this work we measure 13C T2 and 1H T1ρ in order to examine the difference in 
motional rates for M2TMP at several different temperatures, and the effect of drug binding 
on M2 motion. In a membrane sample, there are a large number of slow motions that are of 
little interest here. Since T2 and T1ρ relaxation probe molecular motion on the microsecond 
time scale(2, 3), we are able to probe fast local motions that are strongly dependent on 
sample temperature, membrane environment, and ligand binding. As mentioned above, the 
correlation functions for these relaxation times are dependent on the 1H decoupling field in 
the case of T2 or the 1H spin-locking field in the case of T1ρ.   
T1ρ and T2 relaxation rates are measured by monitoring the rate of signal decay as a 
function of the length of time Bi is applied to the system. The pulse sequence for the 
measurement of 13C T2 relaxation under 1H decoupling is shown in Figure 1.2, and consists of 
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a 1H-13C cross polarization period followed by a Hahn echo (10) period with varying τ. 
Several time points are measured by adjusting the delay time, τ, and then the 13C signal 
intensity is plotted as a function of 2τ. T2 relaxation is governed by its spectral density 
function, which is dependent on 1H decoupling field strength during the echo delay. 
Therefore, stronger decoupling will result in a longer T2.  
There are several disadvantages to the Hahn echo experiment. For example, strong 1H 
decoupling fields are required and the delay time may be increased to tens of milliseconds, 
which can put undue stress on the NMR probe. Additionally, 13C-13C J-coupling is not 
eliminated in this simple sequence and may contribute to signal decay. J-coupling can be 
eliminated through the use of a selective 180° pulse on 13C, however this is limiting when 
many uniformly labeled residues are being measured in a particular sample.    
 
 
Figure 1.2. Pulse sequence for measurement of 13C T2 relaxation time.  
 
 1H T1ρ relaxation measurements also probe molecular motions on the microsecond 
time scale. In the pulse sequence, shown in Figure 1.3, a spin-locking field is applied to the 
1H channel after the initial 90° pulse, and the magnetization will experience no precession in 
the rotating frame (4). The transverse magnetization will decay as a function of the spin-lock 
time, τSL. Here the correlation function is inversely proportional to the locking field (3), 
which is usually at a field strength of 50-100 kHz. 
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Figure 1.3. Pulse sequence for measurement of 1H T1ρ relaxation time.  
 
 Since the signal is detected on the 13C channel, we have employed a Lee-Goldberg 
spin-lock (11) to ensure 1H magnetization transfer to directly bonded carbons. The effective 
spin lock field is applied at the magic angle, , by applying a transverse field at a 
specific field offset such that the effective field is applied at 54.7° relative to B0. For 
example, a 50 kHz transverse field will be applied with a field offset of 35.4 kHz, resulting in 
an effective field of 62.5 kHz at the magic angle.  
 
1.3 Molecular Orientation 
 The focus of this work is the structure, orientation, and function of the M2TMP of the 
influenza A virus. The orientation of M2TMP has been studied extensively with aligned 
samples by Cross and coworkers (12, 13), where the peptide is incorporated into lipid 
membranes on glass plates, and rehydrated to form aligned bilayers. In this sample 
configuration, the lipid bilayers are aligned parallel to the magnetic field, B0, and 
consequently the molecular axes of all of the peptides are also oriented with the same angle β 
with respect to B0. Although aligned samples are excellent for orientation determination, it is 
often difficult to obtain sufficiently good sample alignment. Here we present a method of 
orientation determination, using unoriented (powder) samples that contain peptides 
undergoing fast uniaxial motion about the bilayer normal (14).  
 Each molecule in a random powder sample has an orientation relative to the magnetic 
field B0, and its NMR frequency ω is dependent upon the orientation as follows (6): 
€ 
cos−1 1 3( )
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€ 
ω(β,α) = 12δ(3cos2 β −1−ηsin2 βcos2α) +ω iso (1.7) 
where (β, α) are the polar coordinates and δ and η are the asymmetry and anisotropy 
parameters of the principal axis system (PAS) of the spin interaction tensor in the laboratory 
frame: 
  . (1.8) 
The rigid powder spectrum (dashed line) in Figure 1.4 shows an example of the anisotropic 
lineshape one would obtain for a non-spinning powder sample with η ≈ 0.  
 
Figure 1.4. Rigid powder spectrum (dashed line) overlaid with 
€ 
η = 0  motionally narrowed powder 
spectrum (red) and θ = 0° oriented spectrum. The θ = 0° edge position is the same for both the 
oriented and motionally narrowed powder spectra. 
 
Now we consider the orientation of a peptide relative to the lipid bilayer normal. For an 
aligned sample, the bilayer normal is oriented along the B0 field. In the aligned sample 
spectrum, shown in blue in Figure 1.4, the 0° frequency is dependent upon the orientation of 
the molecule relative to B0 (in terms of θ, φ) and the isotropic chemical shift: 
  
  
€ 
ω0 aligned =
1
2δ(3cos2θ −1−ηsin2θ cos2φ) +ω iso (1.9) 
Here (θ, φ) are the polar coordinates for the orientation of the PAS relative to the bilayer 
normal,   
€ 
 n . As mentioned above, we have aligned the bilayer normal along B0, thus (θ, φ) are 
also the orientation angles relative to the bilayer normal. Uniaxial rotation about the bilayer 
€ 
η =
ωy −ωx
ωz
      and      δ =ωz
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normal does not change the polar coordinates (θ, φ), and consequently does not affect the 
frequency.  
 In the case of a mobile unoriented sample, the averaged anisotropy parameter, 
€ 
δ , can 
be obtained for those liposomes with bilayer normals that are parallel to B0: 
  
  
€ 
δ =ω0 aligned −ω iso =
1
2δ(3cos2θ −1−ηsin2θ cos2φ). (1.10) 
The averaged anisotropy parameter and the averaged asymmetry parameter of 
€ 
η = 0 define 
the powder lineshape for a sample composed of uniaxially mobile molecules. The 0° edge of 
this powder lineshape is defined by (14):  
  
  
€ 
δ // = δ +ω iso =ω0 aligned  (1.11) 
which is equal to the peak of the 0° aligned sample (14). This is shown in Figure 1.4, where 
the β = 0° edge of the motionally narrowed powder pattern (red) and the 0° peak of the 
aligned sample (blue) are at the same position. The β = 90° edge of the motionally narrowed 
powder pattern is also related to the average anisotropy parameter and the isotropic shift: 
  
€ 
δ ⊥ −ω iso = −
1
2δ = −
1
2 (δ // −ω iso) (1.12) 
Since the 
€ 
δ ⊥  frequency, or 90° edge of the unoriented powder spectrum is much higher 
sensitivity than the 0° edge, we read off the 90° frequency when reporting the chemical shift 
anisotropy of a particular spectrum. 
 Once 
€ 
δ  is known, taking the averaged anisotropy parameter in Equation 1.10 with 
€ 
η = 0, we can determine the orientation θ of a molecule relative to the bilayer normal:  
  
€ 
δ // −ω iso = δ =
1
2δ 3cos2θ −1( )  (1.13) 
For dipolar and quadrupolar couplings, the ratio of 
€ 
δ  with the rigid limit δ is the bond order 
paramter, S: 
 . (1.14) 
€ 
S = δ
δ
= 12 3cos2θ −1( )
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Thus, if we measure an averaged NMR interaction for a molecule undergoing fast uniaxial 
rotational diffusion, we can divide the averaged coupling by the rigid limit coupling, which is 
generally known. This gives the order parameter S and allows for the extraction of the 
orientation angle θ. We have shown that the orientation of the NMR interaction tensor is 
directly related to the order parameter, S. In this work we have measured heteronuclear 
dipolar couplings, quadrupolar couplings, and chemical shift anisotropies of a uniaxially 
diffusing peptide, and using the bond order parameter we are able to measure the orientation 
of the peptide relative to the bilayer normal in an unoriented liposome sample.  
 
1.4 Motional Amplitude and Rates of Diffusion 
 It has been mentioned in the preceding section that the chemical shift anisotropy 
narrows for a uniaxially mobile molecule. However, only if a molecule is undergoing 
diffusion at a rate faster than the NMR interaction being measured will the observed coupling 
be smaller than the rigid limit. Not all NMR interactions are created equal, and this is 
reflected in the size of the interaction, otherwise known as the coupling strength. The largest 
coupling that we have observed in this work is the 2H quadrupolar coupling with a rigid limit 
of about 120 kHz. This can be contrasted with 13C-1H dipolar coupling of about 22 kHz, and 
15N-1H dipolar coupling of about 11 kHz. Chemical shift anisotropy for Cα spans 20-40 ppm 
giving a coupling of 2-6 kHz, for fields ranging from 400-600 MHz. 15N gives chemical shift 
anisotropy spans 20-70 ppm for a range of couplings from 2-10 kHz depending on B0. Rates 
of rotational diffusion are discussed in detail in Chapters 3 and 8. Here we will present the 
methods for measurement of 2H quadrupolar and heteronuclear dipolar couplings, and the 
interpretation of motionally narrowed couplings for uniaxially mobile proteins.  
 
2H Quadrupolar NMR 
 Measurement of 2H quadrupolar coupling is a convenient method for the observation 
of molecular motion and motional amplitude. 2H-labeled amino acids are readily available 
from stable isotope suppliers, and we have measured methyl-deuterated leucine and alanine 
residues in the peptide. The rigid limit 2H quadrupolar coupling is significantly larger than 
the dipolar or J-couplings observed in spin-1/2 nuclei, but it is small when compared with the 
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large quadrupolar couplings observed for nuclei such as 85Rb and 25Mg (15). Figure 1.5 
shows the quadrupolar echo pulse sequence used to acquire static 2H spectra, where two 90° 
pulses sandwich two adjustable delay times τ1 and τ2. Here, τ2 is usually 6-10 µs less than τ1. 
The quadrupolar echo experiment (16) is different from a Hahn echo experiment (10) in that 
it refocuses Hamiltonians that are bilinear (6). The two 90° pulses must be 90° out of phase, 
as shown in Figure 1.5.  
Since the 2H lineshape is very broad, it may be necessary to manually adjust τ1 and τ2 
to obtain a flat baseline after acquisition by left-shifting the FID any number of points. This 
is attainable when τ2 < τ1, thus causing the acquisition to begin before the echo maxima. 
Theoretically the number of left shift points can be calculated as  (τ1- τ2)/dwell time, where 
dwell time is the time in between digitized points in the FID. However, the empirical value 
that gives the best baseline may be slightly different from the calculated value.  
 
Figure 1.5. Quadrupolar echo pulse sequence. The τ2 time is generally 6-10 µs less than τ1 so that 
acqusition begins before the echo maxima, and the detected FID can be adjusted using left shift.  
 
The rigid limit 2H quadrupolar coupling is approximately 120 kHz, as shown for the 
CD2 spectrum in Figure 1.6(c). However, when a methyl group is deuterated, the CD3 
deuterons undergo a three-site jump on the order of 3 x 109 Hz (17), which is much faster 
than the rigid quadrupolar coupling of 120 kHz. Since a methyl group has tetrahedral 
geometry, the deuterons are rotating at an angle of 109.5° with respect to the motional axis, 
which can be inserted Equation 1.14, giving an order parameter S = 0.34. Thus, the CD3 
lineshape is narrowed by ~1/3 relative to the rigid limit coupling, as shown in Figure 1.6(b).  
In the protein, we have selectively replaced alanine residues with CD3-alanine, so we 
now have a CD3 group that is directly bonded to the peptide backbone. The average 
quadrupolar tensor for the CD3-alanine residue is along the alanine Cα-Cβ bond, as shown in 
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Figure 1.7. Alanine has no χ1 or χ2 angle, so any observed motional narrowing in Figure 
1.6(a) is due to uniaxial rotation of the Cα-Cβ bond, most likely about the bilayer normal. 
Since the average quadrupolar tensor is along the Cα-Cβ bond, we can now calculate the 
angle θ between the bond and the bilayer normal. This is achieved by taking the motionally 
averaged 2H coupling as shown in Figure 1.6(a) divided by the rigid limit CD3 splitting of 
about 40 kHz, which gives the Cα-Cβ bond order parameter S as defined by Equation 1.14. 
The measurement of 2H quadrupolar coupling of CD3- alanine labeled peptides is a useful test 
to determine if a peptide is undergoing fast uniaxial motion. If this is the case, we can 
continue with peptide orientation measurements, which are detailed in Chapters 3 and 4.  
 
Figure 1.6. Comparison of 2H quadrupolar couplings for (a) a motionally averaged deuterated methyl 
(CD3) group, (b) a deuterated methyl group in a rigid crystalline molecule, and (c) a deuterated 
methylene group (CD2) in a rigid molecule.  
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Figure 1.7. Methyl-deuterated (CD3) alanine. The average quadrupolar tensor is along the Cα-Cβ 
bond, and the orientation of the bond relative to the bilayer normal can be calculated.  
 
Heteronuclear Dipolar Coupling 
 The measurement of heteronuclear dipolar couplings has proven to be an important 
technique throughout this work. In addition to 2H quadrupolar couplings, it has been used 
extensively to measure peptide motional amplitude and orientation, and these measurements 
are shown in Chapters 3, 4 and 8. Since the 2H quadrupolar spectrum is quite broad, it is 
difficult to obtain site-resolved coupling measurements. Additionally, in a traditional 1D 
magic-angle spinning experiment, the dipolar coupling is averaged out over the rotor period. 
Thus we require a pulse sequence that recouples the heteronuclear interaction by interfering 
with the magic angle spinning dipolar averaging. Here we demonstrate the direct, site-
resolved measurement of multiple 1H-15N or 1H-13C dipolar couplings for orientation 
determination  
A separated-local field 2D experiment in which chemical shift is detected in one 
dimension and dipolar coupling in the other was first developed by Munowitz, et al. (18) and 
has been modified by Hong, et al. (19) so that the dipolar couplings can be quantum-
mechanically “doubled” in order to achieve greater dipolar coupling resolution among sites. 
This pulse sequence is referred to as dipolar doubled DIPSHIFT. This more recent pulse 
sequence is used to measure 1H-13C and 1H-15N dipolar couplings in protein samples 
throughout this work.  
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 We have chosen to measure the 1H-X dipolar couplings of backbone 15N and 13Cα for 
two reasons. First, the 1H-X bond should have a fixed orientation relative to the peptide 
backbone that is not subject to torsional motions, given that the only peptide motion is fast 
uniaxial rotational diffusion. Second, the presence of only one directly bonded 1H makes the 
analysis of dipolar coupling uncomplicated.  
The pulse sequence for dipolar doubled DIPSHIFT is shown in Figure 1.7. The first 
180° pulse occurs during homonuclear 1H-1H decoupling, and this doubles the 1H-X dipolar 
interaction. 1H-1H homonuclear decoupling is applied in order to ensure that only the directly 
bonded 1H contributes to the dipolar coupling measurement. The second 180° refocuses the 
chemical shift interaction, which is also doubled during the first 180° pulse. The two 180° 
pulses are rotor-synchronized and occur at the same time during two subsequent rotor 
periods. The final experiment consists of a series of 1D spectra obtained for several t1 
increments, and the intensity of the peak of interest can be plotted as a function of t1. 
 
 
Figure 1.7. Dipolar doubled DIPSHIFT pulse sequence.  
 
1.5 Chemical Shift Correlation 
 It is well known that 13C chemical shift for Cα, Cβ and CO resonances in the protein 
backbone are very sensitive to protein secondary structure (20). Figure 1.8 shows the 
chemical shift difference between α-helical and β-sheet peptides. It can be observed that the 
Cα chemical shift for the β-sheet peptide is more upfield than the α-helical peptide, and the 
opposite situation is true for the Cβ chemical shift. CO chemical shift follows a trend similar 
to Cα. Since the M2 transmembrane peptide (M2TMP) forms relatively stable α−helicies in 
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lipid bilayers (21), it is not the main goal of this project to determine the secondary structure 
of the peptide. Rather, we hope to observe chemical shift perturbations upon binding drug to 
the channel in order to pinpoint areas most affected by drug binding.  
In order to measure 13C chemical shifts, several methods can be employed. The 
simplest and most common for organic chemists in the solution state would be a 1D 13C 
spectrum. However, since solid-state NMR samples typically have broad lines, and amino 
acids in peptides do not have a large range of chemical shifts, spectral overlap is an issue and 
the importance of 2D correlation experiments becomes apparent.  
 
 
Figure 1.8. Leucine Cα and Cβ chemical shifts shown for a β-sheet protein (KL10) and an α-helical 
protein (KvAP). (Figure courtesy T. Doherty) 
 
2D 13C-13C Correlation Under 13C-1H Dipolar Assisted Rotary Resonance (DARR) 
 A simple 2D 13C-13C correlation experiment with high sensitivity the 13C-1H dipolar 
assisted rotatry resonance or DARR experiment (22). This method of polarization transfer 
combines both a 1H-driven and rotor-driven mechanism. This results in spectral broadening 
of both the 1H-1H and 13C-1H interactions, and increased spectral overlap and magnetization 
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transfer (22). The 13C-1H dipolar coupling is recoupled by applying a weak 1H rf pulse at the 
rotor frequency during the chemical shift evolution and mixing times, as shown in Figure 1.9. 
Spinning speeds for the 4 mm rotor are typically in the 5-8 kHz regime and 
€ 
γB1 /2π of the 
corresponding DARR recoupling pulses equals νr. This contrasts with a typical 1H 
heteronuclear decoupling pulse in the 50-83 kHz regime. Due to the weak field of the 13C-1H 
recoupling pulse, the mixing time tm can be as long as 50 ms, resulting in the observation of 
many long range contacts in the final spectrum. 
 
 
Figure 1.9. Pulse sequence for proton driven 13C-13C spin diffusion experiment with 13C-1H dipolar 
assisted rotary resonance decoupling.  
 
2D 13C-13C Correlation with Double-Quantum Filtration 
 Although the DARR experiment has high sensitivity and produces a spectrum with 
many long-range correlations, it is also desirable to have a 13C-13C correlation experiment that 
selectively recouples only those 13C spins that are directly bonded to another 13C. Moreover, 
since the peptides studied are typically bound to a lipid membrane at a ratio of one peptide to 
fifteen or twenty lipids, the natural abundance 13C signals from the lipid can be the dominant 
feature in both 1D and 2D spectra. The peptides have been selectively labeled with uniform 
13C, 15N amino acids for specific residues, but the lipid contains just 1% natural abundance 
13C dispersed randomly throughout the molecule. Thus, the probability that a 13C spin will 
have a one-bond 13C neighbor in the peptide is 99% (the typical level of enrichment for 
isotopically labeled amino acids), whereas this probability drops to 1% in lipid molecules. 
Therefore, selective filtering by recoupling only those 13C spins bonded to other 13C removes 
all observable lipid signals from the spectrum.  
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 In order to achieve double-quantum recoupling, we have used the SPC-5 pulse 
sequence (23), which is a broadband homonuclear recoupling sequence. This pulse sequence 
has many predecessors (24, 25), which similarly include a rotor-synchronized radiofrequency 
field and a symmetric pulse. Compared with other double-quantum recoupling sequences, 
SPC5 has the advantage that the recoupling rf field strength is only ν1 =5νr, thus making the 
requirement of 3*5νr for 1H decoupling field more attainable for probe with larger coils, i.e. 4 
mm rotor size. For example, most SPC-5 experiments in this work are conducted at νr=7 
kHz, thus requiring a 13C-13C recoupling field of 35 kHz and 1H decoupling strength of 105 
kHz during homonuclear recoupling. Experimentally, 1H decoupling in the range of 71-83 
kHz is more than adequate for obtaining maximum transfer efficiency on our equipment.   
 
 
Figure 1.10. Double quantum 13C-13C correlation pulse sequence.  
 
2D 15N-13C Correlation Experiments 
 Although 15N is an NMR spin of low natural abundance and generally of low 
sensitivity, the use of 13C, 15N labeled proteins allows us to measure 13C-15N heteronuclear 
correlation spectra, or CN HETCOR. Unfortunately, due to the weak 13C-15N dipolar 
coupling, it is difficult to achieve much more than one or two bond correlations. Particularly 
in this work, the 15N chemical shift has proven to be extremely sensitive to local 
conformation changes. 15N chemical shifts for helical proteins are not well-resolved, with the 
15N shifts for most amino acids falling around 117-124 ppm. Thus, a 2D correlation 
experiment is useful in separating 15N chemical shifts and observing chemical shift changes.  
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Figure 1.11. 2D 13C-15N HETCOR pulse sequence for a REDOR-like CN magnetization transfer.  
 
The pulse sequence shown in Figure 1.11 is the 2D HETCOR experiment (26) using a 
REDOR-type (27) 13C-15N magnetization transfer through dipolar recoupling. The 15N 
chemical shifts are encoded during the t1 period. Here it is possible to measure inter- and 
intra-residue contacts due to the through-space dipolar recoupling that is achieved by the 
180° pulses. However, as mentioned above, weak 13C-15N dipolar couplings prohibit long-
range couplings from being measured.  
 
1.6 Thesis Organization 
  This thesis is composed mainly of published journal papers on the structure, 
orientation and dynamics of the M2 transmembrane peptide of the influenza A virus. Some 
papers contain supplementary information that was only published in the online edition of the 
journal, and this data is located at the end of its respective chapter.  
Chapter 1 has covered important facets of NMR methodology and has also offered a 
brief overview of the techniques used for the study of membrane protein structure and 
dynamics in subsequent chapters. Chapter 2 is a review article that compiles the body of 
knowledge that is currently about the influenza A M2 protein structure, orientation, 
dynamics, and the interaction with the anti-influenza drug amantadine. The different crystal, 
micelle and membrane-bound structures of M2 will be discussed. The debate regarding the 
location of the amantadine block and the mechanism of H+ transport through the channel will 
also be reviewed. In Chapter 3, we show that M2TMP undergoes fast uniaxial motion in a 
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model phosphocholine lipid bilayer, and use this physical property to show that the 
orientation of M2TMP is dependent on membrane thickness. This is achieved through the 
measurement of motionally narrowed 2H and 15N static lineshapes and N-H dipolar 
couplings.  Different sample preparation techniques and the effect they have on the rotational 
diffusion of the peptide will also be discussed.  In Chapter 4, we use the motionally scaled N-
H dipolar couplings to measure the orientation of a peptide relative to the bilayer normal in 
an unoriented sample with several uniformly labeled residues. In Chapter 3, we had only one 
15N labeled residue per sample due to the need to measure static 15N chemical shift 
anisotropy. However, through the use of 13C detection of N-H dipolar couplings, we are able 
to measure multiple motionally reduced couplings at once. The couplings are plotted on a 
dipolar wave, which gives the same information regarding peptide orientation as the 
CSA/dipolar coupling correlated plots discussed in Chapter 3.  
In Chapter 5, we begin to discuss the implications of adding the anti-influenza drug 
amantadine to membrane-bound M2TMP. Through the use of a variety of 13C-13C and 13C-15N 
correlation techniques, we show significant chemical shift changes occur at several key sites 
along M2TMP upon amantadine addition. We also show that amantadine increases 13C T2 
times and propose that the increased 13C T2 is due to a more homogeneous tetramer bundle 
that is stabilized by amantadine. Chapter 6 extends this work by studying the amantadine-
induced chemical shift changes of three more residues, including the proposed binding site 
Serine 31. We observe large chemical shift changes at S31 for both 13C and 15N, and from the 
chemical shifts measured for the amantadine-bound and apo peptide, we construct a model 
using chemical shift-constrained torsion angle calculations using computer simulations. This 
structure was deposited in the Protein Data Bank with accession number 2KAD.  
Chapter 7 extends the idea of chemical shift dependence of torsion angles from 
protein backbones to sidechains.  The chemical shift difference of stereospecifically assigned 
methyl groups valine γ1/γ2 and leucine δ1/δ2 was analyzed for several protein structures 
deposited in the Protein Data Bank. This chemical shift difference was correlated with 
sidechain rotamer, and a data trend indicates that the difference in methyl chemical shift is 
correlated with the sidechain torsion angle. This analysis is applied to several valine and 
leucine sidechains measured in M2TMP with and without amantadine. We show that 
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chemical shift and direct torsion angle measurement techniques indicate the same sidechain 
torsion perturbation for Val 27 and Val 28 upon amantadine addition.  
Chapter 8 analyzes the observed dynamics changes of M2TMP upon amantadine 
addition. In previous chapters we have shown that M2TMP is undergoing fast uniaxial 
rotational diffusion in hydrated DLPC bilayers, and we have also observed that 13C 
linewidths are narrowed upon the addition of amantadine. To understand the origin of 13C 
line narrowing, the 1H T1ρ was measured at several temperatures for eleven uniformly labeled 
residues in M2TMP. From these variable temperature measurements, we are able to extract 
the activation energy and correlation times of M2TMP in the lipid bilayer. It is shown that 
the diffusion correlation time of amantadine-bound M2TMP is reduced relative to the apo 
state, and also that the peptide has an increased activation energy for the diffusion process. 
Finally, three appendices are located at the end of the thesis.  Appendix A covers the 
synthesis of 15N labeled amantadine in great detail. Appendix B covers the 207Pb temperature 
calibration experiments that were conducted on the 4 mm probe on the 600 MHz machine. 
Lastly, Appendix C covers the sample transfer technique for hydrated liposome samples.   
 
1.7 Copyright Permission 
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Abstract  
 The M2 protein of influenza A viruses forms a tetrameric pH-activated proton-
selective channel that is targeted by the amantadine class of anti-viral drugs. Its ion channel 
function has been extensively studied by electrophysiology and mutagenesis; however, the 
molecular mechanism of proton transport is still elusive, and the mechanism of inhibition by 
amantadine is controversial. We review the functional data on proton channel activity, 
molecular dynamics simulations of the proton conduction mechanism, and high-resolution 
structural and dynamical information of this membrane protein in lipid bilayers and lipid-
mimetic detergents. These studies indicate that elucidation of the structural basis of M2 
channel activity and inhibition requires thorough examination of the complex dynamics of 
the protein and the resulting conformational plasticity in different lipid bilayers and lipid-
mimetic environments.  
 
A. Function of the M2 proton channel of influenza A viruses 
 The M2 protein of influenza A and B viruses forms tetrameric proton channels that 
are important for the viral life cycle. After the virus enters the infected cell by endocytosis, 
the M2 proton channel opens in response to the low pH of the endosome, allowing proton 
flux into the virus, which triggers the dissociation of the viral RNA from the matrix proteins 
and the fusion of the viral and endosomal membranes. These events release the viral RNA to 
the cytoplasm for replication by the host cell (1). In a later stage of virus replication, the M2 
protein maintains the high pH of the trans-Golgi network and prevents premature 
 25 
conformational changes of hemagglutinin in viruses with a high pH optimum of 
hemagglutinin-induced fusion (2).  
 The influenza A M2 (AM2) protein contains a short N-terminal periplasmic domain, 
a transmembrane (TM) domain, and a C-terminal cytoplasmic tail (Figure 2.1). It is one of 
the smallest ion channel proteins and thus an excellent system for elucidating the structure-
function relation of ion channels. Extensive mutagenesis, electrophysiology (3, 4) and 
sedimentation equilibrium experiments (5) have been conducted to characterize the function 
and stability of AM2 (for recent reviews, see (6, 7)). The AM2 proton channel is also the 
target of the amantadine class of drugs, one of only two anti-influenza drugs currently 
available. However, the efficacy of amantadine dropped by two orders of magnitude since 
2002, mainly due to the S31N mutation in the TM domain (8). Thus, elucidating the 
mechanism of amantadine inhibition of AM2 has great public health relevance.  
 
 
Figure 2.1. Amino acid sequence of influenza A/Udorn/72 M2 protein. The TM domain containing 
the crucial His37 and Trp41 residues (red) are underlined.  
 
 Recently, several high-resolution structural studies have been carried out to determine 
the structural basis of AM2 proton conductance and inhibition. In this article, we summarize 
the main functional data of AM2 and high-resolution structural information available on the 
TM domain, to promote future investigations of this intriguing and far from understood 
membrane protein.  
 
Proton transport, selectivity, and activation. The proton conductance of AM2 has been 
well studied both in vivo and in vitro since its discovery as an ion channel (3). The gold 
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standard of M2 functional assays is the replication of live viruses in infected cells, followed 
by the “silver standard” of whole-cell conductance data in Xenopus laevis oocytes. The wild-
type protein is activated below pH 6.2 and its current is sensitive to amantadine. The single-
channel activity under a -130 mV voltage is ~0.16 µA/ng protein at pH 6.2 for the 
A/Udorn/72 strain of M2 (4), which corresponds to 12 aA per channel or a conductance of 
~100 aS. Extraction of single-channel currents requires quantification of the amount of 
protein, and the assumption that all proteins form open channels or the knowledge of the 
fraction of open channels.  
 For in-vitro liposome assays, several additional factors such as the orientation of the 
protein in the membrane, the size and buffering capacity of the liposomes, and the fluxes of 
other monovalent ions (Na+ and K+) can affect the measured conductance. One of the most 
reliable liposome assays employed an intravesicular pH-sensitive dye to measure proton 
fluxes, and obtained a single-channel current of 2.7 aA at pH 5.7 and 18˚C (conductance = 29 
aS) for full-length M2 in DMPC/DMPS vesicles (9). These values agree well with the oocyte 
result (4). Several other liposome assays gave more divergent values due to different 
experimental designs and protein constructs (10-12). However, the general consensus is that 
the single-channel conductance of M2 ranges from tens of aS to a few hundred aS, indicating 
low transport rates of ten to several hundred protons per second at mildly acidic pH. It is 
thought that the low currents are a result of the low physiological proton concentration (9), 
although the idea that M2 may have some characteristics of transporters has also been 
proposed (13).  
 There is general consensus that AM2 is selective for protons over Na+ and K+ by a 
factor of 1.5–3.0 x 106 (9, 14, 15), and that the increased proton current at low exterior pH 
(pHout) is due to true activation of the channel rather than mere mass action, since increased 
pHout stops the outward current of acidified cells (15, 16). The site of activation is His37, the 
only residue in the TM domain that can be protonated within the relevant pH range. Mutation 
of His37 to either Gly or Glu results in channels that are no longer modulated by pHout (17). 
Solid-state NMR (SSNMR) studies of His37 in the TM peptide M2(22-46) suggest that it is 
the third protonation at pH 6.3 that opens the channel (18).  
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His37 selectivity filter and Trp41 gate in the TM domain. His37 and Trp41 are the two most 
conserved residues in the M2 protein of influenza A strains (19) and are essential for channel 
function. His37 protonation is responsible for the activation and selectivity of the channel. The 
wild-type (WT) A/Udorn/72 M2 protein has 50-fold conductance difference between pHout of 
4.5 and 8.2. In contrast, many His37 mutants, while still forming channels, are toxic to 
oocytes and have pH-independent currents, indicating non-specific conductance of other 
cations (17). These mutants can be neither activated effectively by low pHout (H37G, H37S 
and H37T) (20) nor inactivated by high pHout (H37G, H37E and H37A) (17). The mutant 
channels are not proton selective and are only partially and reversibly blocked by amantadine 
(20), in contrast to the WT protein (16). Analytical ultracentrifugation (AUC) experiments 
indicate that H37A and H37F mutants are about 3.1 and 1.8 kcal/mol less stable than the WT 
peptide in DPC micelles (21). 
 When a high concentration of imidazole buffer is added to the bathing solution, 
proton-selective conductance and gating are partially restored to the His37 mutants (20). This 
chemical rescue is specific to imidazole and does not require interaction with Trp41. Thus, 
His37 was proposed to be an intermediate proton acceptor and donor, consistent with SSNMR 
titration data of the TM peptide (18).  
 The M2 proton channel responds exclusively to external pH: low pHout activates the 
channel and high pHout closes the channel, regardless of the interior pH. Mutagenesis data 
indicates that Trp41 acts as the gate in concert with His37 (22). At high pHout and low pHin, the 
WT protein does not exhibit outward current while W41A/C/F mutants do, indicating loss of 
gating by the mutants (22). Further, intracellular Cu2+ inhibited the open W41A channel but 
not the WT channel, indicating that Trp41 shields His37 from coordination by Cu2+ (22, 23). 
These data suggest that the indole rings adopt distinct conformations at different pHout to 
obstruct or open the pore. Resonance Raman data indicate that the Trp41 conformational 
change must be small to keep its environmental hydrophobicity unchanged (24). Concerted 
conformational changes seem necessary for His37 to act as the selectivity filter and Trp41 as 
the gate. Compared to His37, the two Trp41 mutants that abolish gating (W41A and W41F) 
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(22) actually have enhanced tetramer stability in DPC micelles (21), indicating that this 
residue has evolved for function rather than stability.  
 
Mechanism of proton transport. Molecular dynamics (MD) simulations have been used 
extensively to study the M2 proton transport mechanism. The basic premise is that protons 
hop along a water wire via the Grotthuss mechanism, but the water wire is broken at the 
narrow His37 constriction (and possibly other locations along the channel). Thus, the 
mechanism of proton passage through the His37 tetrad is the central question. Two main 
models have been proposed: the gating model and the shuttle model. In the gating model, 
protonation of the His37 tetrad at low pH causes pore opening by electrostatic repulsion, so 
that a continuous water wire is formed (25). Conformational changes of the His37 and 
possibly Trp41 are necessary in this model. MD simulations suggest that a 60˚ change of the 
His37 χ2 angle may be sufficient to open the pore (26), and the excess proton may form a 
Zundel complex with two water molecules on the extra- and intracellular side of the histidine 
rings (27, 28). Early MD simulations postulated various charged states of His37 for channel 
activation (29). However, with SSNMR data indicating the third protonation of the His37 
tetrad to be responsible for channel opening (18), recent simulations confirmed that the +3 
state has the lowest proton permeation free energy (30). The channel water molecules that 
transport the protons were calculated to have three-fold lower diffusion coefficients than bulk 
water (27, 31). 
 The second proton transport model is the shuttle model, where the imidazole nitrogen 
facing the extracellular side binds one proton to form a biprotonated intermediate, then the 
other nitrogen releases the proton on the intracellular side and returns the imidazole to the 
neutral form (32). The initial state is then recovered by tautomerization or ring flip of the 
imidazole. This model explains the low proton transport rate and low-pH saturation of the 
channel, since both would be associated with the limiting rate of His37 sidechain torsional 
motion or tautomerization.  
 Simulations of the protein conformation at different pH also shed light on the 
mechanism of proton transport. One proposal is that in addition to His37, Val27 may act as a 
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secondary gate that breaks the water wire, especially in the presence of amantadine (33). The 
two gates may not be static but instead may move synchronously in response to His37 
protonation: at high pH the Val27 region opens while the His/Trp region narrows, and the 
opposite is found at low pH (13). Thus, instead of equating high pH with the closed state and 
vice versa, these simulations suggest a more complex view of an Openout-Closedin 
conformation at high pH and Closedout-Openin conformation at low pH. This model reconciles 
the different helix orientations and packing in different high-resolution structures (34-37).  
 
Inhibition of the AM2 channel. Three classes of M2 inhibitors have been identified so far: 
the adamantane analogs (38, 39), the spirene-containing compounds (40), and Cu2+ ions. The 
FDA approved amantadine achieves its antiviral effect by inhibiting the M2 proton channel 
activity (3): 100 µM amantadine nearly irreversibly blocks > 90% of the channel activity of 
A/Udorn/72 (H3N2) M2 in several minutes at both acidic and neutral pH (16, 41, 42). For 
some other influenza strains the amantadine block is stronger at neutral pH than at low pH 
(16). The Hill coefficient of the amantadine block is 1, consistent with the scenario that a 
single drug inhibits each functional channel (16).  
 Naturally occurring mutations in the TM domain that confer amantadine resistance 
include L26, V27, A30, S31, and G34, all N-terminal to G34 (8, 38, 43, 44) (Figure 2.1). 
Extensive whole-cell conductance studies have been carried out on these mutants. S31N, the 
most common resistant mutant (8), has an IC50 of 199.9 µM, more than ten times higher than 
that of the WT (IC50 = 16 µM) (41). The resistance is not due to altered channel activity, as 
S31N has very similar specific activity and acid activation as the WT (4, 42). L26F has ~35% 
higher channel activity than S31N but is more sensitive to amantadine (42). G34E has a 3-
fold higher specific activity than S31N and is about 5-fold less sensitive to amantadine than 
S31N (4). V27 mutants have mixed phenotypes: V27A and V27S are amantadine resistant 
but V27T is amantadine sensitive, and all V27 mutants have significantly increased (~ 3 fold) 
channel activities than WT (4). In contrast, the A30T mutant has a greatly reduced but still 
detectable activity, while the A30P mutant is inactive (4). Thus, residue 30 appears to be 
important for maintaining a functional structure of the protein. Among the resistant mutants, 
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S31N was found by thiol-disulfide exchange experiments to be stable in both bilayers and 
micelles (42), suggesting a reason for its dominance in current flu strains that is independent 
of the selective pressure of amantadine. The stability and similar channel activity of S31N to 
the WT protein argue against the model that the S31N variant is resistant to amantadine by 
destabilizing the closed state and favoring the open state of the channel (45). The latter 
hypothesis was made based on the larger NMR linewidths of S31N than WT proteins in the 
presence of rimantadine. However, since S31N does not bind rimantadine, the correct 
comparison should be between S31N and the apo WT protein, which is known to exhibit 
broad linewidths as well.  
 In the C-terminal region of the TM domain, L38F, W41A, and D44A mutants 
incorporated into influenza viruses showed similar growth as the WT protein in infected 
cells, and the growth is sensitive to amantadine (41) (despite the fact that the W41A mutant 
does not gate properly (22)). Electric recordings in oocytes indicate that the IC50 of D44A is 
15.8 µM, indistinguishable from the WT protein. Thus, no amantadine-resistant mutations 
have been found C-terminal to G34, implicating the segment between L26 and G34 to be the 
amantadine-binding region (41). Further, when residues 6-18 of the amantadine-insensitive 
BM2 were replaced by AM2 residues 24-36, the chimeric protein showed amantadine-
sensitive currents in oocytes (41), strongly indicating that the C-terminal region of the AM2 
TM helix is not required for amantadine binding. In contrast, a recent liposome proton flux 
assay of M2(18-60) found the D44A mutant to be resistant to rimantadine while the S31A 
mutant to be sensitive, supporting a C-terminal binding model (34, 45). This liposome assay 
result is in serious contradiction with the finding from the “gold standard” assay that 
replication of live virus bearing the D44A mutation is inhibited by rimantadine (41).  
 The second class of M2 inhibitors are spirene-containing compounds, initially 
discovered from a growth impairment assay where the M2 toxicity to yeast cells due to its 
proton channel activity is reversed by inhibitors (40). The first compound, BL-1743 (2-[3-
azaspiro(5,5)undecanol]-2-imidazoline), has similar inhibition rate, Hill coefficient, and 
spectra of resistance as amantadine (46). However, BL-1743 inhibition is reversible (~12 
minutes) while amantadine block is irreversible on the experimental time scale (~30 
minutes). BL-1743 also differs from amantadine in its interaction with I35: the I35T mutant 
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is resistant to BL-1743 but is reversibly inhibited by amantadine (46). The cause of this 
difference is suggested by a recent SSNMR study of the analogous spirene-piperidine 
compound, 3-azaspiro (5,5) undecane hydrochloride (IC50 = 0.92 µM) (47). This compound 
reduces the dynamic disorder of the G34-I35 backbone of AM2, suggesting that spirene-
amine inhibitors bind more extensively and strongly with the TM helices than the 
adamantane inhibitors.  
 
B. High-resolution structure of AM2 TM domain 
Orientation of the TM helices in lipid bilayers. The TM peptide of AM2 has been a prime 
target for high-resolution structure investigation by a number of biophysical techniques. Both 
global structural information such as helix orientation and site-specific information of key 
residues have been obtained. The orientation of the TM helices in lipid bilayers has been 
extensively studied by SSNMR, EPR and IR techniques. The majority of SSNMR studies 
measured orientation-dependent 15N tensors on glass-plate aligned M2(22-46) (37, 48-51) 
and to a small extent on aligned full-length M2 (52, 53). From 1D 15N chemical shift 
anisotropies (CSA), Cross and coworkers obtained a helix tilt angle of 33˚-37˚ for M2(22-46) 
in DMPC bilayers (49, 50) and 33˚ in DOPC bilayers. 2D NMR spectra correlating 15N-1H 
dipolar couplings and 15N CSAs gave more precise orientational constraints, including both 
the tilt angle (τ) and the rotation angles (ρ) of individual residues. From these 2D spectra, the 
tilt angle of apo M2(22-46) in DMPC bilayers was refined to 38˚ (51), while the rotation 
angles are consistent with the pore- or lipid-facing positions of residues inferred from 
functional data (PDB: 1NYJ).  
 Prior to 2001, the oriented NMR studies were conducted on peptides that were first 
mixed with lipids in organic solvents before hydration. These samples were not pH 
controlled and may be acidic due to residual TFA. After 2001, the oriented membranes were 
prepared by an aqueous protocol where M2 was reconstituted into lipid bilayers by detergent 
dialysis at controlled pH before alignment on glass plates. The amantadine-bound M2(22-46) 
and the full-length M2 were studied in this way. In DMPC/DMPG lipid bilayers, the 2D 
spectra of uniformly 15N-labeled full-length M2 at pH 8.0 showed a TM helix with a 25˚ tilt, 
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which is smaller than the tilt of the TM peptide alone, and an 80˚ tilted helix, which is 
attributed to an amphipathic helix C-terminal to the TM domain (52). Hydrogen/deuterium 
exchange of full-length M2 showed that the TM helix underwent fast H/D exchange, 
consistent with its participation in forming an aqueous pore, while the 80˚-tilted helix resisted 
H/D exchange, indicating that it is shielded from water. Full resonance assignment is 
necessary to elucidate the orientation and depth of this C-terminal amphipathic helix.  
 Upon amantadine binding, M2(22-46) exhibits a pronounced kink at G34 in DMPC 
bilayers, with a tilt angle of 31˚ for the N-terminal segment and 20˚ for the C-terminal 
segment (PDB: 2H95) (Figure 2.5a) (48). While it is tempting to conclude that amantadine 
caused this kink, the bound peptide spectra were obtained from aqueous prepared samples at 
pH 8.8, under which condition there is no comparable apo peptide data. It is thus possible 
that the kink may already be present in the apo state, especially given the known propensity 
of Gly to perturb α-helices. Indeed, other high-resolution structures of AM2 suggest a G34 
kink already in the apo state. For example, MAS-NMR data of DLPC-bound M2 suggest a 
kink of 5° for the bound peptide and 8˚ for the apo peptide (36), while the crystal structure of 
apo M2 at neutral pH shows a distribution of helix kink angles (35).  
 Direct comparison of the orientation of apo and amantadine-bound M2(22-46) 
prepared under the same conditions was reported recently (54). Using unoriented DLPC 
vesicles and dialysis reconstituted M2(22-46), Hong and coworkers determined the helix 
orientations by exploiting the uniaxial diffusion of the helical bundles around the bilayer 
normal. The N-terminal half of the TM segment was found to have a tilt angle of 35˚ in the 
apo state and a slightly larger tilt of 38˚ in the amantadine-bound state (55) (Figure 2.5d), 
indicating that the drug slightly enlarges the pore vestibule.   
 The TM helix orientation is also sensitive to membrane thickness. EPR spectra of N-
terminus nitroxide labeled M2(22-46) reconstituted into DLPC, DMPC, DOPC, and POPC 
bilayers showed the least dipolar broadening in the thinnest DLPC membrane and the 
strongest broadening in the thickest POPC membrane (56). The broadening is attributed to 
shorter interhelical distances as the peptide decreases its tilt angle in the thicker membrane. 
The orientational change was detected directly in SSNMR spectra of unoriented M2(22-46). 
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The TM helices showed a tilt angle of 35˚ in DLPC bilayers but a much smaller angle of 26˚ 
in the thicker POPC bilayers (54). These results are consistent with AM2 adjusting its TM 
helix orientation to minimize the hydrophobic mismatch with the lipid bilayer, as also 
observed for other membrane peptides (57, 58). These results revise an earlier conclusion 
that the M2 helix orientation is intrinsic to the peptide and unaffected by the membrane (50), 
made based on the fortuitously similar orientations of the peptide in DMPC and DOPC 
bilayers because of the similar thickness of these two bilayers.  
 The SSNMR and EPR orientational studies do not detect evidence of rotational angle 
change of M2 by pH: both the organic-solvent prepared samples, which likely have acidic 
pH, and the aqueous samples at high pH, gave the same rotation angles. These results are 
consistent with the functional requirement for a hydrophilic pore. Distances between the 
Trp41 indole 5-19F of neighboring helices were also found to be the same (11.8 Å) at pH 7.5 
and pH 4.5 (Figure 2.2), consistent with the lack of ρ change (59). Thus, it is surprising that a 
recent IR study of M2(22-46) in DMPC bilayers reported a one-residue (100˚) rotation of the 
helices between low and high pH (60). The ρ angle of the low pH samples was found to 
agree well with early SSNMR data (37, 51) while that of the high pH samples differ by 
~100˚. When the ρ angles were combined with the +3 protonated His37 tetrad, MD 
simulations found that the rotated helices reduce His37 exposure to water at high pH, thus 
rationalizing channel closure (61). The ρ angles were extracted from diagonal linewidths of 
2D IR spectra, which reflect the electrostatic environment of the 13C=18O groups, the main 
contributor of which is thought to be the water contact. However, the 2D lineshape analysis 
requires the distinction of homogeneous and inhomogeneous linewidths, consideration of 
population relaxation times, and consideration of water-independent electrostatic effects such 
as hydrogen bond network of the peptide. Thus the origin of the diagonal linewidth change is 
complex. In addition, linear FT-IR dichroism data for the high pH samples reported in this 
work do not show a clear sinusoidal dependence with the residue number, casting further 
doubt on the high pH ρ angle result (60).  
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Tetramer stability and packing. In mammalian cells and oocytes the functional state of M2 
is tetrameric, as shown by sucrose gradient, chemical cross-linking (62) and conductance 
experiments (5). In detergents and lipid bilayers, the TM peptide retains the tetrameric state 
under a wide range of conditions, and the monomer-tetramer equilibrium is readily shifted by 
membrane thickness, pH, amantadine binding, cholesterol, and amino acid sequence. The 
environmental effects on the free energy of tetramer association have been the focus of study 
using AUC in micelles (21, 63) and thiol disulfide exchange in lipid vesicles (64). It was 
shown that M2(19-46) tetramers are increasingly stabilized in the direction of detergents << 
DLPC < DMPC < POPC. Among lipid bilayers the hydrophobic-thickness matched bilayers 
produce the most stable tetramers (64), but even the thinnest bilayer (DLPC) induces 100-
fold tighter tetramer association than detergents. Both amantadine and cholesterol shift the 
equilibrium to tetramers (64, 65). Compared to external environmental factors, the sequence 
requirement for tetramer formation is much more lenient: Ala and Phe mutations of a number 
of pore residues retain stable M2(22-46) tetramers in DPC micelles, with the exception of the 
functionally essential His37 (21). However, more stable tetramers are often less functional 
tetramers, as manifested by their reduced ability to bind amantadine (63). For example, the 
most amantadine-resistant S31N mutant forms 0.4 kcal/mol more stable tetramers than the 
WT protein (42). This inverse relationship between stability and function suggests that the 
multiple M2 functions –proton conduction, gating and inhibitor binding – may require 
conformational flexibility, which cannot be provided by highly stable mutants locked in the 
wrong conformational minima.  
 Direct distance constraints for M2 tetramers in lipid bilayers were recently reported 
based on 19F spin diffusion SSNMR experiments that probe 19F-19F distances in the ~10 Å 
range (66, 67). So far, four interhelical 19F-19F distances have been reported for M2(22-46) in 
DMPC bilayers. On 4-19F labeled A30F M2, the 19F spin diffusion equilibrium value of 1/4 
directly proved the tetrameric state, and the decay trajectory yielded a distance of 8.5 ± 0.6 Å 
between nearest neighbor helices (Figure 2.2a). This distance rules out helix tilt angles 
smaller than 20˚ and constrains the Phe χ1 angle. The 19F NMR data of V27F suggest 
incomplete tetramer formation (partial dimers), which is consistent with the reduced stability 
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of this mutant seen in AUC experiments (21).  The L38F NMR data also indicated distance 
heterogeneities (59).  
 
His37 and Trp41 sidechain conformation. A semi-quantitative 13C-15N distance between 
His37 Nπ and Trp41 Cγ was measured on DMPC-bound M2(22-46) at pH 7 and 38˚C using 
SSNMR REDOR experiments (37). Significant dipolar dephasing was observed that 
corresponded to a minimal coupling of 63±12 Hz (37) or a maximum distance of 3.9 Å. The 
limiting nature of this result is because the measurements were done at physiological 
temperature where M2(22-46) undergoes uniaxial diffusion around the bilayer normal, which 
averages the dipolar coupling (50, 54). Scanning the possible His and Trp rotameric states 
indicate that this C-N distance must be between helices i and i+1, and suggested that His37 
adopts the t-160 (χ1=180˚, χ2=-160˚) rotamer while Trp41 adopts the t-105 rotamer (PDB 
code: 1NYJ) (37). Subsequent reexamination of the conformational space of the two residues 
indicates that other possible solutions also exist: His37 can adopt the t-160 or the t60 rotamer, 
while Trp41 can adopt the t-105 or the t90 rotamer. Density functional theory calculations and 
MD simulations suggest that the most stable combination is (t60, t90) (26).  
 19F spin diffusion NMR experiments provided a direct distance constraint on the Trp41 
sidechain conformation. The i - i+1 distance between 5-19F-Trp41 of M2(22-46) was measured 
to be mainly 11.8 Å at pH 7.5 (59) (Figure 2.2a), and the value does not change significantly 
with amantadine binding and pH. When the helix orientation is fixed to 35˚ and the channel 
diameter is fixed to 10.2 Å between G34 Cα, the only Trp41 rotamer that is consistent with 
the 19F-19F distance is t90, which is consistent with the MD prediction (26). Combined with 
the measured His37-Trp41 C-N distance, the (t-160, t90) rotamer pair was proposed for the 
closed state of His37 and Trp41 (59). This conformation suggests that it may not be Trp41 alone 
but rather the cation-π interaction between His37 and Trp41 that is responsible for gating and 
the shielding of His37 from intracellular ions (Figure 2.2b).   
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Figure 2.2. (a) Interhelical 19F-19F spin diffusion data of 5-19F-Trp41 WT M2 (red) and 4-19F-A30F M2 
(black) in DMPC bilayers (59, 67). The best-fit distances confirm the tetrameric state of the peptide, 
and constrain the Trp41 sidechain (χ1, χ2) torsion angles (inset). (b) Trp41 t90 and His37 t-160 rotamers 
proposed from the distance data.  
 
 A third Trp41 rotamer of (χ1=-100˚, χ2=+100) was proposed for the high pH state of 
M2 based on analysis of 19F NMR lineshapes under the combined effects of 19F CSA and 19F-
19F interhelical dipolar couplings (68). However, the presence of intermediate time scale 
broadening of the spectra and the lack of information on the orientational angles between the 
19F chemical shift tensor and the F-F dipolar tensors make this analysis a severely under-
determined problem. The resulting rotamers are also inconsistent with any of the 
computational predictions (26).  
 
His37 protonation state. The charged state of His37 gives crucial information on the 
activation of the M2 proton channel. The pKa of His37 in micelle-bound M2(22-46) was 
measured by 1H solution NMR to be 6.8 for the monomer and 6.4 for the tetramer in the 
absence of drug (65). Amantadine decreases the tetramer pKa to 5.8. UV resonance Raman 
experiments on M2(22-46) in POPE/POPS membranes found a pKa of 5.7 based on the 
intensity of the 1407 cm-1 band (24). This imidazole band has the same intensity in liposomes 
and in SDS micelles at pH 4.0, indicating that all four His residues are protonated at pH 4.0 
(24).  
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 By far the most definitive study of His37 protonation states came from 15N SSNMR 
experiments of M2(22-46) in DMPC/DMPG bilayers by Cross and coworkers (18), who 
monitored the imidazole Nδ1 and Nε2 15N isotropic chemical shifts as a function of pH. Two 
neutral tautomers were found at pH 8.6, with the unprotonated nitrogen exhibiting a large 
isotropic shift of ~230 ppm. Between pH 8.0 and pH 7.0, two +1 dimer species, His-HisH+, 
were concluded. Based on the relatively large 15N linewidths in this pH range, which suggest 
intermediate time scale motion, low-barrier hydrogen bonds between imidazole and 
imidazolium within each dimer were proposed. Below pH 6.5 and pH 5.0, the third and 
fourth His are protonated. Quantification of the spectral intensities yielded four pKa’s at 8.2, 
8.2, 6.3 and < 5.0. Thus, the first two histidines titrate cooperatively at higher pH than the 
aqueous pKa of His (6.0). Since the +1 dimers already exist at neutral pH, they are proposed 
to form a histidine-locked state that occludes the pore (18). The binding of the third proton 
below pH 6.3 was proposed to break the two-fold symmetry of the +1 dimers and thus 
activates the channel.  
 Amantadine binding changes the titration curve of the His37 tetrad (69). The 230 ppm 
unprotonated 15N peak persisted to a much lower pH of 6.0 in the presence of the drug. 
Intensity analysis shows that the bound peptide has only one pKa near 5.4. The nature of this 
apparently highly cooperative protonation event is still unknown. In addition, the 15N peak 
associated with the His-HisH+ dimer is no longer observed in the amantadine-bound peptide, 
suggesting that the neutral tautomers directly form biprotonated histidines in the presence of 
amantadine. Further studies are necessary to elucidate the amantadine-induced changes of 
His37 protonation.  
 
Extensive conformational dynamics of AM2. The M2 homo-tetramer exhibits extensive 
conformational dynamics in lipid bilayers and lipid-mimetic detergents, as well documented 
by SSNMR and solution NMR spectra. Membrane-bound apo M2(22-46) shows dynamically 
broadened lines in both unoriented vesicle spectra (36, 55) and oriented spectra (70) at 
ambient temperature in a range of model membranes: DLPC, DMPC/DMPG, and POPC. The 
fact that the line broadening is mainly dynamic in origin rather than due to static 
 38 
conformational distributions is proved by the temperature dependence of the linewidths. The 
broadest lines are observed between 298 K and 263 K (54), above and below which the lines 
narrow (Figure 2.3a). Acidic pH broadens the lines compared to neutral pH for both 
membrane-bound M2(22-46) (70) and detergent-bound M2(18-60) (34). In all solvent 
environments and for both M2(22-46) and M2(18-60), amantadine noticeably narrows the 
linewidths (Figure 2.3b). The line broadening or narrowing occur for all residues, thus it 
reflects the dynamic property of the whole protein rather than segmental motion.  
 
 
Figure 2.3. 13C MAS spectra of DLPC-bound M2(22-46). (a) Variable temperature 13C MAS spectra 
indicate large-amplitude intermediate timescale motion at ambient temperature (54). (b) Amantadine 
narrows the linewidths of most residues at 313 K (55).  
 
 The origin of the broad linewidths and their narrowing by amantadine has been 
examined in detail by SSNMR (54, 71). The main motion accounting for the broad linewidth 
is the whole-body uniaxial diffusion of the tetramers around the bilayer normal, as shown by 
motionally averaged 2H, 15N and 13C NMR lineshapes (Figures 2.4a, b) (54). The correlation 
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time of this uniaxial diffusion has been estimated from relaxation studies to be ~3 µs (71) for 
DLPC-bound apo M2(22-46) at 313 K, which is very close to the time scale of the radio-
frequency pulses and nuclear spin interactions (2-4 µs), thus causing intermediate time scale 
broadening. Amantadine binding reduces the correlation time by 2-3 fold at 313 K (71) 
(Figure 2.4c), thus avoiding exchange broadening and narrowing the NMR lines. The larger 
diffusion rates strongly suggest that amantadine promotes the formation of more 
homogeneous helical bundles (Figure 2.4d), which is consistent with the increased tetramer 
stability observed in thiol disulfide exchange experiments (64). The NMR relaxation data 
also indicate that excess amantadine in the bilayer increases the membrane viscosity. Since 
protein rotational diffusion is generally sensitive to membrane viscosity, cholesterol-rich 
virus-mimetic membranes immobilize this diffusion, and was found to suppress exchange 
broadening and give rise to high-resolution NMR spectra in a wide temperature range (72).  
 Whether the whole-body uniaxial diffusion has functional importance is not known. If 
the viral envelope is in a liquid-ordered phase, then M2 is most likely immobilized. But if the 
virus envelope contains significant liquid-disordered domains, then the fact that M2 is poorly 
incorporated into raft-like microdomains (73) should promote uniaxial diffusion in the 
functional state. Most spectroscopic studies so far were carried out on M2 bound to non-
cholesterol-containing membranes or bound to detergents, which favor the whole-body 
motion. Thus site-specific conformational dynamics have not been separated from the whole-
body motion. In this light, the larger linewidths of M2 at low pH are at least partly due to 
global motional changes, and their interpretation in the context of pH activation needs to be 
considered carefully (34, 70). 
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Figure 2.4. Uniaxial diffusion of M2(22-46) helical bundles around the bilayer normal. (a) 15N CSA 
of L26 is uniaxially averaged from the rigid-limit pattern (dashed line) (54). (b) L26 N-H dipolar 
coupling is reduced from the rigid-limit coupling. (c) Amantadine decreases 1H T1ρ relaxation rates at 
high temperature, indicating it speeds up protein motion (71). (d) Schematic of M2 uniaxial diffusion. 
Amantadine binding creates better packed tetramers, thus speeding up rotational diffusion.  
 
Amantadine binding in high-resolution structures. Two atomic-resolution structures of 
TM-containing portions of AM2 were recently solved using X-ray crystallography and 
solution NMR, which shed light on the pH activation of the channel and led to two different 
models of M2 inhibition (74).  
The crystal structures were solved on M2(22-46) in octyl-β-D-glucopyranoside (OG) 
at pH 7.3 in the absence of amantadine (PDB: 2BKD) (2.0 Å resolution) and at pH 5.3 in the 
presence of amantadine (PDB: 3C9J) (3.5 Å resolution) (35). In both structures, the N-
terminal half of the TM domain has a tilt angle of ~35˚, consistent with SSNMR data (51, 
54). The orientation of the C-terminus half of the TM helix depends on the pH: at low pH the 
helices are uniformly straight and diverge toward the C-terminus, creating an open cavity, 
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but at pH 7.3 two of the four helices bend and create a small pore at the His37/Trp41 region. 
The amantadine-bound structure, solved with a 1.3 : 1 protein : amantadine molar ratio, 
shows a single drug molecule in the pore, surrounded by residues that confer drug resistance 
(Figure 2.5b). Thus, the amantadine binding site and stoichiometry agree with 
electrophysiology data (16), and the crystal structure supports a occlusion model for channel 
inhibition.  
 The solution NMR structure was solved on rimantadine-bound M2(18-60) in DHPC 
micelles at pH 7.5 (PDB: 2RLF) (34). The sample contains 0.75 mM protein, 40 mM 
rimantadine and 300 mM DHPC, thus the drug is in 53-fold excess to the protein or ~210 
fold excess to the channel. The TM helix is tilted by ~15˚ from the bilayer normal and the C-
terminal amphipathic helix is roughly perpendicular to the TM helix. Low pH broadens the 
linewidths and increases the millisecond motion of Trp41. Four protein-rimantadine NOEs 
were found to lipid-facing residues L40, I42, L43, and R45 near the C-terminus of the TM 
helix, with four rimantadine molecules per tetramer (Figure 2.5c). Since this surface binding 
site is inconsistent with the large body of mutagenesis data that place drug-resistant 
mutations at pore-facing residues at the N-terminus, the authors proposed that rimantadine 
inhibits the channel by stabilizing its closed state and making the channel harder to open, 
whereas drug-resistant mutations destabilize the closed channel and make it easier to open. 
However, this allosteric inhibition model is inconsistent with the one-drug-per-channel 
stoichiometry of amantadine (16), and also contradicts virus replication and whole cell 
conductance data that showed D44A and R45A mutants to be amantadine sensitive (41). The 
drug – protein NOEs involve residues in the headgroup region of the micelle, exactly where 
the amphiphilic rimantadine is located based on paramagnetic relaxation NMR data (75, 76). 
At the high concentration of 40 mM, rimantadine constitutes 12 mol% of the micelle, making 
the surface binding site a likely secondary lipid binding site rather than the true inhibition 
site. Given the abundant reorientational dynamics of the peptide and amantadine discussed 
above (55, 71), the lack of NOEs between the N-terminal pore residues and rimantadine 
could arise from motion on unfavorable time scales that broadens the NMR signals and/or 
make the NOE intensity vanish. Thus, while this work shows the presence of rimantadine on 
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the outside of the protein, they do not provide strong evidence against an additional binding 
site within the pore.  
  It is unlikely for the different protein lengths to be the cause for the drug binding site 
difference, since the TM peptide is capable of binding amantadine, folding into appropriate 
tetramers, and having at least 50% of the proton conductance of full-length M2 (77).  
 
 
Figure 2.5. High-resolution structures of the TM domain of AM2. (a) Amantadine-bound 
orientational structure of M2(22-46) in DMPC bilayers at pH 8.8 from oriented-membrane SSNMR 
(PDB: 2H95) (48). The drug binding site was not directly studied but was implicitly assumed to be in 
the pore at the N-terminus side. (b) Amantadine-bound crystal structure of M2(22-46) in OG at pH 
5.3 (PDB: 3C9J) (35). (c) Rimantadine-bound solution NMR structure of M2(18-60) in DHPC 
micelles at pH 7.5 (PDB: 2RLF) (34). Only the TM part is shown. (d) Amantadine-bound structure of 
M2(22-46) in DLPC bilayers at pH 7.5 from MAS SSNMR (PDB: 2KAD) (36). The amantadine 
position is hypothesized based on chemical shift perturbation of S31. The bilayer planes are drawn for 
reference. In each structure, two of the Trp41 indole rings (green) are shown, and the drug molecules 
are shown in red. IN (c), only two rimantadine molecules are shown for clarity.  
 
The above two high-resolution structures were solved in detergents and micelles. 
Recently, an amantadine-bound structure of M2(22-46) in DLPC bilayers was reported based 
on MAS SSNMR data (36, 55). The experiments were carried out at a peptide : amantadine : 
DLPC molar ratio of 1 : 8 : 15. The main conformational constraints came from 13C and 15N 
isotropic chemical shifts (CS) measured at 243 K where the protein dynamics is frozen. 
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Comparison of the apo and bound peptide chemical shifts indicated that the M2(22-46) 
conformation is most perturbed by amantadine at S31, with a large 15N CS change of 7 ppm, 
strongly suggesting drug binding near S31 (Figure 2.6a). The CS perturbation is also high for 
G34 and V28, while the C-terminal L38 and D44 are minimally affected (Figure 2.6b). The 
chemical-shift predicted (φ, ψ) angles for the apo and bound monomers also show that the 
apo peptide has a slightly larger kink than the amantadine-bound peptide. The monomer 
structure was combined with the helix orientation and inter-helical 19F-19F distances to lead to 
a tetramer structure for M2(22-46) at pH 7.5 (PDB: 2KAD). The tetramer has larger N-
terminus vestibule than the other structures, and differs in the Trp41 conformation (36) 
(Figure 2.5d). SSNMR studies also found that amantadine slightly perturbs the sidechain 
conformations of V27 and V28 (78).  
 
 
Figure 2.6. SSNMR evidence for amantadine binding near S31. (a) 2D 15N-13C correlation spectra of 
DLPC-bound M2(22-46) in the absence (black) and presence (red) of amantadine (36). (b) Chemical 
shift perturbation by amantadine in bilayer-bound M2(22-46).  
 
C. Future directions  
 While a large amount of biochemical and structural information have been obtained 
for the M2 proton channel, many open questions remain about this fascinating multi-
functional protein. So far the most complete three-dimensional structures were solved in 
detergents and micelles, which are only partial mimics of lipid bilayers. Given the plasticity 
of the protein, high-resolution structural studies in lipid bilayers that mimic the virus 
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envelope will be very valuable. Most structural studies so far used partial constructs of the 
full-length protein, thus future studies of the full-length protein will clearly be desirable, 
especially to understand the role of the C-terminal amphipathic helix, which was found to be 
able to affect ion channel function by interacting with the TM helix (79). Elucidating how 
M2 changes its conformation and dynamics between high pH and low pH is central to 
understanding its activation, and will require atomic-resolution information of His37 and Trp41 
conformation as a function of pH. Clearly, protein-drug distances in lipid bilayers will be 
essential for resolving the controversy of M2 inhibition. Finally, the ultimate public health 
benefit of this research is to develop new antiviral drugs to target the dominant mutants of 
influenza A viruses to prevent future influenza pandemics. Achieving this end will require a 
combination of pharmacological, biochemical, and structural studies.  
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Chapter 3 
 
Determining the Orientation of Uniaxially Rotating Membrane Proteins  
Using Unoriented Samples 
A paper published in Journal of the American Chemical Society 
2007 vol. 129 (17) pp. 5719-5729 
Sarah D. Cady, Catherine Goodman, Chad D. Tatko, William F. DeGrado and Mei Hong 
 
Abstract  
 Membrane protein orientation has traditionally been determined by NMR using 
mechanically or magnetically aligned samples.  Here we show a new NMR approach that 
abolishes the need for preparing macroscopically aligned membranes. When the protein 
undergoes fast uniaxial rotation around the bilayer normal, the 0˚-frequency of the 
motionally averaged powder spectrum is identical to the frequency of the aligned protein 
whose alignment axis is along the magnetic field. Thus one can use unoriented membranes to 
determine the orientation of the protein relative to the bilayer normal. We demonstrate this 
approach on the M2 transmembrane peptide (M2TMP) of influenza A virus, which is known 
to assemble into a proton-conducting tetrameric helical bundle. The fast uniaxial rotational 
diffusion of the M2TMP helical bundle around the membrane normal is characterized via 2H 
quadrupolar couplings, C-H and N-H dipolar couplings, 13C chemical shift anisotropies, and 
1H T1ρ relaxation times. We then show that 15N chemical shift anisotropy and N-H dipolar 
coupling measured on these powder samples can be analyzed to yield precise tilt angles and 
rotation angles of the helices. The data show that the tilt angle of the M2TMP helices 
depends on the membrane thickness to reduce the hydrophobic mismatch. Moreover, the 
orientation of a longer M2 peptide containing both the transmembrane domain and 
cytoplasmic residues is similar to the orientation of the transmembrane domain alone, 
suggesting that the latter regulates the orientation of this protein and that structural 
information obtained from M2TMP may be extrapolated to the longer peptide. This powder-
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NMR approach for orientation determination is generally applicable and can be extended to 
larger membrane proteins.  
 
Introduction  
 Orientation determination of membrane proteins by solid-state NMR traditionally 
requires mechanically or magnetically aligned proteins (1, 2). A uniformly aligned protein 
produces resolved spectra where the anisotropic frequency - chemical shift or dipolar 
coupling – reports the orientation of the molecule-fixed spin interaction tensor, from which 
the orientation of the protein can be obtained. However, this approach is constrained by the 
degree of alignment. Poor alignment can occur for many reasons: the size of the protein may 
be too large; the protein-lipid molar ratio may be too high, which is important for achieving 
sufficient sensitivity but deleterious for alignment; the protein may be inherently membrane-
disruptive by causing curvature and non-lamellar phases (3, 4); and often only a narrow set of 
lipids is conducive to alignment for a specific protein, thus the dependence of orientation on 
environmental parameters such as membrane thickness and membrane composition is 
difficult to study. These factors severely restrict the determination of membrane protein 
orientation.   
 It is thus desirable to develop alternative approaches for determining membrane 
protein orientation that do not require macroscopic alignment, but use straightforward 
unoriented liposomes. We demonstrate here that this is possible as long as the membrane 
protein undergoes fast uniaxial rotational diffusion around the bilayer normal on the 
timescale of the NMR spin interactions. Under this condition, the protein orientation can be 
extracted with high precision using unoriented membranes and magic-angle spinning (MAS) 
or static experiments. The elimination of macroscopic alignment also increases the sample 
amount in the radiofrequency (rf) coil by removing the alignment media, thus giving 
intrinsically higher sensitivity.  
 The M2 protein of the influenza A virus is a well studied proton channel that initiates 
the release of the viral ribonuclear protein complex into the host cell, which is necessary for 
viral replication (5, 6). The transmembrane domain of the M2 protein, M2TMP (residues 22-
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46), has been extensively studied by a number of biophysical techniques, including 
electrophysiological measurements (7, 8), analytical ultracentrifugation (9, 10), solid-state 
NMR (11, 12), neutron diffraction (13), and molecular dynamics simulation (14-17). The 
results indicate that M2TMP has the essential characteristics of the intact protein: it forms 
tetrameric helical bundles with proton-conducting abilities in the lipid membrane (18). Cross 
and coworkers used glass-plate aligned membranes and 2D 15N correlation experiments to 
show that the helices in this tetrameric bundle are tilted by 38˚±3˚ (11) from the bilayer 
normal in DMPC bilayers. The availability of this information makes M2TMP an excellent 
model system to test the principle of orientation determination using powder samples. 
Moreover, the orientation of M2TMP has been measured in detail only in DMPC (14:0) 
bilayers. A more limited set of NMR data on M2TMP bound to DOPC bilayers, which have 
longer acyl chains (18:1) than DMPC (14:0), found a similar orientation as that in DMPC 
bilayers (19). This was interpreted to suggest that M2TMP orientation is an inherent property 
of the protein and is independent of the membrane thickness. However, a more recent EPR 
study of M2TMP bound to DLPC, DMPC, POPC, and DOPC bilayers suggested that the 
peptide orientation does change with the membrane thickness (20). Thus, further experiments 
are of interest to resolve this discrepancy.  
 Another issue investigated in the current paper is the role of a C-terminal helix, which 
occurs just beyond the transmembrane helix. Previously, limited proteolysis of full length M2 
protein in micelles and CD spectroscopy were used to identify a cytoplasmic amphiphilic 
helix that follows the transmembrane helix in the sequence of M2 (21). The C-terminal helix 
increases the stability of the tetramer (relative to a peptide spanning only the TM helix), and 
this cytoplasmic helix was also essential to obtain full proton channel activity when deletion 
mutants were expressed in oocytes (7). The role of this C-terminal segment in stabilizing the 
channel is currently not known. Originally, it was suggested that the cytoplasmic helix might 
have one of two orientations: in one model it formed an extension of the transmembrane 
helix, possibly explaining the increased stability of the tetramer.  In a second model, the helix 
was proposed to lie parallel to the membrane surface, radiating out from the transmembrane 
helix bundle in a rosette-like structure with a radius of 35 to 40 Å (21). Subsequent solid-
state NMR studies of the full-length M2 protein (22) were more consistent with the rosette 
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model, although there were also features in these experiments that were difficult to 
understand.  Hydrogen-deuterium exchange data indicated that the amide NH groups of all 
residues in the transmembrane helix exchanged with solvent very rapidly, irrespective of 
whether they faced the phospholipid acyl chains or the transmembrane pore.  By contrast, in 
the cytoplasmic helix, the putative lipid-facing amides were found to exchange very slowly 
with the bulk water (22). However, because the studies were not conducted with site-
specifically labeled proteins, there remained some ambiguity in the conclusions. Thus, in this 
paper, we include initial data on a 42-residue peptide spanning both the transmembrane and 
the cytoplasmic helix. 
 In this work, we first examine the rotational dynamics of the M2TMP helical bundle 
under different sample preparation conditions and in lipid bilayers of different thicknesses. 
Multiple NMR spin interactions, including 2H quadrupolar couplings, 13C chemical shift 
anisotropy (CSA), C-H dipolar couplings, and 1H rotating-frame relaxation time (T1ρ), are 
used to examine the amplitude and rate of M2TMP rotational diffusion. We then measure the 
15N-1H dipolar couplings and 15N CSAs of site-specifically labeled M2TMP in unoriented 
membranes under MAS or static conditions. These anisotropic couplings are summarized in 
the same 2D correlation patterns – “PISA” wheels – as those obtained from oriented 
membrane samples. These powder PISA wheel spectra show that the orientation of M2TMP 
does depend on the lipid bilayer thickness: it decreases from 35˚±3˚ in DLPC bilayers to 
26˚±3˚ in POPC bilayers. Finally, we show that the longer segment of the M2 protein 
encompassing both the transmembrane domain and cytoplasmic residues has the same 
orientation in DLPC bilayers as M2TMP, suggesting that the transmembrane domain 
regulates the orientation of the protein.  
 
Material and Methods 
Peptides and lipids  
 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dimyristoyl-sn-
glycero-3-phosphocholine (DMPC), and 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) 
were obtained from Avanti Polar Lipids (Alabaster, AL). 13C, 2H, and 15N labeled Leu and 
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Val (Sigma) were FMOC-protected in house using standard methods (23). Other FMOC-
protected amino acids were purchased from Sigma (Miamisburg, OH) and Cambridge 
Isotope Laboratories (Andover, MA). 
 The transmembrane domain (residues 22-46) of the M2 protein of the 
A/Udorn/307/72 (H3N2) influenza A virus (SSDPLVVAASIIGILHLILWILDRL) (24) was 
synthesized and purified by Primm Biotech (Cambridge, MA). These samples contain 
various site-specific 2H, 13C, and 15N labels. One sample contains a L38F mutation to allow a 
4-19F label at the phenylene ring. This L38F variant is found in the Weybridge (FPVW27) 
strain of the influenza A virus (24) and has similar biological activity as the Udorn strain 
(25).  
 
Membrane sample preparation  
Peptide-containing membrane samples were prepared either by an aqueous-mixing 
method or by an organic-phase mixing method. The aqueous samples were prepared by 
mixing the peptide with pH 7.5 lipid vesicle solutions at a peptide/lipid molar ratio (P/L) of 
1:15. The lipid solution was vortexed, freeze-thawed 6-8 times to create uniform vesicles of 
< 200 nm diameter (26), then added to the appropriate amount of M2TMP. The solution was 
incubated at 30 °C for 2 days, after which it was ultracentrifuged at 150,000 g for 3 hours 
above the lipid main phase transition (Tm) temperature. The resulting pellet typically 
contained ~50% water by mass. UV-VIS absorption and a photometric assay of the 
supernatant (27, 28) show that ~98% of the peptide is bound to the pellet. The organic-phase 
mixed samples used P/L = 1:20 and were prepared by codissolving M2TMP with lipids in 
trifluoroethanol, drying the mixture with nitrogen gas, redissolving it in cyclohexane, 
lyophilization, then rehydration to 50% water by mass using a phosphate buffer (pH 8.1). We 
refer to these two types of samples as “aqueous samples” and “organic samples”, even 
though the final products are both well-hydrated proteoliposomes.  
Importantly, we have confirmed by independent 19F spin diffusion experiments that 
the oligomeric state of M2TMP is indeed tetramer at the peptide concentrations used here, 
whether the sample is prepared by aqueous-phase mixing or organic-phase mixing (18, 29). 
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This is manifested as an equilibrium value of ~0.25 at long spin diffusion mixing times. 
Thus, the mobility and orientation observed in this work are those of the tetrameric M2 
peptide.  
 
Solid-state NMR spectroscopy  
 NMR experiments were carried out on a Bruker AVANCE-600 (14.1 Tesla) 
spectrometer and a DSX-400 (9.4 Tesla) spectrometer (Karlsruhe, Germany). The 2H 
experiments were carried out using a quadrupolar echo pulse sequence with a 2H 90° pulse 
length of 5 µs. Static 15N chemical shift spectra were measured using a Hahn-echo sequence. 
13C-1H and 15N-1H dipolar couplings were measured using the 2D DIPSHIFT experiment (30) 
at 2.4 – 3.5 kHz MAS with MREV-8 for 1H homonuclear decoupling. Pulse lengths of 3.5 – 
5.2 µs were used in the MREV-8 pulse train, the longer values due to the rf power loss on 
some of the hydrated membrane samples. Tests on the model compound 15N-acetyl-valine 
indicate that the measured dipolar coupling is unaffected by the varying MREV-8 field 
strengths within the range used. The N-H DIPSHIFT experiments were performed with 
dipolar doubling (31, 32) to increase the precision of the measured couplings. The 13C 
chemical shift anisotropy (CSA) was measured using the 2D SUPER experiment (33) under 
2.5 kHz MAS. The corresponding 13C field strength was 30.3 kHz. 1H T1ρ was measured 
using a spin-lock field strength of 62.5 kHz.  
 The 2H and 13C 1D spectra were recorded between 243 K and 313 K. All 15N chemical 
shift and N-H dipolar coupling experiments were carried out at 313 K where the peptide is 
mobile to determine the helix orientation.   
 
Results and Discussion 
Equivalence of aligned and powder samples for uniaxially mobile molecules 
 For a membrane protein undergoing fast uniaxial rotational diffusion around the 
bilayer normal, the 0˚-frequency, 
€ 
δ//, of the motionally average powder spectrum is identical 
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to the frequency when the protein is uniformly aligned, with the alignment axis parallel to the 
magnetic field (0˚-aligned sample) (34):  
 
  
€ 
δ // =ω0˚  aligned = 12 δ 3 cos
2θ − 1−η sin2θ cos 2φ( ) +ωiso  (3.1) 
 
 Here δ = δzz-δiso and η = (δyy - δxx)/δ are the anisotropy and asymmetry parameters, 
respectively, of the rigid-limit interaction tensor. The angles (θ, φ) are the polar coordinates 
of the magnetic field B0 in the principal axis system of the spin interaction tensor. Equation 
3.1 can be derived, as we showed recently (34), by considering consecutively the frequency 
of an aligned sample without motion, then the frequency of an aligned sample undergoing 
uniaxial rotation around the alignment axis of bilayer normal, then the motionally averaged 
anisotropy parameter of the same aligned and mobile sample, finally the powder spectrum of 
the mobile sample without alignment. The essential link between the frequency of a 0˚-
aligned aligned sample and that of an unoriented sample is the realization that 
€ 
δ// of the 
motionally averaged powder pattern is obtained when B0 is along the motional axis, the 
bilayer normal. This is identical to the geometry of a 0˚-aligned sample, when B0 coincides 
with the alignment axis, also the bilayer normal.   
 Once 
€ 
δ// is known, the motionally averaged anisotropy parameter, 
€ 
δ , and the 
frequency of the powder pattern maximum, 
€ 
δ⊥ , are also known, since these are related by 
 
  
€ 
δ⊥ −ωiso = − 12 ω0˚  aligned −ωiso( ) = − 12 δ // −ωiso( ) = − 12 δ . (3.2) 
 
Thus one can extract the orientation information by measuring the high-sensitivity 
€ 
δ⊥ (90˚) 
edge, rather than the low-intensity 
€ 
δ// edge, of the uniaxially averaged spectrum.  
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Predicted rates of rotational diffusion of membrane proteins  
 The prerequisite for this powder-sample orientation determination approach is that the 
membrane protein must undergo uniaxial rotational diffusion at a rate larger than the NMR 
spin interaction. The rotational diffusion rate of proteins in two-dimensional membranes is 
given by the Saffman-Delbrück equation (35):  
  
€ 
Dr =
kT
4πηr2h
 (3.3) 
where the diffusion coefficient, Dr is directly proportional to the temperature T and inversely 
proportional to the membrane viscosity η, the square of the radius (r) of the diffusing 
cylinder, and the height (h) of the cylinder.  
  
 
Figure 3.1. Calculated rotational diffusion rates of membrane proteins as a function of radius 
compared to various NMR spin interactions. The rotational rates of a single TM α-helix (circles) and 
a tetrameric α-helical bundle (squares) are indicated. For the calculated curves, a membrane viscosity 
of 10 poise and a temperature of 298 K are used. A diffusion cylinder height (h) of 19.5 Å (solid line) 
and 27 Å (dashed line) are used, corresponding to the hydrophobic thickness of DLPC and POPC 
bilayers, respectively. Superimposed are the 2H quadrupolar coupling strength, C-H and N-H dipolar 
couplings, and 15N and 13Cα chemical shift anisotropies for magnetic field strengths of 9.4 – 14.1 
Tesla.  
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 Equation 3.3 allows us to estimate the diffusion rates of membrane proteins of 
varying sizes. Figure 3.1 plots the calculated rotational diffusion rates Dr as a function of r at 
T = 298 K, with h = 19.5 Å for DLPC bilayers and 27 Å for POPC bilayers, and assuming a 
membrane viscosity of 10 poise (35), A single TM α-helix, which has a radius of ~5 Å, gives 
a Dr of ~6.7 x 105 s-1 and 4.9 x 105 s-1 for DLPC and POPC bilayers, respectively. These rates 
are much larger than any spin interactions in proteins, thus a single TM helix in liquid-
crystalline bilayers should give motionally narrowed spectra.  
 If the α-helix is surface-bound instead of transmembrane, the radius of the diffusing 
cylinder will be on the order of the length of the helix while h is roughly the radius of the 
helix. For a 25-residue α-helix, using r = 37.5 Å and h = 5 Å, we find a Dr of ~4.7 x 104 s-1. 
This is smaller than the 2H quadrupolar coupling of 125 kHz. Indeed, a recent 2H NMR study 
of an in-plane 26-residue α-helix found the peptide to be immobilized on the 2H NMR 
timescale (36). 
 A TM helical bundle has a larger r than a single helix, thus should have a lower 
rotational diffusion rate. The M2TMP tetramer is estimated to have a radius of ~12.5 Å based 
on the existing structural model (PDB code: 1NYJ). The resulting Dr is ~105 s-1, which is 
comparable to the 2H quadrupolar interaction and much larger than any spin-1/2 interactions 
such as C-H dipolar couplings and 15N CSA (Figure 3.1). Since the membrane viscosity used 
in the calculation is an estimated value and since T is an adjustable parameter, the rotational 
diffusion rate may exceed the 2H quadrupolar interaction under experimentally accessible 
conditions. Certainly, the rotational diffusion of this tetrameric helical bundle is sufficiently 
fast to average spin-1/2 interactions.  
 It is important to note that the fast uniaxial rotation relevant for orientation 
determination is the rotation of the entire helical bundle together around the membrane 
normal, and that the individual helices do not rotate around their own molecular axes. That 
the bilayer normal is the motional axis is dictated by the two-dimensional nature of the 
membrane, which makes intermolecular potentials symmetric around this bilayer normal. 
Moreover, the bundle axis is parallel to the bilayer normal, making the orientation of all 
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helices relative to the bilayer normal identical, since only a single anisotropic NMR signal 
was observed for each residue (9, 11). Thus, rotation around the membrane normal is also 
rotation around the bundle axis.  
 
2H spectra of M2TMP in lipid membranes: conditions for fast uniaxial rotation 
 Previous 15N spectra of glass-plate aligned M2TMP with the alignment axis 
perpendicular to the magnetic field showed narrow peaks that indicate the presence of fast 
uniaxial rotation of this helical bundle (37). However, whether this motion is fast on the 
timescales of larger spin interactions such as 2H quadrupolar coupling is not known, and the 
rates and amplitudes of the motion have also not been characterized. We first measured the 
2H spectra of site-specifically deuterated M2TMP in various lipid membranes to provide a 
lower limit of the rotational diffusion rates. Figure 3.2 shows the 2H spectra of 5,5,5-d3-L38-
M2TMP in POPC bilayers at several temperatures. In the Lα-phase of the membrane, the 
Leu38 CD3 group experiences methyl three-site jumps, χ1 and χ2 torsional motion, and 
possible backbone motion. The methyl three-site jumps reduce the rigid-limit 2H quadrupolar 
coupling to 40 kHz (38). Any further coupling reduction must be a result of the two other 
motional mechanisms. 
  The 2H spectra in Figure 3.2 show different dynamics for different sample preparation 
conditions. For the organic sample (a), the spectra show 
€ 
η = 0 lineshapes and couplings of < 
15 kHz in the Lα phase (Figure 3.2a). For the aqueous sample, the spectra show couplings of 
> 25 kHz and non-uniaxial lineshapes at the same temperatures. Mildly below the phase 
transition temperature, the same trend is seen: organic mixing yielded a splitting of 16 kHz 
whereas aqueous mixing yielded a coupling of 31 kHz. Since χ1 and χ2 torsional motion is 
inherently non-uniaxial, the 
€ 
η = 0 lineshape (Figure 3.2a) at high temperatures cannot be 
solely due to the sidechain motion, but the helix backbone must undergo uniaxial rotation 
faster than the rigid-limit 2H quadrupolar coupling of 125 kHz. Moreover, since the backbone 
motion should have a higher energy barrier than sidechain motion, the couplings of 26 – 31 
kHz in the aqueous sample (Figure 3.2b) must reflect χ1/χ2 torsional motions while the 
backbone rotation has stopped.  
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 The different backbone mobility of M2TMP in the two sample preparation methods 
suggests different aggregation states of the protein. Mixing the peptide and lipid in organic 
solvents before the assembly of lipid bilayers in water may result in a homogeneously mixed 
membrane mixture in which the tetrameric bundles are well isolated from each other. In 
contrast, mixing M2TMP with preformed lipid vesicles may not fully solubilize the peptide 
in the membrane, leading to aggregates of tetramers that inhibit fast rotation on the 2H 
timescale.  
 
Figure 3.2. 2H spectra of d3-L38-M2TMP in POPC membranes prepared via (a) organic mixing and 
(b) aqueous mixing at various temperatures. Quadrupolar splittings of the organic sample are 13.8 
kHz, 15.0 kHz, and 16.0 kHz from top to bottom (a). Quadrupolar splittings of the aqueous sample 
are 26.0 kHz, 26.0 kHz, and 31.0 kHz from top to bottom (b).   
 
 To confirm the backbone motion of the helical bundles in the organic samples, we 
measured the 2H spectra of d3-A29 labeled L38F-M2TMP in DLPC and POPC bilayers above 
and below the Tm of 271 K. Since the Ala methyl group is directly attached to the backbone, 
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there is no sidechain torsional motion other than the methyl three-site jump, and quadrupolar 
couplings smaller than 40 kHz must be attributed to backbone reorientation. Figure 3.3 
shows that above Tm, the peptide exhibits uniaxial lineshapes and 16 kHz couplings in both 
DLPC and POPC membranes, confirming that the helical bundles undergo fast uniaxial 
rotation. Below Tm, between 243 K and 262 K, the 2H spectra broaden to 32 kHz in the 
DLPC membrane and 39 kHz in the POPC membrane. The prediction that rotational 
diffusion should be slower in the thicker membrane (larger h) is confirmed by the larger 
quadrupolar couplings in the gel-phase POPC membrane at the same reduced temperature as 
the DLPC sample. In addition, the zero-frequency signal is more completely suppressed in 
POPC bilayers than in DLPC bilayers.  
 The fact that the M2TMP spectra in the Lα-phase are the same between DLPC and 
POPC membranes with different h suggests that as long as the rotational diffusion rate 
exceeds the coupling strength, it gives the same motionally averaged couplings, which 
depend only on the orientation of the spin interaction tensor, in this case the Cα-Cβ bond, 
with respect to the bilayer normal. Equation 3.1 indicates that an order parameter can be 
defined: 
€ 
S ≡δ δ =δ 40 kHz , that is related to the angle θ of the Cα-Cβ bond relative to the 
bilayer normal as 
€ 
S = 12 3cos
2θ −1( ) . Thus, the measured splitting of 16 kHz in fluid DLPC 
and POPC membranes indicates a Cα-Cβ bond orientation of 39˚ (or 141˚) for S = +0.4 or 
75˚ (or 105˚) for S = -0.4. The existing M2TMP tetramer model gives a Cα-Cβ bond 
orientation of 92˚, in reasonable agreement with one of the predicted values (105˚). However, 
this Ala Cα-Cβ constraint, while easy to obtain, is not very sensitive to the helix axis 
orientation because the Cα-Cβ bond is roughly perpendicular, rather than parallel, to the 
helical axis. It has been shown that multiple Ala CD3 groups need to be measured to obtain 
accurate helix tilt angles (39).  
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Figure 3.3. 2H spectra of d3-A29 L38F-M2TMP in (a) DLPC and (b) POPC membranes at various 
temperatures. Both samples were prepared by organic mixing. The quadrupolar splittings in (a) are 16 
kHz, 16 kHz, 32 kHz, and 32 kHz from top to bottom. The quadrupolar splittings in (b) are 16 kHz, 
20 kHz, 38 kHz, and 39 kHz from top to bottom.  
 
Rates of M2TMP uniaxial rotational diffusion  
 We characterized the rotational diffusion rates of the M2TMP tetramers by 13C cross-
polarization (CP) MAS spectra as a function of temperature. Figure 3.4 shows the 13Cα 
signals of L40 and G34 in DLPC membrane between 258 K and 318 K. The sample was 
prepared by organic-phase mixing. The two Cα signals are strong below the phase transition 
temperature, disappear between 288 K and 298 K, then reappear above 313 K. The same 
trend is observed in the organic POPC membrane whereas the aqueous POPC sample showed 
strong signals that are independent of temperature (spectra not shown). The suppression of 
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the 13C signals at intermediate temperatures in the organic samples is a classic signature that 
motions with similar rates as the C-H dipolar coupling and the 1H decoupling strength, 
20,000–50,000 s-1, are present (40). When this motion is either frozen or sped up by varying 
the temperature, the 13C signals reappear.  
 
Figure 3.4. Temperature-dependent 13C spectra of [13Cα-L40, 13Cα-G34] M2TMP in DLPC 
membrane prepared by organic mixing.  Below Tm (271 K), the L40α and G34α signals are strong.  
With increasing temperature, the peak intensities decrease and almost disappear due to intermediate 
timescale motion (288 – 298 K). The signals reappear as the peptide reaches the fast motion limit 
(313 – 318 K).  
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Figure 3.5. Temperature-dependent 1H T1ρ of M2TMP in different lipid membranes. (a) 13C-detected 
1H T1ρ curves of L40α at various temperatures. The aqueous POPC sample is shown with filled 
symbols and solid fit curves. The organic DLPC sample is shown with open symbols and dashed fit 
curves. (b) 1H T1ρ versus inverse temperature for lipid CH2 and L40α in the organic DLPC sample, 
and L40α in the aqueous POPC sample.  
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 Motions with rates of 105 s-1 are readily detectable in rotating-frame spin-lattice 
relaxation time (T1ρ) measurements. Figure 3.5a shows the 13C-detected L40 Hα T1ρ relaxation 
curves at various temperatures under a 1H spin-lock field of 62.5 kHz. In the aqueous POPC 
membrane, the peptide has a long 1H T1ρ of > 5 ms that is independent of the temperature 
between 298 K and 313 K. In contrast, the organic DLPC sample gave much shorter and 
temperature-dependent 1H T1ρ values. Above Tm, the 1H T1ρ is only 0.8 ms whereas below Tm, 
the 1H T1ρ increases to 3.45 ms at 258 K. Figure 3.5b plots the 1H T1ρ of the lipid CH2 and L40 
Hα in the two samples as a function of temperature. The lipid CH2 groups show increasing 
T1ρ with increasing temperature, indicating that they are in the fast motional limit in the 
temperature range examined (Figure 3.5c). The organic DLPC sample shows decreasing T1ρ 
with increasing temperature, indicating that the peptide motion is near the minimum of the 
T1ρ curve. Finally, the temperature-independence and long T1ρ of the aqueous POPC sample 
indicates that M2TMP is in the slow motional limit.  
 
Amplitudes of backbone motion from 13C-1H dipolar coupling and 13C CSA 
 Direct evidence of backbone motion can be obtained from Cα-Hα dipolar couplings 
and Cα CSAs. Figure 3.6 shows the L40 Cα-Hα dipolar coupling curves in three different 
samples obtained from the indirect dimension of the 2D DIPSHIFT spectra. In the aqueous 
POPC membrane, a coupling of 10.6 kHz was measured (Figure 3.6a). Taking into account 
the MREV-8 scaling factor (0.47), this corresponds to an unscaled coupling of 22.6 kHz, 
which is the rigid limit C-H dipolar coupling. In contrast, POPC and DLPC organic 
membranes (b, c) gave significantly reduced couplings of 3.4 kHz and 4.0 kHz, respectively, 
which correspond to order parameters of ±0.32 and ±0.37. The sign degeneracy, similar to 
the 2H quadrupolar interaction, is due to the uniaxial nature of the dipolar interaction. The 
negative S values indicate a Cα-Hα angle of 70˚ (110˚) for POPC and 73˚ (107˚) for DLPC 
with respect to the bilayer normal. The existing M2TMP structural model, obtained from 
experiments conducted on DMPC bilayers, gives a Cα-Hα orientation of 73˚ or 107˚ from 
the bilayer normal, in excellent agreement with the present data. 
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Figure 3.6. 13C-1H DIPSHIFT curves of 13Cα-L40 in M2TMP in different membrane samples. (a) 
POPC aqueous sample (P/L = 1:20). (b) POPC organic sample (P/L = 1:15). (c) DLPC organic 
sample (P/L = 1:15). The POPC aqueous sample (a) gave a rigid-limit 13C-1H dipolar coupling 
whereas the two organic samples (b, c) have motionally averaged dipolar couplings.  
 
The similarity of the two C-H couplings belies the fact that the helix orientation is detectably 
different between the two membranes, as we show by 15N experiments below. Again, this is a 
result of the roughly perpendicular orientation of the Cα-Hα bond to the helix axis, which 
makes it not extremely sensitive to the helix tilt angle.  
 The same backbone uniaxial rotation also averages the Cα CSA, which can be 
measured under MAS using the recoupling experiment SUPER (33, 41). Figure 3.7 shows 
the CSA spectra of L40 in various membranes, obtained from the indirect dimension of the 
2D SUPER spectra. Only the organic DLPC sample in the liquid crystalline phase shows a 
motionally narrowed CSA (
€ 
δ=9.2 ppm) while the gel-phase sample or aqueous samples gave 
CSAs of 18 ppm, which is the rigid-limit CSA of α-helical Leu predicted by quantum 
chemical calculations (42). 
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Figure 3.7. 13C CSA spectra of the 13Cα-L40 in M2TMP in various membranes, extracted from the 
indirect dimension of 2D SUPER spectra. (a) DLPC organic sample at 318 K. (b) DLPC organic 
sample at 258 K. (c) DMPC aqueous sample at 310 K. (d) POPC aqueous sample at 298 K. Spectra 
(b-d) show rigid-limit CSAs, as simulated in (e). Spectrum (a) is the only one narrowed by fast 
backbone motion of the peptide. 
 
M2TMP orientation from powder samples using 15N NMR 
 To determine the orientation of α-helical peptides with high angular resolution, the 
most sensitive nuclear spin interactions are the N-H dipolar coupling and 15N CSA, as both 
tensors are roughly parallel to the helix axis. The PISEMA experiment, commonly used for 
aligned samples, correlates these two spin interactions in a 2D spectrum, producing wheel-
like patterns called “PISA wheels”. The size and frequency position of the PISA wheels 
depend on the tilt angle of the helices whereas the residue position on the wheel depends on 
the rotation angle around the helix axis (43, 44). Figure 3.8a shows the calculated PISA 
wheels for tilt angles of 15˚–45˚ for 0˚-aligned membranes. The center of the wheels shifts 
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towards lower frequencies in both dimensions as the tilt angle increases. When the alignment 
axis is perpendicular to the magnetic field, and the protein undergoes fast rotational 
diffusion, “90˚ PISA wheels” are obtained that are half-sized mirror images of the 0˚ PISA 
wheels (Equation 3.2), reflected around the isotropic shift and zero dipolar coupling axis 
(Figure 3.8b). These 90˚ wheels have been observed in membrane proteins bound to 
“unflipped” bicelles (45).  
 
 
Figure 3.8. Calculated PISA wheel spectra for (a) 0˚-aligned membranes, (b) 90˚-aligned membranes, 
and (c) 0˚ N-H coupling and 90˚ 15N chemical shift from unoriented membranes. Tilt angles of 15˚–
45˚ are shown. In (c), the resonances of A30, V28, and L26 at a tilt angle of 35˚ and with rotation 
angles reproducing the previous glass-plate aligned data are shown (11).  
 
 The presence of protein uniaxial rotation enables PISA wheels to be obtained from 
powder samples using MAS and static experiments. For example, N-H dipolar couplings can 
be measured in a site-specific fashion using the 2D DIPSHIFT (46) or LG-CP (47) 
experiments under MAS, giving the 
€ 
δ //  frequency or 0˚ dipolar coupling. The 15N CSA can 
be obtained from the 
€ 
δ⊥ singularity of the static 15N spectra of site-specifically labeled 
samples or by CSA recoupling experiments under MAS on multiply labeled samples. When 
the 0˚ dipolar coupling is correlated with the 90˚ chemical shift, we obtain 0˚/90˚ PISA 
wheels (Figure 3.8c). Whichever PISA wheels to use, multiple 15N-labeled residues are 
necessary to determine both the tilt and the rotation angles of the helix.  
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 We demonstrate this powder orientation determination approach by measuring the 15N 
chemical shift and N-H dipolar couplings of site-specifically labeled M2TMP. Figure 3.9 
shows static 15N spectra of M2TMP in DLPC and POPC organic membranes. L26, V28, and 
A30 were 15N-labeled to cover different rotational angles around the helix axis. Most spectra 
show well-defined 
€ 
δ⊥ singularities, 
€ 
δ// edges, and 
€ 
η = 0 lineshapes and a “magic-angle 
hole” at the isotropic shift. 
 
Figure 3.9. 15N static spectra of 15N-labeled M2 peptides in DLPC and POPC bilayers. (a) L26 of 
M2TMP in DLPC bilayers. (b) V28 of M2TMP in DLPC bilayers. (c) A30 of M2TMP in DLPC 
bilayers. (d) A30 of L38F-M2TMP in POPC bilayers. (e) V28 of M2TMP in POPC bilayers. (f) V28 
of M2(19-60) in DLPC bilayers. (g) Calculated rigid-limit 15N powder pattern.  
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This magic-angle hole results from the collinearity of the chemical shift tensor and the 
dipolar coupling tensor in uniaxially mobile molecules (48).  The exception is V28, whose 
€ 
δ⊥ singularity nearly coincides with the isotropic shift in various samples so that the magic-
angle hole is not visible (Figure 3.9b, e, f). This indicates that the V28 main 15N chemical 
shift tensor axis, which is near its N-H bond, is incidentally aligned near the magic angle 
with respect to the bilayer normal, so that the CSA tensor is motionally averaged to vanishing 
anisotropies. Also observed is a 6 ppm difference in the A30 
€ 
δ⊥ frequency between DLPC 
and POPC bilayers (Figure 3.9c, d), indicating that the helix orientation differs between the 
two lipid bilayers.  
 Figure 3.10 shows the N-H dipolar-doubled DIPSHIFT curves of the same 15N 
labeled residues. A range of couplings from 2.6 kHz to 8.5 kHz is observed. After taking into 
account the dipolar doubling and MREV-8 scaling factor, we find unscaled couplings from 
4.7 kHz to 9.0 kHz (Table 3.1). The rigid-limit one-bond N-H dipolar coupling is 10.5 kHz, 
thus these N-H bonds are variably tilted from the bilayer normal.  
 
Table 3.1: 15N 90˚ chemical shifts (ωN) and N-H dipolar couplings (ωNH) of several residues in M2 
peptides in various lipid membranes. 
15N-labeled peptide lipid bilayer ωN (ppm)  ωNH (kHz) 
L26, M2TMP DLPC 78±3 4.8 
V28, M2TMP DLPC 117±4 2.8 
V28, M2TMP POPC 106±4 6.3 
V28, M2(19-60) DLPC 123±3 NA 
A30, M2TMP DLPC 87±2 5.1 
A30, L38F-M2TMP POPC 81±3 9.0 
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Figure 3.10. N-H dipolar-doubled DIPSHIFT curves of selected residues of M2TMP in DLPC and 
POPC bilayers. (a) A30 of L38F-M2TMP in POPC bilayers. (b) A30 of M2TMP in DLPC bilayers. 
(c) V28 of M2TMP in POPC bilayers. (d) V28 of M2TMP in DLPC bilayers. The DIPSHIFT curve 
of crystalline rigid N-acetyl-valine (NAV) is shown in (a) for comparison. The best-fit N-H dipolar 
coupling (bold solid lines) is indicated for each site. All spectra were measured at 313 K under 3.23 
kHz MAS.  
 
 Figure 3.11 summarizes the N-H dipolar coupling and the 
€ 
δ⊥ 15N chemical shift of 
A30, V28, and L26 in DLPC and POPC bilayers. Superimposed on the experimental data are 
the best-fit 0˚/90˚ PISA wheels calculated using the ideal α-helical geometry. The DLPC 
data (filled squares) are best fit to a 0˚/90˚ PISA wheel of τ = 35˚±3˚. The rotation angle, 
determined by the relative positions of the three sites on the wheel, is 105˚, where ρ = 0˚ is 
defined by the Ser22 CO – Ser23 N peptide bond direction. With the same reference, the 
oriented-membrane 15N data gave a rotation angle of ~95° (11). L26 shows an 15N chemical 
shift that falls outside the calculated 35˚ PISA wheel, but the measured N-H dipolar coupling 
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is consistent with the predicted frequency for τ = 35˚. This may result from a deviation of the 
15N chemical shift tensor magnitude or orientation at this site from the literature value used in 
the simulation of the PISA wheel. Indeed, 15N chemical shift tensor variations in proteins can 
be significant, as shown by a recent study of the protein GB1 (49). Fortunately, the dipolar 
coupling information is intrinsically more accurate, which is the reason that N-H dipolar 
couplings only are used in the dipolar wave analysis for orientation determination (50). In 
POPC bilayers, the A30 and V28 data are best fit by a tilt angle of 26˚±3˚ and the same 
rotation angles. The N-H dipolar couplings are significantly larger than in DLPC bilayers and 
the 
€ 
δ⊥  chemical shifts are further away from the isotropic chemical shift. Both indicate 
larger anisotropies, which shift the 0˚/90˚ PISA wheels to a smaller tilt angle. Interestingly, 
as the PISA wheels become smaller, the tilt angle resolution improves, thus although the 
rotation angle is defined only by two residues, the precision of the tilt angle is still high.  
 
 
Figure 3.11. Orientation of M2TMP using 0˚/90˚ PISA wheels constructed from data collected from 
unoriented samples. The DLPC membrane results of A30, V28, and L26 are shown in filled squares 
and solid lines. The POPC membrane data are shown in open squares and dashed lines.  
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 The comparison between the DLPC and POPC data indicates clearly that the M2TMP 
helix tilt angle is affected by the membrane thickness: increasing the membrane thickness 
decreases the tilt angle, as expected for the hydrophobic thickness of the peptide to match the 
hydrophobic thickness of the lipid bilayer. The similar rotation angle between the two 
membranes is also expected, since the residues facing the pore lumen must be maintained to 
carry out the proton-conducting function (51). Mutation of key channel-facing residues can 
destabilize the channel (10, 52).  
 The tilt angle of 35±3˚ in the DLPC membrane is similar to, instead of larger than, the 
tilt angle found in the thicker DMPC membrane (11). This may be a result of the competition 
between increasing the tilt angle to minimize the hydrophobic mismatch and the need to 
maintain channel stability through sufficient hydrophobic contacts between the residues on 
different helices. The similarity suggests that a tilt angle of 35˚-38˚ is the maximum 
achievable for this peptide while still maintaining its tetrameric state.  
 Below this maximum tilt angle, M2TMP orientation appears to still depend on the 
membrane thickness. The current result that the peptide orientation differs between DLPC 
and POPC bilayers supports a recent EPR study showing that the intermolecular distance 
between spin-labeled M2 helices changes with the membrane thickness (20). The previous 
observation by Cross and coworkers that the M2TMP orientation doesn’t change 
significantly between DMPC and DOPC bilayers (19) may be coincidental: DOPC lipids 
differ from DMPC lipids not only in the chain length but also in having a double bond per 
chain, thus the lateral pressure of the two membranes differs. The unsaturated DOPC bilayer 
may laterally expand to adopt a similar thickness as the saturated DMPC bilayer, thus giving 
the same tilt angle for the M2 helices.  
 Figure 3.12 summarizes the orientation of M2TMP determined from the current 
study. M2TMP shows different tilt angles between DLPC and POPC bilayers. The P-P 
distances of the two membranes are ~30 Å and ~45 Å, respectively. The 25-residue M2TMP 
has a length of 37.5 Å if the ideal rise of 1.5 Å per residue is used. Thus a tilt angle of 35˚ 
and 26˚ yields, respectively, a vertical length of 31 Å and 34 Å, respectively. The former 
agrees well with the DLPC P-P distance, while the latter is shorter than the POPC P-P 
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distance but closer to the average between the estimated POPC hydrophobic thickness of 27 
Å and the P-P distance (20).  
 
 
Figure 3.12. Orientation of M2TMP helical bundles in membranes of different thicknesses. (a) DLPC 
bilayer. (b) POPC bilayer. The P-P boundaries of the bilayer are shown in orange. The peptide 
lengths and P-P distances are shown to scale. Red: hydrophobic residues. Blue: polar and charged 
residues. The tilt angle of M2TMP is 35˚ in DLPC bilayers and 26˚ in POPC bilayers.  
  
M2(19-60) orientation from powder samples using 15N NMR 
 Finally, we apply this powder orientation determination technique to a longer 
construct of the M2 protein, M2(19-60), whose orientation has not been determined before. 
This construct encompasses all the structured regions of the M2 protein, and has been shown 
to be functional in oocytes (7). With a molecular weight of 4878, the M2(19-60) peptide 
would be more difficult to align than M2TMP. Figure 3.9e shows the static 15N spectrum of 
V28 in M2(19-60) bound to DLPC bilayers: a chemical shift of 123 ppm is observed, similar 
to the value found for M2TMP in the same membrane. Since the rotation angle of the protein 
is fixed, the similarity in the 15N CSA indicates that M2(19-60) has the same tilt angle as 
M2TMP within experimental uncertainty. This implies that structural conclusions made on 
the M2TMP helical bundle can be reasonably extrapolated to the longer peptide. 
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Interestingly, the V28 15N chemical shift lineshape in M2(19-60) is much narrower than in 
M2TMP, suggesting that the inclusion of the extra-membrane residues creates a 
conformationally more homogeneous peptide.  
 Although a complete investigation of M2(19-60) is beyond the scope of the current 
paper, the data is quite interesting with respect to the role of the C-terminal helix in 
influencing the properties of the M2 proton channel. Previous studies of M2TMP suggested 
that the tetramer formed by this peptide had multiple conformations, some of which could be 
stabilized by specific mutations to its sequence (53).  The decrease in heterogeneity in 
M2(19-60) versus M2TMP suggests that the C-terminal helix helps specifically stabilize one 
or a small subset of conformations within the transmembrane helix. Furthermore, the C-
terminal helix lies just C-terminal to and structurally interacts with the His37-Trp41 pair that 
forms the proton selectivity filter in M2. Thus, it might modulate the properties of this 
essential motif, which is known to be required for proton conduction. Finally, while we have 
not yet made measurements involving labeled residues in the C-terminal helix, it is clear that 
the present approach has considerable promise for examining the conformation of this region 
of the protein.   
 
Conclusion  
 We have shown that in the presence of fast uniaxial rotational diffusion, orientation-
dependent PISA wheels in a 2D N-H/N correlation pattern can be obtained from unoriented 
membrane protein samples. This allows membrane protein orientation to be determined 
without macroscopic alignment, thus offering an important opportunity for studying 
membrane proteins that naturally disrupt lipid bilayers or that are difficult to align. In this 
work the M2TMP samples are studied under conditions where the peptide forms tetrameric 
helical bundles, as determined by separate 19F spin diffusion experiments. Thus, the observed 
fast uniaxial motion of the whole helical bundle, with a total molecular weight of 10.9 kDa, 
indicates that membrane proteins with an effective size smaller than 100 residues have the 
requisite uniaxial mobility to give orientation-dependent NMR spectra for interactions as 
large as the 2H quadrupolar coupling. But since the spin interactions most sensitive to helix 
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orientations are 15N-related tensors, the minimum required rotational diffusion rates is much 
lower (Figure 3.1), and membrane proteins with a radius as large as 30 Å should be 
accessible to this powder sample approach using 15N NMR. Further experiments are 
necessary to show whether uniaxial rotations fast compared to the 15N NMR timescale are 
indeed general in larger proteins. In addition to the protein molecular weight, the P/L ratio 
may also affect the uniaxial rotational rate. The motionally averaged spectra shown here were 
obtained from samples containing relatively high mass concentrations of peptide, ~20%. This 
suggests that it is not necessary to lower the protein concentration significantly to ensure 
motion. Instead, it is more important to maintain the protein or peptide assembly in their 
natural functional states without non-specific aggregation, as indicated by the dramatically 
different mobilities observed between the organically mixed and aqueous mixed M2TMP 
samples.   
 The powder samples allow MAS experiments to be used for orientation 
determination. Combining 13C and 15N labeling, one can in principle employ 
multidimensional correlation experiments to simultaneously extract multiple orientational 
constraints. While for demonstration we only measured site-specifically 15N-labeled samples 
here, the 2D N-H DIPSHIFT and 15N CSA filter experiments can be extended to three 
dimensions, where an additional 13C chemical shift dimension can be used to resolve multiple 
residues in the protein. The main challenge will be to conduct these experiments in the 
liquid-crystalline phase of the membrane where the protein is mobile, with motionally 
averaged dipolar couplings for polarization transfer.   
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Abstract  
 A 13C-detected N-H dipolar coupling technique is introduced for uniaxially mobile 
membrane proteins for orientation determination using unoriented samples. For proteins 
undergoing rigid-body uniaxial rotation in the lipid bilayer, the intrinsic equality between the 
dipolar coupling constants measured in unoriented samples and the anisotropic coupling 
measured in static oriented samples has been shown recently. Here, we demonstrate that the 
orientation-sensitive backbone N-H dipolar couplings can be measured with 13C detection 
using 2D and 3D MAS correlation experiments, so that maximal site resolution can be 
achieved and multiple orientational constraints can be extracted from each experiment. We 
demonstrate this technique on the M2 transmembrane peptide of the influenza A virus, where 
the N-H dipolar couplings of various residues fit to a dipolar wave for a helical tilt angle of 
37˚, in excellent agreement with data obtained from singly 15N-labeled samples.  
 
Introduction 
 Orientation determination of membrane proteins by solid-state NMR traditionally 
requires mechanically or magnetically aligned proteins under the static condition (1, 2). The 
alignment results in resolved spectra with anisotropic frequencies - chemical shift or dipolar 
coupling – indicative of the protein orientation relative to the membrane normal. While this 
approach has been successfully used to determine the orientation of many membrane 
peptides and proteins (1, 3), macroscopic alignment is a rate-limiting step to this technique. 
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High-quality alignment usually requires extensive optimization of sample conditions such as 
the types of lipids, the protein/lipid molar ratio, and the degree of hydration. These factors 
can severely restrict the determination of membrane protein orientation. To facilitate 
membrane protein orientation determination, we have recently introduced a powder sample 
approach that relies on the presence of uniaxial rotational diffusion of the protein in the lipid 
bilayer (4, 5). When the protein undergoes rigid-body uniaxial rotation with respect to the 
bilayer normal, the NMR order parameters depend on the angle between the molecule-fixed 
spin interaction tensor and the motional axis. Thus, by measuring the motionally averaged 
dipolar couplings or chemical shift anisotropies in powder samples, one can extract the same 
orientation information as in aligned samples.  
 We previously demonstrated this powder-sample orientation determination technique 
on a tetrameric α-helical bundle, the M2 transmembrane domain (M2TMP) of the influenza 
A virus, by measuring, on singly 15N-labeled samples, the static 15N chemical shift powder 
patterns and the N-H dipolar couplings under magic-angle spinning (MAS) using the 
DIPSHIFT (6) method (4). The choice of 15N spin interactions is natural because their 
principal axis systems are approximately along the helix axis, thus their spectra are sensitive 
to the tilt and rotation angles of the helical axis. However, to obtain many orientational 
constraints simultaneously, static chemical shift anisotropy (CSA) measurement with no site 
resolution is clearly undesirable. Even if MAS-based 2D 15N CSA or N-H dipolar recoupling 
techniques are used to give site-resolved information, the 15N isotropic shift resolution is 
usually limited compared to the 13C spectra. The chemical shift ranges for α-helical proteins, 
defined as twice the standard deviations, are about 6.0 ppm for 15N and 8.5 ppm for 13Cα (7). 
Considering that the typical 13C linewidths of membrane proteins are 1-2 ppm whereas the 
15N linewidths are often about 3 ppm, the effective resolution, estimated as the shift 
range/linewidth ratio, is 2-4 times higher for 13Cα than 15N. Moreover, 13C detection has 
higher sensitivity than 15N. Thus, it is desirable to convert the 15N-detected N-H dipolar 
coupling experiment to 13C detection. Further, it would be desirable to use two chemical shift 
dimensions instead of one to resolve the resonances and using a third dimension to sample 
the N-H dipolar evolution. The challenge is to carry out the necessary coherence transfer 
between 13C and 15N nuclei under the condition that the protein is mobile, which entails 
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reduced dipolar couplings and possibly unfavorable relaxation properties. Provided that this 
coherence transfer is feasible, the N-H dipolar couplings from multiple residues can be 
measured simultaneously with 13C detection to map out the orientation of the protein. It is not 
essential to measure the 15N chemical shift anisotropies since the N-H dipolar couplings 
exhibit a periodicity with respect to residue number that is already sufficient for determining 
the helix orientation. The residue-periodic N-H dipolar couplings yield the so-called dipolar 
wave (8), which contains full information on the tilt and rotation angles of the protein. In this 
work, we show that such a 13C-detected N-H dipolar wave method is indeed feasible under 
MAS for an unoriented membrane protein with the requisite uniaxial mobility.  
 
Materials and Methods 
Uniformly 13C, 15N-labeled and Fmoc-protected amino acids were either obtained 
from Sigma (Miamisburg, OH) and Cambridge Isotope Laboratories (Andover, MA), or 
prepared in house.  The transmembrane domain of the M2 protein of the Udorn strain of 
influenza A virus (9) was synthesized by PrimmBiotech (Cambridge, MA) and purified to 
>95% purity. The amino acid sequence is SSDPLVVAASIIGILHLILWILDRL. Two peptide 
samples each containing four U-13C, 15N-labeled residues were synthesized. The first sample 
contains 13C, 15N-labeled residues at L26, A29, G34 and I35. The second sample contains 
labels at V27, A30, I33 and L38.  
M2TMP was reconstituted into liposomes by a detergent dialysis protocol (10). 
Briefly, 1,2-dilauroyl-sn-glycero-3-phosphatidylcholine (DLPC) (Avanti Polar Lipids) was 
suspended in 1 mL phosphate buffer (10 mM Na2HPO4/NaH2PO4, 1 mM EDTA, 0.1 mM 
NaN3, 10 mM amantadine) at pH 7.5. 10 mM amantadine is present in all solutions. The lipid 
solution was vortexed and freeze-thawed to make uniform vesicles of about 200 nm in 
diameter. M2TMP was codissolved with the detergent octyl-β-D-glucopyranoside (OG) in 2 
mL phosphate buffer at an OG concentration of 30 mg/mL. The M2TMP/OG solution was 
then mixed with the DLPC vesicle solution, reaching an OG concentration of 15 mg/mL. The 
mixture was vortexed for 1 hour, allowed to stand for 6-8 hours at room temperature, and 
dialyzed against 1 L phosphate buffer at 4°C while changing the buffer every 8-12 hours for 
3 days. The dialyzed M2TMP/DLPC solution was centrifuged at 150,000 g for 3 hours at 
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10˚C to give a membrane pellet that is about 50 wt% hydrated. The final protein/lipid molar 
ratio is 1:15. UV-VIS absorption and photometric assay of the supernatant showed 98% 
binding of the peptide to the membrane.  
 Solid-state NMR experiments were carried out on a Bruker AVANCE-600 (14.1 
Tesla) spectrometer using a 4 mm triple-resonance MAS probe. Typical 90° pulse lengths for 
1H, 13C and 15N were 4 µs, 5 µs and 6 µs respectively. 1H decoupling strengths were 71 kHz 
during 13C-15N REDOR and acquisition, and 76.5 kHz FSLG homonuclear decoupling during 
N-H dipolar dephasing.  
 N-H dipolar waves for various orientations were calculated using a home-written 
Fortran program. A 25-residue ideal α-helix is used as the input structure for the calculation 
and is rotated to different tilt angles with respect to the z-axis. The calculated N-H dipolar 
couplings are plotted against the residue number and fit to a sinusoidal equation 
€ 
y τ,ρ( ) = C(τ) + A(τ)sin 2n ⋅ 100360 + φ(ρ)( )π( ) , where the offset C(τ) and amplitude A(τ) reflect 
the tilt angle while the phase φ(ρ) of the wave depends on the rotation angle ρ. The rotation 
angle in the simulation was fixed to within 10˚ by our previous orientation data obtained in 
DLPC bilayers (4, 11) and the data of Cross and coworkers measured in DMPC bilayers (12). 
It was subsequently held constant in the simulations. This is reasonable because the proton 
channel function of the M2TMP helical bundle dictates that the helices have a well defined 
rotation angle that places certain residues in the channel lumen to carry out the proton 
conduction and gating functions (13).  
 
Results and Discussion 
Pulse sequence 
 Figure 4.1 shows the 13C-detected N-H dipolar coupling pulse sequences in the 2D or 
3D mode. 13C-15N two-spin coherences are generated from 13C magnetization by a REDOR 
pulse train (14). The resulting 15N antiphase magnetization is allowed to evolve under the 
scaled N-H dipolar coupling for a period t1. Subsequently, 15N chemical shift evolution may 
be added as the t2 dimension if the 3D experiment is desired. The 15N antiphase 
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magnetization is then reconverted back to 13C magnetization using an identical REDOR pulse 
train, and detected in the t3 period. Thus, the 13C and 15N coherence transfer is achieved in an 
out-and-back heteronuclear single-quantum coherence fashion (15).  
 
 
Figure 4.1. Pulse sequence for the 13C-detected N-H dipolar coupling measurement. The 1H 
homonuclear decoupling sequence depicted is FSLG. The optional 15N chemical shift evolution 
period can be inserted to make this a 3D experiment to enhance site resolution.  
 
 During the N-H dipolar evolution period, frequency-switched Lee-Goldburg (FSLG) 
1H homonuclear decoupling (16) was applied for a whole rotor period, while a 15N 180˚ pulse 
was moved through the rotor period to induce dipolar dephasing. A second rotor period with 
1H heteronuclear decoupling and a synchronously moving 15N 180˚ pulse refocuses the 
chemical shift anisotropy encoded in the first rotor period while retaining the N-H dipolar 
phase. As shown before, this method doubles the dipolar dephasing compared to the case of 
incrementing the 1H homonuclear decoupling period (17). Due to the short cycle time of the 
FSLG sequence, relatively fast spinning speeds of 7-10 kHz can be used, which is necessary 
for suppressing residual 13C-13C dipolar interactions in uniformly 13C labeled proteins.  
 
Model peptide formyl-MLF 
 We first demonstrate this 13C-detected N-H dipolar coupling experiment on U-13C, 
15N-labeled formyl-MLF, a rigid crystalline peptide with good spectral resolution (18, 19). 
Figure 4.2 shows the 15N 1D CP-MAS spectrum and the 13C spectrum after passing through 
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the 13C-15N REDOR filter. For this well ordered crystalline peptide, the 15N spectrum is 
already resolved for the three sites; however this is not generally true for membrane proteins. 
Figure 4.2c-d show the 2D 13C-15N correlation spectra with no N-H dipolar evolution (c) and 
with half a rotor period of dipolar evolution (d), measured using the 3D mode of the pulse 
sequence in Figure 4.1. Both spectra were plotted with the same absolute-intensity contour 
levels to show the intensity reduction after 65 µs of N-H dipolar evolution. At 7 kHz MAS, 
65 µs corresponds to half a rotor period of net evolution. A 1H FSLG t360˚ pulse length of 
13.06 µs was used in the experiment.  
 
 
Figure 4.2. Detecting N-H dipolar dephasing of formyl-MLF by 13C detection. (a) 15N CP-MAS 
spectrum. (b) 13C MAS spectrum after a 1.42 ms 13C-15N REDOR filter. (c) 2D 13C-15N correlation 
spectrum with no N-H dipolar dephasing. (d) 2D 13C-15N correlation spectrum with 65 µs N-H dipolar 
dephasing. The data were obtained under 7 kHz MAS at ambient temperature.  
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 The N-H dipolar dephasing curves of the three residues are plotted in Figure 4.3. The 
data of three experiments are shown: the normal 2D 15N-detected DIPSHIFT curves 
(triangles), the 2D 13C-detected DIPSHIFT curves (open squares) using the pulse sequence of 
Figure 4.1 without 15N chemical shift evolution, and the 3D 13C-15N resolved DIPSHIFT 
curves (filled squares). All three methods produced the same couplings of 11.7 kHz for each 
residue within experimental uncertainty, which is ±0.5 kHz or smaller. The 13C-detected 
spectra were obtained using a 13C-15N REDOR mixing time of 1.42 ms, including the 
excitation and reconversion periods. When shorter 13C-15N mixing times were used, we found 
that the 13C-detected N-H dipolar couplings decreased by ~10%, indicating incomplete 
powder averaging that biases the N-H dipolar couplings. With 1.42 ms of 13C-15N REDOR 
coherence transfer, the sensitivity of the experiment on formyl MLF is about 10% of CP. 
Overall, the consistency between the 13C-detected and 15N-detected N-H dipolar dephasing 
indicates that the technique indeed works as expected.  
 
 
Figure 4.3. N-H dipolar dephasing curves of the three residues of formyl-MLF, measured by three 
methods: 15N-detected 2D DIPSHIFT (open triangles), 13C-detected 2D DIPSHIFT (open squares), 
and 13C-15N resolved 3D DIPSHIFT (filled squares).  
 
Influenza A virus M2 transmembrane peptide 
For motionally averaged proteins in lipid membranes, the intrinsic sensitivity of the 
13C-detected N-H dipolar coupling experiment is lower due to the small amount of protein in 
a sample that is largely composed of lipid, and due to the lower efficiency of the 13C-15N 
coherence transfer. Due to motion, the 13C-15N dipolar coupling driving the coherence 
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transfer is scaled by the order parameter 
€ 
S ≡ δ δ = 12 3cos
2 θ−1( ), where θ is the angle 
between the C-N bond and the motional axis. It is thus necessary to test the feasibility of this 
technique in a real membrane protein under the condition of uniaxial mobility. We chose the 
M2 transmembrane protein of the influenza A virus, since its tetrameric helical bundle (20) 
has been shown to undergo rigid-body uniaxial rotational diffusion around the bilayer normal 
in DLPC, DMPC and POPC bilayers (4, 21). We carried out the experiment on M2TMP 
reconstituted in DLPC bilayers with the drug amantadine present (22). The use of amantadine 
is essential for the experiment because the drug significantly orders the peptide structure 
(11), which is manifested by much higher spectral resolution and longer 13C T2 relaxation 
times (11). Without amantadine, the Cα T2 values are only 1.0 – 1.8 ms, which makes the 
efficiency of 13C-15N coherence transfer prohibitively low. With amantadine, the Cα T2 
increases to 2.1 – 3.5 ms (11).  
Figure 4.4a shows the 15N CP-MAS spectrum of one of the M2TMP samples. While 
the linewidth is quite narrow for a membrane protein, two of the sites still overlap 
completely. The corresponding 13C spectrum after 1.42 ms of REDOR filter (Figure 4b), on 
the other hand, shows complete resolution of the Cα signals. The use of the 13C-15N REDOR 
filter not only selected the Cα signals of the protein but also completely removed the lipid 
background 13C signals, thus significantly simplifying spectral assignment. Two 
representative N-H dipolar dephasing curves, for residues I35 and G34, are shown in Figure 
4.4(c-d). The curves were measured with 13C detection without 13C-15N correlation. The two 
residues show very different N-H dipolar couplings of 3.0 kHz and 6.1 kHz, indicating the 
difference in their N-H bond orientations relative to the motional axis. The two residues have 
very different sensitivities in the 13C spectrum; but even the less sensitive G34 signal gave a 
self-consistent dephasing curve.  
A total of six N-H dipolar couplings were resolved and measured in this way. They 
are plotted with respect to the residue number and shown in Figure 4.5. Indeed, the data fit to 
a periodic pattern, which is best represented by a dipolar wave for an ideal helix whose axis 
is tilted by 37˚ from the bilayer normal. This is in good agreement with the recently 
measured M2TMP tilt angle in the DLPC bilayer using singly 15N-labeled samples (4, 11).  
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Figure 4.4. N-H dipolar couplings of 13C, 15N-labeled amantadine-bound M2TMP in DLPC bilayers 
at 313 K. (a) 1D 15N CP-MAS spectrum. Two of the four 15N labels overlap completely. NS = 5120. 
(b) 13C MAS spectrum after 1.42 ms 13C-15N REDOR filter. All four 13Cα labels are resolved. NS = 
27,648. (c, d) 13C-detected N-H dipolar dephasing curves for I35 (c) and G34 (d). The couplings 
indicated are the true values after dividing the fit values by 1.154 = 0.577 x 2 to take into account the 
FSLG scaling factor 0.577 and the doubling factor of 2. The experiment was conducted under 7 kHz 
MAS.  
 
Figure 4.5. 13C-detected N-H dipolar couplings of M2TMP as a function of residue number. The 
peptide is bound to DLPC bilayers with the drug amantadine present. The calculated wave 
corresponds to a tilt angle τ of 37˚. The calculated wave for a tilt angle 27˚ is also shown for 
comparison (dotted line).  
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In Figure 4.5, two sites, A30 and L38, exhibit couplings significantly larger than the 
expected values for the 37˚ dipolar wave. At present we do not know the exact reason for 
these outliers. They may partly reflect a true helix axis orientation difference. Cross and 
coworkers recently reported that the helical segment C-terminal to G34 in M2TMP is kinked 
from the N-terminal segment in the presence of amantadine (23). Using glass-plate aligned 
DMPC membranes, they found a tilt angle of 30˚ for residues N-terminal to G34 but 20˚ for 
residues C-terminal to it. A similar helix kink may be present in the current DLPC bilayers as 
well, which could then explain the L38 data. More residues C-terminal to G34 need to be 
measured to test this hypothesis. Alternatively, the larger couplings could result from 
deviation of the helix from the ideal backbone conformation. It is certain that the abnormally 
large couplings do not result from the lack of uniaxial rotation, since the 2H spectrum of CD3-
labeled A29 in the same sample showed a quadrupolar coupling of 15.5 kHz (not shown), 
which is much narrower than the 40 kHz expected when methyl rotation is the only motion. 
In other words, the peptide backbone must undergo reorientational motion to reduce the Cα-
Cβ order parameter of A29 to an effective value of 0.39 (relative to the methyl group rigid 
limit of 40 kHz). We can also rule out segmental motion of A30 and L38 as the reason for the 
outliers, since any internal motion additional to the whole-body motion can only make the 
couplings smaller, instead of bigger, than the expected values. Thus, either a true helix 
orientation change or non-ideal backbone conformation at these residues account for the 
abnormal N-H couplings.  
 
Sensitivity of the MAS 13C-detected N-H dipolar wave experiment 
 The 13C-detected N-H DIPSHIFT data on the amantadine-complexed M2TMP 
samples required signal-averaging of 23,000-27,000 scans per t1 slice and nine t1 slices, thus 
resulting in a total experimental time of about 5 days per sample. The efficiency of the 
experiment compared to CP is 5-15%, depending on the 13C T2 of the individual residues. To 
increase the sensitivity of the experiment, one could use an alternative method for C-N 
coherence transfer, which is double cross polarization (CP). The 15N magnetization can be 
directly polarized from 1H and evolves under the N-H dipolar coupling. It can then be 
transferred to 13Cα by frequency-specific CP (24). Our tests on formyl-MLF showed that 
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indeed this SPECIFIC-CP method has a higher efficiency of ~40% compared to REDOR at a 
15N-13C contact time of 3 ms. However, with 3 ms contact, the 13C-detected N-H dipolar 
couplings were about 12% weaker than the rigid-limit value (10.4 kHz instead of 11.7 kHz) 
measured using the direct 15N-detected DIPSHIFT experiment, suggesting incomplete 
powder averaging. Increasing the N–C CP contact time to as much as 7 ms did not change 
the situation. The dephasing value at the middle of the rotor period for Leu was 0.39 for the 
13C-detected DIPSHIFT experiment versus 0.31 for the direct 15N-detected experiment. For 
all sites, a 25-50% increase in the intensity in the middle of the rotor period is seen, 
indicating weaker dipolar couplings. Moreover, using a long C-N contact time places a 
higher demand on the probe due to the simultaneous radiofrequency (rf) irradiation. In real 
membrane proteins with the requisite mobility, long contact times may also cause potential 
T1ρ losses. These shortcomings may be circumvented, however, if the reduced dipolar 
couplings due to incomplete powder averaging can be calculated and corrected for, in which 
case this CP-based DIPSHIFT method would be significantly more sensitive.  
 
Conclusion 
 In conclusion, we have demonstrated an MAS 13C-detected N-H dipolar coupling 
technique to simultaneously extract multiple orientational constraints of membrane proteins 
in unoriented lipid bilayers by virtue of their uniaxial motion. The enhanced site resolution 
provided by 13C chemical shifts is a significant advantage over the 15N-detected experiment, 
and the ability to extend this approach to 3D to further resolve resonances makes this 
approach more applicable to larger membrane proteins. The elimination of sample alignment 
and the adoption of MAS technology for orientation determination are major advantages of 
this approach. In this way, multiple orientation-dependent N-H dipolar couplings can be 
measured to yield dipolar waves, from which both the helix orientation and helical structure 
defects can be detected.  
For this 13C-detected 15N-1H dipolar wave technique to be generally applicable, long 
13C T2 is essential to facilitate the 13C-15N coherence transfer. In the case of the M2TMP 
helical bundle, the use of a natural channel blocker, amantadine, made the dynamic property 
of the protein sufficiently favorable to be amenable to this technique. Future development of 
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more efficient coherence transfer techniques for mobile systems will be desirable to further 
increase the sensitivity of this class of techniques.  
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Abstract  
 The M2 protein of influenza A virus forms a transmembrane proton channel 
important for viral infection and replication. Amantadine blocks this channel, thus inhibiting 
viral replication. Elucidating the high-resolution structure of the M2 protein and its change 
upon amantadine binding is crucial for designing antiviral drugs to combat the growing 
resistance of influenza A viruses against amantadine. We employed magic-angle-spinning 
solid-state NMR to determine the conformation and dynamics of the transmembrane domain 
of the protein, M2TMP, in the apo- and amantadine-bound states in lipid bilayers. 13C 
chemical shifts and torsion angles of the protein in DLPC bilayers indicate that M2TMP is a-
helical in both states, but the average conformation differs subtly, especially at the G34-I35 
linkage and V27 sidechain. In the liquid-crystalline membrane, the complexed M2TMP 
shows dramatically narrower lines than the apo-peptide. Analysis of the homogeneous and 
inhomogeneous linewidths indicates that the apo-M2TMP undergoes significant 
microsecond-timescale motion, and amantadine binding alters the motional rates, causing 
line narrowing. Amantadine also reduces the conformational heterogeneity of specific 
residues, including the G34/I35 pair and several sidechains. Finally, amantadine causes the 
helical segment N-terminal to G34 to increase its tilt angle by 3˚, and the G34-I35 torsion 
angles cause a kink of 5˚ in the amantadine-bound helix. These data indicate that amantadine 
affects the M2 proton channel mainly by changing the distribution and exchange rates among 
multiple low-energy conformations, and only subtly alters the average conformation and 
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orientation. Amantadine-resistant mutations may thus arise from binding-incompetent 
changes in the conformational equilibrium.  
 
Introduction  
 The M2 protein of the influenza A virus forms a membrane-bound proton channel 
that acidifies the endosomally trapped virus, which triggers the release of the viral RNA into 
the infected cell, initiating viral replication (1, 2). The cationic amine amantadine inhibits 
viral replication by blocking this proton channel, thus has been used for the prophylaxis and 
treatment of influenza A infections (3, 4). However, in the last few years amantadine 
resistance skyrocketed among influenza A viruses in Asia and North America (5), making it 
imperative to develop alternative antiviral drugs.  
 The M2 protein contains a transmembrane a-helical domain (6) that has the essential 
amantadine-sensitive proton channel activity of the intact protein (7). Mutagenesis and 
electrophysiological experiments showed that the residues important for proton conduction 
and amantadine interaction lie on one face of the helix, namely V27, A30, S31, and G34 (8, 
9). Neutron diffraction data indicated that the amantadine ring is localized at ~6 Å from the 
center of DOPC bilayers, close to V27 (10). Fourier analysis of the periodic oscillations in 
the channel reversal potential, pH-sensitive current, and amantadine resistance of cysteine 
mutants of the M2 protein yielded a functional structure of the channel (11). The active form 
of the channel is a tetramer for the intact protein (12, 13) as well as the transmembrane 
peptide (M2TMP) (14), as shown by 19F solid-state NMR (SSNMR) of the membrane-
bound peptide.  
 The most extensive molecular-level structural information of M2TMP came from 
static 15N SSNMR data of Cross and coworkers. Using uniaxially aligned lipid membranes, 
they determined the orientation of M2TMP in the apo- (15) and complexed (16) states from 
15N chemical shift and N-H dipolar couplings. The apo-peptide is tilted by 38˚ from the 
bilayer normal (15), whereas the amantadine-complexed peptide exhibits a kink with 31˚ and 
20˚ tilt angles (16). However, sample preparation conditions such as solvents, membrane 
composition and peptide concentration varied greatly in these studies, which may contribute 
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to the observed orientation difference. From the 15N orientational data no direct information 
on the backbone and sidechain conformations can be extracted. The sidechain conformation 
may be especially sensitive to amantadine binding, yet so far only one 13C-15N distance (17) 
and four 19F-19F distances (14, 18) have been reported. Recently, amantadine was found to 
cause substantial narrowing of the 15N NMR spectra (19, 20), suggesting that it either 
reduces the conformational heterogeneity or changes the dynamics of the protein, but which 
factor dominates is unknown.   
 To elucidate the atomic-resolution conformation and dynamics of the backbone and 
sidechains of this important proton channel with and without amantadine, we have employed 
magic-angle-spinning (MAS) 13C and 15N NMR techniques on M2TMP bound to DLPC 
bilayers. To identify sites of structural perturbation, we measured and compared the 13C and 
15N isotropic shifts and torsion angles of eight residues spread throughout the peptide. The 
data indicate that amantadine most significantly perturbs the backbone of G34 and I35 and 
the sidechain of V27. Analysis of the homogeneous and inhomogeneous 13C linewidths in 
the gel and liquid-crystalline (LC) phases of the membrane indicates that the apo-peptide 
backbone undergoes significant motion on the microsecond timescale. Amantadine binding 
alters the motional rates and reduces the conformational distribution. Thus the central feature 
of M2TMP structure appears to be the presence of multiple low-energy conformations, which 
are readily modified and selected by amantadine.  
 
Results and Discussion 
M2TMP conformation with and without amantadine 
 We chose eight residues in M2TMP for 13C and 15N labeling. Based on the 
approximate seven-residue periodicity of the protein (11), these sites cover channel-lining 
positions (V27, A30, and G34), helix-helix interfaces (L26, I33, L38), and lipid-facing 
positions (A29, I35). In this way, we assess the impact of amantadine binding to M2TMP 
structure from all regions of the tetrameric bundle. Two peptides were synthesized that each 
contains four uniformly 13C, 15N-labeled residues. The “LAGI” sample contains labeled L26, 
A29, G34 and I35, and the “VAIL” sample contains labeled V27, A30, I33, and L38. Figure 
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5.1 shows representative 13C cross-polarization (CP) MAS spectra of the peptide in DLPC 
bilayers with (red) and without (black) amantadine at 303 K. The 13C isotropic linewidths 
narrow substantially upon amantadine binding. In the apo peptide many backbone signals 
such as G34 Cα are broad and poorly defined, while with amantadine all Cα resonances 
narrow and increase in intensity. Sidechain signals are also narrowed but less dramatically. 
This 13C line narrowing is similar to that seen in 15N spectra of the protein (16, 19). In the 
next section we investigate the origin of this line narrowing.  
 
Figure 5.1. 13C CP-MAS spectra of M2TMP at 303 K with (red) and without (black) amantadine. (a, 
b) LAGI. (c, d) VAIL. Note the significant line narrowing and intensity increase in the presence of 
amantadine.  
 
 To determine the M2TMP conformation and its perturbation by amantadine, we 
measured the 13C and 15N isotropic chemical shifts of the peptide without and with 
amantadine. 13C-13C 2D double-quantum (DQ) filtered correlation spectra and 15N-13C 
correlation spectra were measured at 243 K where the peptide motion is frozen. Both spectra 
remove all lipid natural-abundance 13C signals, thus simplifying resonance assignment. 
Figure 5.2 shows the 2D 13C-13C correlation spectra of LAGI and VAIL with (red) and 
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without (black) amantadine. The spectra are readily assigned based on the connectivity 
patterns. Various chemical shift changes are observed, for example at V27α, A30β, I35γ1 
and L38β. The largest Cα shift change occurs at V27, which exhibits a 1.0 ppm upfield shift 
in the complex. G34 Cα is not detected in the 2D 13C-13C correlation spectrum due to the DQ 
excitation condition, but its signal is visible in the 2D 15N-13C spectra (Figure 5.7, supporting 
information) and shows a downfield 15N chemical shift change of 2.5 ppm. Interestingly, the 
two Ile residues flanking G34 also exhibit 15N chemical shift changes but in opposite 
directions, causing their amantadine-bound 15N shifts to differ by 5.8 ppm. Table 5.2 
(supporting information) lists the isotropic shifts of the apo and complexed M2TMP.  
Despite the chemical shift perturbations by amantadine, no change is large enough to 
indicate a non-helical structure (21). This is reflected by the positive Cα and C’ secondary 
shifts and negative Cβ secondary shifts (Figures 5.3a-c) for all eight labeled residues. Figure 
5.3d plots the amantadine-induced average absolute chemical shift changes of each residue. 
The maximum perturbation occurs at the channel-lining G34, followed by its adjacent I35 
and I33. A second local maximum is seen at V27, consistent with its proximity to amantadine 
(10). In terms of residue location, the channel-lining residues, the interfacial residues, and the 
lipid-facing residues except for the G34-neighboring I35 have average chemical shift 
changes of 0.79 ppm, 0.46 ppm, and 0.33 ppm, respectively.  
To obtain more quantitative conformational constraints, we measured φ, ψ, and χ1H 
torsion angles using dipolar correlation techniques. The φ angles of all labeled residues 
except for G34 were measured using the HNCH technique (22), which correlates the N-H 
and Cα-Hα bond orientations of each residue. Most φ angles fall between –45˚ and –85˚, 
with no large difference between the apo and complexed peptide within the angular 
resolution of the technique (Figure 5.4a, Table 5.1). 
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Figure 5.2. 2D 13C-13C DQ filtered spectra of M2TMP in DLPC bilayers without (black) and with 
(red) amantadine at 243 K. Intra-residue connectivities and cross peaks with chemical shift changes 
are indicated. (a) LAGI. (b) VAIL. (c) Selected 1D cross sections that exhibit line narrowing and 
chemical shift changes upon amantadine binding. The G34α trace was extracted from 1D CP spectra.  
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Figure 5.3. Amantadine-induced isotropic shift and T2 changes of M2TMP. Secondary shifts are 
plotted for (a) Cα, (b) Cβ, and (c) C’. Open and filled bars correspond to the apo- and complexed 
M2TMP, respectively. The average chemical shift uncertainty is 0.35 ppm, estimated from the 
intrinsic linewidths of the spectra. (d) Average absolute chemical shift changes (filled squares) and 
fractional 13C T2 increase at 303 K (open circles). Local maxima of chemical shift and T2 perturbation 
occur at V27 and G34.  
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Figure 5.4. Selected torsion angle data of M2TMP without (open squares) and with (filled squares) 
amantadine, along with their RMSD-quantified best-fit simulations (lines). Red lines: best-fit curves 
for the complexed M2TMP when different from the apo-peptide. (a) V27 φ. (b) I35 φ. (c) G34 ψ. 
Inset shows the RMSD between the simulation and the experiment.  (d) V27 χ1H.  
 
When taking into account the significant 15N, 13Cα and 13C’ shift changes at G34-I35, the 
observed I35 φ angles of -80˚ for the apo-M2TMP and -85° for the complex (Figure 5.4b) 
may reflect a real torsion angle difference. The ψ angle of G34 was measured using the 
NCCN technique. The data (Figure 5.4c) yielded a best-fit ψ angle of -80˚ at 243 K with and 
without amantadine. However, the angular resolution of the technique is limited in the α-
helical region (23), as shown by the shallow RMSD minimum. Thus, we used the TALOS 
program (24) to predict the G34 torsion angles based on the experimental chemical shifts of 
the I33/G34/I35 triplet. This gave G34 (φ, ψ) of (-66˚, -37˚) and (-67˚, -42) for the apo- and 
complexed peptide, respectively (Table 5.1). Indeed, the calculated -40˚ NCCN curve agrees 
well with the experimental data.  
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For the β-branched Val and Ile residues, the χ1H torsion angle were obtained by 
correlating the Cα-Hα and Cβ-Hβ bond orientations (25). Here the angular resolution is 
much higher, ±3˚, due to the nearly trans nature of the measured conformation. I33 and I35 
show no χ1H change, consistent with their lack of Cα/Cβ chemical shift perturbation. In 
contrast, the channel-lining V27 exhibits a significant χ1H difference of 5˚ (Figure 5.4d), 
consistent with the 1.0 ppm Cα and Cγ1 chemical shift change at this residue (Table 5.2).  
 Overall, the chemical shifts and torsion angle data indicate that amantadine induces 
only small conformational changes in M2TMP, with the main sites of perturbation being the 
G34-I35 pair and V27. This small conformational change contrasts with the large and 
extensive dynamic changes shown below.  
 
M2TMP dynamics and conformational heterogeneity 
 The 1D 13C MAS spectra show dramatic differences in the linewidths of the apo- and 
amantadine-complexed M2TMP. In general, NMR linewidths have two contributions: 
inhomogeneous linewidths due to, mainly, conformational heterogeneity, and homogeneous 
linewidths due to relaxation induced by stochastically fluctuating local fields on the 
microsecond timescale and residual dipolar couplings (26). Homogeneous broadening is not 
refocused in a spin-echo experiment while inhomogeneous broadening is. Thus, to 
distinguish conformational heterogeneity from microsecond-timescale dynamics and to 
compare them between the apo- and complexed M2TMP, we measured the 13C T2 relaxation 
times using a Hahn-echo experiment (27). The echo-derived T2 is related to the homogeneous 
linewidth Δ by 
€ 
T2 =1 πΔ  (28). Since residual dipolar couplings resulting from imperfect 1H 
decoupling or insufficiently fast MAS are the same between the apo and complexed peptide, 
any T2 or Δ differences should mainly result from dynamic differences of the two states. 
Figure 5.8 (supporting information) shows representative T2 decay curves at 303 K. All 
resolved sites exhibit longer T2’s with amantadine than without. This is true for both the 
backbone and sidechains and for both channel-lining residues and other residues (Table 5.3, 
supporting information). For backbone Cα, sidechain carbons, and methyl carbons, the 
average T2 increases by 1.5 ms, 2.1 ms, and 2.5 ms, respectively. The T2 increase also varies 
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with the residue location with respect to the channel: the three channel-lining residues 
experience the largest average T2 increase of 2.0 ms, followed by T2 increases of 1.9 ms and 
1.4 ms for the interfacial and lipid-facing residues, respectively. Figure 5.3d plots the 
fractional 13C T2 increase of the complexed peptide over the apo-M2TMP as a function of 
residues, calculated as 
€ 
1
n T2,+Amt
i − T2,−Amti( ) T2,−Amti
i=1
n
∑ , where n is the number of sites 
measured in each residue. The largest T2 increase is seen at V27, which again correlates with 
its purported close distance to the fused ring of amantadine (10, 29).  
 In 1H-decoupled solids, 13C T2 relaxation times increase when motional correlation 
times either decrease or increase beyond the microsecond time window (26). Thus both fast 
motions in the extreme narrowing limit and slow motions in rigid solids give rise to long 
T2’s. Comparison of the 13C T2 at 303 K, 243 K and other temperatures (Table 5.4, supporting 
information) suggests that the motional rates of Cα sites in the apo-peptide are near the 
characteristic frequency of the T2 minimum (~
€ 
2π ⋅ 70 kHz) in the LC phase, and that 
amantadine binding increases the motional rates. This suggests that amantadine may widen 
the pore slightly, reducing steric hindrance and facilitating motion (30). Indeed, most 
sidechain methyl groups show an increase in the motional rates in the amantadine-bound 
state based on the temperature-dependent T2’s, consistent with their motion being facilitated 
by a widening of the pore.  
 To assess the conformational heterogeneity of the protein, we compare the 
homogeneous linewidths Δ derived from the T2 with the apparent linewidths Δ* measured 
from the spectra. In the LC phase, the Cα linewidth of apo-M2TMP is almost completely 
homogeneously broadened by motion, as seen by the similar Δ and Δ* (Figure 5.9, 
supporting information). Amantadine binding reduces Δ by a factor of two. For the 
sidechains, conformational heterogeneity is detectable in both the apo and complexed peptide 
due to narrower intrinsic linewidths. To evaluate the conformational heterogeneity without 
different homogeneous linewidths between the apo and complexed peptide, we froze the 
DLPC-bound M2TMP to 243 K, where the homogeneous linewidths become similar between 
the two states (Table 5.5, supporting information). Under this condition, most sites show 
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similar Δ* and hence similar conformational heterogeneity between the apo and complexed 
peptide. The exceptions are G34, I35 and the sidechains of L26, A30 and L38, where the 
complexed peptide has significantly narrower lines, indicating reduced conformational 
heterogeneity. This is also seen in the cross sections of the 13C 2D spectra (Figure 5.2c).  
In summary, in the LC phase of the lipid bilayer, the apo-M2TMP backbone 
undergoes large-amplitude microsecond-timescale motion that causes significant 
homogeneous broadening of the 13C spectra and consequent loss of intensity. Amantadine 
binding increases the T2  relaxation times for all sites by changing the motional rates, thus 
narrowing the intrinsic linewidths. When the motion is frozen, the conformational 
distribution of the peptide is revealed to be reduced by amantadine at specific residues, 
including the G34-I35 junction and several methyl-rich sidechains.  
 
Amantadine-induced M2TMP orientation change  
We recently measured the orientation of the apo-M2TMP using a powder-sample 
approach that exploits fast rigid-body uniaxial diffusion of the peptide backbone around the 
bilayer normal (31). Under this condition, motionally averaged powder spectra are obtained 
that indicate the peptide orientation from the bilayer normal (32). We now use this approach 
to determine the orientation of M2TMP in complex with amantadine. 15N-1H dipolar 
couplings and 15N chemical shift anisotropies (CSA), which are extremely sensitive to the 
helix orientation, were measured. Figure 5.5(a, b) shows the N-H DIPSHIFT curves of V28 
and A30 at 313 K where the peptide is uniaxially mobile. Amantadine binding decreases the 
N-H dipolar coupling of both residues. Correlating the motionally averaged 
€ 
δ // N-H dipolar 
coupling with the 
€ 
δ ⊥ edge of the 15N CSA obtained from static 1D spectra (not shown), we 
obtain 2D “PISA wheels” (33, 34) (Figure 5.5c).  
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Figure 5.5. Orientation of amantadine-bound M2TMP. (a, b) 15N-1H dipolar coupling of unoriented 
M2TMP in DLPC bilayers with amantadine (filled squares, red line). For comparison, the apo-peptide 
data published recently are superimposed (open squares, black line) (31). (a) V28. (b) A30. (c) PISA 
wheels of M2TMP constructed from the 
€ 
δ// N-H dipolar couplings and 
€ 
δ⊥  15N anisotropic shifts. The 
data fit to a wheel with a tilt angle τ of 38˚ (red). The apo-peptide shows a τ = 35˚ (open symbols and 
black line) (31).  
 
For the apo peptide in DLPC bilayers, previous data yielded a tilt angle τ of 35˚ (31), while 
the current amantadine-bound M2TMP has a slightly larger τ of 38˚. The rotation angle of 
the wheel is unchanged. The 3˚ increase, while small, is consistent with amantadine binding 
at the N-terminus of the helix, pushing it open slightly. The orientation of the segment C-
terminal to G34 is not probed here since no 15N labels are used in that region.  
 Figure 5.6 shows the chemical shift and torsion-angle constrained structure of 
M2TMP in the presence of amantadine, refined from the 15N-NMR-derived model 1NYJ 
(15). At the G34-I35 junction, a G34 ψ angle of –42˚ and I35 φ of –85˚ were used. The 
resulting helix shows a small kink of 5˚ between the segments N-terminal and C-terminal to 
G34, visible in the top view (Figure 5.6b). The kink is defined as the angle between the 
average N-H bond orientation for residues 27-33 and for residues 37-43. This kink is 
reminiscent of the recent 15N NMR data of DMPC-bound M2TMP, which showed a bend of 
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11˚ at G34 (16). We found that the exact value of the kink is sensitive to the G34/I35 torsion 
angles. With ψ34 = -60˚, the kink increases to ~16˚, while with a more ideal φ35 of –60˚, the 
kink is almost completely removed.  
 
Conclusion 
 The NMR data here provide the first extensive set of high-resolution conformational 
and dynamical constraints of the backbone and sidechains of M2TMP in lipid bilayers 
without and with amantadine, and elucidate the nature of the spectral line narrowing caused 
by amantadine. The data indicate that amantadine binding to M2TMP exerts the largest effect 
on the dynamics and conformational heterogeneity of the protein, to a lesser extent on the 
average backbone and sidechain conformations, and only subtly affects the helix orientation. 
The apo-peptide exhibits large-amplitude microsecond-timescale motion that homogeneously 
broadens the NMR lines. Amantadine increases the motional rates of most backbone Ca sites, 
causing substantial line narrowing. It also reduces the conformational heterogeneity of 
certain residues, including G34, I35 and the sidechains of L26, A30 and L38. Perturbation of 
the average conformation mainly occurs at G34-I35 and at V27 sidechain. Combined, the 
data strongly suggests that conformational plasticity is essential to proton conduction and 
gating of the apo-channel, and at least part of amantadine’s mechanism of action is to modify 
and select among the multiple low-energy conformations of M2TMP. This is consistent with 
energy surface mapping (35) and analytical ultracentrifugation data of M2TMP and its 
mutants (36, 37). It is possible, then, that amantadine resistance can arise from mutations that 
alter the protein conformational distribution and dynamics, thus preventing amantadine 
binding.  
The observed large V27 chemical shift and T2 changes are in excellent agreement with 
mutagenesis data indicating strong interaction of this residue with amantadine. Mutation of 
V27 to Ala, Ser, Ile and Thr caused either complete or partial resistance to amantadine in 
various viral strains (3, 9). Thus, the interaction of amantadine with the channel is exquisitely 
sensitive to the size and hydrophobicity of the sidechain at this position.  
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Figure 5.6. Chemical shift and torsion-angle restrained backbone and partial sidechain structure of 
amantadine-bound M2TMP. (a) Side view. (b) Top view. The exact position and orientation of 
amantadine is unknown, and is shown here only as a reference to the peptide. The G34 ψ and I35 φ 
angles create a helix kink of 5˚, highlighted by the blue N-terminal and the cyan C-terminal segments.  
 
Complexed with amantadine, the M2TMP helix shows a small degree of non-ideality 
in the backbone torsion angles. In particular, the deviation of the G34-I35 conformation from 
the ideal helix geometry causes a helix kink of 5˚, which may have an effect on the inter-
helical interaction of H37 imidazole rings downstream (19). The exact value of the kink and 
the exact orientation of the helix in the DLPC membrane differ slightly from those found in 
the DMPC membrane. Given the differences in sample preparation conditions such as 
membrane thickness and the state of alignment (19, 20), these differences further underscore 
the structural plasticity of the peptide. The spectra of the amantadine-bound M2TMP show a 
single signal for each label, thus the four helices of the tetramer are rotationally symmetric 
and chemically identical. This implies that in the LC phase, not only does amantadine have 
the same uniaxial mobility as the tetrameric bundle, but it also exchanges among the four 
helices on a timescale faster than the nuclear spin interactions (< 10-5 s) (19).  
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Material and Methods 
Peptides and lipids  
  Fmoc-protected uniformly 13C, 15N-labeled amino acids were either prepared in-
house (38) or purchased from Sigma and Cambridge Isotope Laboratories. The 
transmembrane peptide of the M2 protein of the Udorn strain (residues 22-46) (39) was 
synthesized by PrimmBiotech (Cambridge, MA) and purified to >95% purity. The amino 
acid sequence is SSDPLVVAASIIGILHLILWILDRL. In addition to peptides containing 
multiple uniformly 13C, 15N-labeled residues, two peptides each containing a single 15N label 
at V28 and A30 were synthesized for orientation measurements.  
 
Membrane sample preparation  
M2TMP was reconstituted into lipid vesicles by detergent dialysis (18). DLPC (1,2-
dilauroyl-sn-glycero-3-phosphatidylcholine) lipids were chosen due to the favorable 
dynamics of the protein in this membrane (31) and the similar phase transition temperature (-
2˚C) of this bilayer to biological membranes. The vesicle solution was prepared by 
suspending dry DLPC powder (Avanti Polar Lipids) in 1 mL phosphate buffer (10 mM 
Na2HPO4/NaH2PO4, 1mM EDTA, 0.1mM NaN3) at pH 7.5, vortexing and freeze-thawing 6-8 
times to create uniform vesicles of ~200 nm diameter (40). M2TMP powder was codissolved 
with the detergent octyl-β-D-glucopyranoside (OG) in 2 mL phosphate buffer to reach an OG 
concentration of 30 mg/mL. The M2TMP/OG solution was then mixed with the DLPC 
vesicle solution, giving a final OG concentration of 15 mg/mL. The mixture was vortexed for 
1 hr, allowed to stand for 6-8 hrs at room temperature, then dialyzed with a 3.5 kDa cutoff 
against 1 L phosphate buffer at 4 °C for 3 days with buffer changes every 8-12 hrs to ensure 
complete removal of the detergent. The dialyzed M2TMP/DLPC solution was centrifuged at 
150,000 g for 3 hours at 10˚C to give a wet pellet with ~50 wt% water. The final 
peptide/lipid (P/L) molar ratio is 1:15. UV-VIS spectrum of the supernatant indicated ~98% 
binding of the peptide to the membrane. For amantadine-bound samples, 10 mM amantadine 
hydrochloride was added to the phosphate buffer throughout the lipid vesicle formation and 
peptide assembly process.  
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For orientation measurements, 15N-labeled M2TMP was codissolved with DLPC 
lipids in trifluoroethanol at a P/L of 1:20, lyophilized, then rehydrated to 50 wt% water using 
a pH 8.1 phosphate buffer. For amantadine-bound samples, 2 mmol of amantadine 
hydrochloride was added to the dry M2TMP/lipid mixture before dissolution in 
trifluoroethanol.  
 
Solid-state NMR spectroscopy  
 Most NMR experiments were carried out on a Bruker AVANCE-600 (14.1 Tesla) 
spectrometer (Karlsruhe, Germany) using a 4 mm triple-resonance MAS probe. 13C-13C and 
15N-13C 2D correlation and torsion angle experiments were conducted at 243 K to freeze 
peptide motion. All other parameters, including 15N CSA, 15N-1H dipolar coupling, and 13C T2 
relaxation times, were measured at 303 K or 313 K where the peptide is uniaxially mobile in 
the LC phase of the DLPC bilayer. Typical radiofrequency pulse lengths were 5 µs for 13C 
and 3.5-4.0 µs for 1H. 1H TPPM (41) or SPINAL (42) decoupling of 60 – 70 kHz were 
applied. 13C chemical shifts were referenced to the α-Gly C’ signal at 176.49 ppm on the 
TMS scale, and 15N chemical shifts were referenced to the 15N signal of N-acetyl-valine at 
122 ppm on the liquid ammonia scale. For G34 torsion angles extraction from TALOS, the 
13C chemical shifts were converted to the TSP scale by adding 1.82 ppm to the measured 
shifts.   
 2D DQ filtered 13C-13C correlation spectra were measured using a SPC5 sequence 
(43) under 7 kHz MAS. DQ filtration removes lipid background 13C signals, thus simplifying 
assignment of the protein signals. 2D 15N-13C correlation spectra were measured using a 
REDOR pulse train (44) of 0.7 – 2.1 ms for 13C-15N coherence transfer (45).  
 φ angles were measured under 6.5 kHz MAS using the HNCH technique, with 
doubling of the N-H dipolar coupling to enhance the angular resolution (22, 46). 1H-1H 
homonuclear coupling was removed by an FSLG sequence (47). The HNCH data were 
simulated using a doubled N-H coupling of 12.0 kHz and a C-H dipolar coupling of 12.5 
kHz, both scaled by the FSLG scaling factor of 0.577. These values were directly measured 
by C-H and N-H dipolar-shift (DIPSHIFT) correlation experiments on the protein at 243 K. 
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ψ  angle was measured with the NCCN experiment (23) correlating the Ni-Cαi and C’i-Ni+1 
bond orientations. Spinning speeds of 4 and 5 kHz were used to obtain multiple time points 
on the angle-dependent curve. χ1H torsion angles (Hα-Cα-Cβ-Hβ) were measured by 
correlating the Cα-Hα and Cβ-Hβ bond orientations using a modified HCCH technique (25) 
under 9 kHz MAS. A HORROR sequence with a resonance condition of 
€ 
ω1 =ωr 2 (48) was 
used to selectively excite the Cα-Cβ DQ coherence, followed by a dipolar-doubled C-H 
DIPSHIFT period. A doubled and FSLG-scaled C-H dipolar coupling of 26.0 kHz was used 
to simulate the angle-dependent curves. All these torsion angles have an inherent double 
degeneracy due to the uniaxial nature of the dipolar coupling. The wrong angle is readily 
identified by the fact that it falls into either unpopulated regions of the Ramachandran 
diagram or the β-sheet region, which contradicts NMR chemical shifts.  
 15N-1H dipolar couplings for orientation determination were obtained from a dipolar-
doubled DIPSHIFT experiment (46, 49, 50) under 7 kHz MAS. An FSLG sequence with an 
effective field of 76.5 kHz was used for 1H homonuclear decoupling. 
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Supporting Information 
 
Table 5.2: 13C and 15N chemical shifts (ppm) of M2TMP in DLPC bilayers at 243 K without and with 
amantadine (Amt). Sites with chemical shift differences greater than 0.5 ppm are bolded. The letters 
s, m, w denote strong, medium, and weak intensities when more than one peak is observed. The 13C 
and 15N shifts are referenced to TMS and liquid NH3, respectively.  
 
residue site - Amt + Amt 
L26 N 117.7 117.5 
 CO - - 
 Cα 55.4  55.4 
 Cβ 39.7 39.4 
 Cγ 25.2 25.1 
 Cδ1 22.3 22.4 
 Cδ2 21.2 21.3 
V27 N 120.4 120.2 
 CO 177.9 178.6 
 Cα 63.8 62.8 
 Cβ 29.8 30.1 
 Cγ1 21.0 20.0 
 Cγ2 19.5 19.9 
A29 N 120.9 121.7 
 CO - - 
 Cα 53.3 53.2 
 Cβ 16.7 16.5 
A30 N 118.7 118.4 
 CO 180.4 180.0 
 Cα 52.8 52.9 
 Cβ 16.5 17.2 
I33 N 120.2 118.8 
 CO 178.8 178.7 
 Cα 63.3 63.1 
 Cβ 35.7 35.5 
 Cγ1 28.6 30.1 
 Cγ2 15.1 16.0 
 Cδ 11.8 12.2 
G34 N 107.1 106.3, 109.7 
 CO 173.5 175.7 
 Cα 45.6 45.9, 44.8 
I35 N 122.3 124.6 
 CO 175.4 176.9  
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 Cα 63.8 63.8 
 Cβ 36.0 35.8 
 Cγ1 28.2 27.0 
 Cγ2 15.8 15.7 
 Cδ 11.8 11.7 
L38 N 117.8 117.1 
 CO 175.8 175.6 
 Cα 56.1 56.2 
 Cβ 39.6s, 36.8w 39.7m, 37.0s 
 Cγ 25.2 25.0 
 Cδ1 22.3 23.3 
 Cδ2 20.1 21.2 
 
 
Table 5.3: 13C homogeneous T2 and apparent T2* (ms) of M2TMP in DLPC lipid bilayers without 
and with amantadine (Amt) at 303 K. T2* is obtained from the observed linewidths by 
€ 
T2* =1 πΔ* .  
 
Residue site T2*, - Amt T2, - Amt T2*, + Amt T2 , + Amt 
L26 Cα 1.0 1.4 1.8 2.1 
 Cβ 1.8 1.8 2.6 3.0 
 Cδ1 3.2 5.8 4.7 9.2 
 Cδ2 - - 3.7 8.4 
V27 Cα 1.1 1.0 1.3 3.4 
 Cγ2 3.7 4.7 3.4 7.2 
A29 Cα 1.1 1.3 2.0 2.5 
 Cβ 2.1 5.2 2.2 9.0 
A30 Cα 1.1 1.8 2.1 3.5 
 Cβ 2.2 3.4 1.3 5.7 
I33 Cα 1.1 1.0 1.4 3.4 
 Cγ2 2.2 3.4 1.3 4.6 
 Cδ 3.7 4.8 3.0 5.6 
G34 Cα 0.9 1.2 1.3 2.1 
I35 Cα 1.4 1.9 2.3 2.1 
 Cβ 1.9 2.1 2.9 2.6 
 Cγ2 2.1 2.1 2.2 3.4 
 Cδ 3.5 4.9 4.1 7.1 
L38 Cα 1.2 1.3 2.1 3.5 
 Cβ 1.2 1.5 2.3 3.6 
 Cγ 2.6 2.7 2.1 3.5 
 Cδ1 3.3 4.5 3.8 8.3 
 Cδ2 3.7 4.7 3.0 8.0 
average  2.1 2.8 2.5 4.9 
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Table 5.4: 13C homogeneous T2 (ms) of M2TMP at 243 K and 303 K of M2TMP without and with 
amantadine (Amt).  
 
Residue Site -Amt, 303 K -Amt, 243 K +Amt, 303 K +Amt, 243 K 
L26 Cα 1.4 3.0 2.1 2.8 
 Cβ 1.8 1.8 3.0 1.5 
 Cγ  2.4   
 Cδ1 5.8 3.0 9.2  
 Cδ2   8.4  
V27 Cα 1.0 2.8 3.4 3.0 
 Cβ  2.4  2.5 
 Cγ2 4.7 4.0 7.2 4.7 
A29 Cα 1.3 3.2 2.5 2.8 
 Cβ 5.2 4.6 9.0 4.9 
A30 Cα 1.8 2.8 3.5 3.2 
 Cβ 3.4 5.1 5.7 7.2 
I33 Cα 1.0 2.8 3.4 3.0 
 Cβ  2.3  2.8 
 Cγ1  2.4  2.5 
 Cγ2 3.4  4.6  
 Cδ 4.8 4.2 5.6 4.3 
G34 Cα 1.2 3.2 2.1 2.6 
I35 Cα 1.9 2.9 2.1 2.8 
 Cβ 2.1 2.2 2.6 1.8 
 Cγ2 2.1  3.4  
 Cδ 4.9 5.3 7.1 4.7 
L38 Cα 1.3 2.9 3.5 3.2 
 Cβ 1.5 1.9 3.6 2.2 
 Cγ 2.7 2.7 3.5 3.0 
 Cδ1 4.5 4.0 8.3 4.7 
 Cδ2 4.7  8.0  
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Table 5.5: 13C apparent linewidths (Δ*) and homogeneous linewidths (Δ) (Hz) of M2TMP in DLPC 
bilayers at 243 K without and with amantadine (Amt). The apparent linewidths Δ* (±20 Hz) are read 
off from 2D correlation spectra, while the homogeneous linewidths Δ are obtained from T2 
measurements as 
€ 
Δ =1 πT2 . Sites of significant linewidth changes upon amantadine binding are 
bolded. Sites without entry are due to resonance overlap.  
 
Residue site Δ*, - Amt Δ, - Amt Δ*, + Amt Δ, + Amt 
L26 Cα 170 100 200 110 
 Cβ 410 180 270 200 
V27 Cα 260 110 260 110 
 Cβ 190 130 180 130 
A29 Cα 160 100 140 110 
 Cβ 240 70 240 70 
A30 Cα 180 110 140 100 
 Cβ 310 60 160 40 
I33 Cα 300 110 300 110 
 Cβ 260 140 230 110 
 Cγ1 360 130 370 130 
 Cγ2 310  280  
G34 Cα 240 100 180 120 
I35 Cα 250 110 130 120 
 Cβ 240 150 160 180 
 Cγ1 290  170  
 Cγ2 210  210  
 Cδ 210 60 170 70 
L38 Cα 190 100 150 100 
 Cβ 380 160 200 150 
average  258 113 207 115 
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Figure 5.7 2D 15N-13C correlation spectra of M2TMP in DLPC bilayers with (red) and without (black) 
amantadine at 243 K. (a) LAGI. 13C chemical shifts change for G34 Cα, G34 C’ and I35 Cα, and 15N 
shift changes are detected at G34 and I35. (b) VAIL. 13C chemical shifts change at V27 Cα, C’ and 
I33 Cβ. (c) 1D 15N cross sections for G34 and I35, showing the chemical shift and linewidth changes. 
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Figure 5.8 13C T2 decay curves of representative backbone (a, c) and sidechain (b, d) carbons of 
M2TMP with (filled squares) and without (open squares) amantadine at 303 K. (a) A30α. (b) A30β. 
(c) L38α. (d) L38δ2. All carbons show longer T2’s upon amantadine binding.   
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Figure 5.9 Average 13C homogeneous (green) and apparent (black) linewidths of M2TMP at 303 K 
without (a, b) and with (c, d) amantadine (Amt). (a, c): Backbone Cα carbons. (b, d) Sidechain 
carbons. The homogeneous linewidths are calculated from the T2 values (Table 3, supporting 
information) according to 
€ 
Δ =1 π T2 , then averaged for all sites within each category. The 
backbone Cα homogeneous linewidths are significantly narrowed by amantadine. However, the 
heterogeneous linewidths are difficult to compare at this temperature.  
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Chapter 6 
 
Structure of Amantadine-Bound M2 Transmembrane Peptide of Influenza A in Lipid 
Bilayers from Magic-Angle-Spinning Solid-State NMR: the Role of Ser31 in Amantadine 
Binding 
A paper published in the Journal of Molecular Biology 
2009, vol. 385 (4) pp. 1127-1141 
Sarah D. Cady, Tatiana V. Mishanina and Mei Hong 
Abstract 
 The M2 proton channel of influenza A is the target of the antiviral drugs amantadine 
and rimantadine, whose effectiveness has been abolished by a single-site mutation of Ser31 to 
Asn in the transmembrane domain of the protein. Recent high-resolution structures of the M2 
transmembrane domain obtained from detergent-solubilized protein in solution and crystal 
environments gave conflicting drug binding sites. We present magic-angle-spinning solid-
state NMR results of Ser31 and a number of other residues in the M2 transmembrane peptide 
(M2TMP) bound to lipid bilayers. Comparison of the spectra of the membrane-bound apo 
and complexed M2TMP indicates that Ser31 is the site of the largest chemical shift 
perturbation by amantadine. The chemical shift constraints lead to a monomer structure with 
a small kink of the helical axis at Gly34. A tetramer model is then constructed using the helix 
tilt angle and several interhelical distances previously measured on unoriented bilayer 
samples. This tetramer model differs from the solution and crystal structures in terms of the 
openness of the N-terminus of the channel, the constriction at Ser31, and the sidechain 
conformations of Trp41, a residue important for channel gating. Moreover, the tetramer model 
suggests that Ser31 may interact with amantadine amine via hydrogen bonding. While the apo 
and drug-bound M2TMP have similar average structures, the complexed peptide has much 
narrower linewidths at physiological temperature, indicating drug-induced changes of the 
protein dynamics in the membrane. Further, at low temperature, several residues show 
narrower lines in the complexed peptide than the apo peptide, indicating that amantadine 
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binding reduces the conformational heterogeneity of specific residues. The differences of the 
current solid-state NMR structure of the bilayer-bound M2TMP from the detergent-based M2 
structures suggest that the M2 conformation is sensitive to the environment, and care must be 
taken when interpreting structural findings from non-bilayer samples.  
 
Introduction 
 The M2 protein of influenza A virus forms a tetrameric proton channel that is the 
target of the antiviral drugs amantadine and rimantadine (1). The drugs were effective until 
recently, when a single-site mutation of S31N in the transmembrane domain of the protein 
caused complete resistance of the viruses to the drugs (2). The M2 proton channel is 
important for viral replication. After the virus enters the infected cell by endocytosis, the 
proton channel acidifies the viral core, which triggers the dissociation of the virus matrix and 
subsequent viral gene expression (3). With 97 amino acids, the M2 protein is small compared 
to typical ion channels, thus it is an excellent system for elucidating the structure-function 
relationship of ion channels. Extensive mutagenesis, electrophysiological (4, 5) and 
sedimentation experiments (6) have been carried out to determine the low-resolution 
structure and stability of this proton channel. Elucidating the high-resolution structure and 
the difference between the drug-free and drug-bound states is the next natural challenge that 
is important not only for developing new inhibitors to curb influenza infection but also for 
understanding the fundamental biophysics of ion channels.  
 The transmembrane domain of the M2 protein spanning residues 22 to 46 (Figure 
6.1a) contains a histidine and a tryptophan that are crucial for proton conduction and gating 
(7, 8). This domain exhibits channel activity (9) and forms a parallel four-helix bundle with 
left-handed crossing angles. The residues facing the channel lumen versus the lipids have 
been identified through experiments probing the effects of mutation on proton currents and 
amantadine inhibition (10). The main channel-facing residues, V27, A30, G34 and H37, fall 
onto the a and d positions of a heptad repeat (Figure 6.1b). The b, c, and f positions of the 
heptad repeat face the lipids, while the e and g positions occupy the helix-helix interfaces. 
Apart from the transmembrane domain, the segment of the protein spanning residues 44-60 
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forms a membrane-proximal amphipathic helix that is important for channel stability (11) 
and is recently found to be involved in pH activation (12).  
 
 
 
Figure 6.1. M2(22-46) sequence and its representation as a heptad repeat. (a) Amino acid sequence. 
The a and d residues of the heptad repeat abcdefg are labeled. The 13C, 15N-labeled residues that have 
been studied so far (13) are colored in red. H37 and W41, which are central for proton conduction and 
channel gating, are shown in blue. (b) Four-helix bundle organization of M2TMP. Channel-facing a 
and d residues are shaded in pink, and interfacial e and g residues are shaded in cyan.  
 
 Recently, two high-resolution structures of portions of the M2 protein containing the 
transmembrane domain were reported simultaneously (14, 15). One structure was obtained 
by X-ray crystallography and the other by solution NMR. The X-ray structure was 
determined on amantadine-bound M2(22-46) in the detergent octyl-β-D-glucopyranoside 
(OG) (15). The solution NMR structure was determined on rimantadine-bound M2(18-60) 
solubilized in DHPC micelles (14). Strikingly, the two structures showed very different drug 
binding sites: the solution NMR structure showed rimantadine to be bound at the helix-helix 
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interfaces of the tetramer near the C-terminus of the transmembrane domain, while the 
crystal structure showed amantadine bound to the channel lumen near the N-terminus. In 
addition, the helix orientation and the sidechain conformations of the two structures differ 
substantially (16).  
 These structural differences underscore the importance of examining the M2 
transmembrane peptide structure using an independent technique and doing so in the most 
biologically relevant environment of lipid bilayers. Detergent micelles are known to cause 
curvature stress to membrane proteins and have been documented to affect the structure of 
proteins compared to bilayer-bound samples (17). Similarly, crystallizing hydrophobic 
membrane proteins in a sparse matrix of detergent molecules leaves open the question of how 
different the structure is from the bilayer-bound state. For these reasons, solid-state NMR 
(SSNMR) spectroscopy, which can be readily applied to lipid bilayers and other semi-solids, 
is the preferred method for determining the high-resolution structures of membrane proteins.  
Until recently, the majority of SSNMR data on the M2 transmembrane peptide 
(M2TMP) consisted of static 15N chemical shift anisotropies and N-H dipolar couplings 
measured on uniaxially aligned membrane samples. These data yielded very precise 
orientation angles of the M2TMP helices in the lipid bilayer (18, 19). However, the 15N NMR 
constraints do not report the sidechain conformation nor the interhelical packing of the 
tetramer. Further, information on the backbone structure is only inferred by pattern 
recognition of the 2D N-H dipolar and 15N chemical shift correlation spectra.  
 We recently undertook a magic-angle-spinning (MAS) SSNMR study of the structure 
and dynamics of M2(22-46) in lipid bilayers. Several types of structural information have 
been obtained so far. First, isotropic 13C and 15N chemical shifts of eight residues in the 
transmembrane domain (L26, V27, A29, A30, I33, G34, I35, and L38) were measured and 
compared between the apo and amantadine-complexed states (13) to determine structure 
perturbation by the drug. Second, φ, ψ and χ1 torsion angles were directly measured at 
selected residues by dipolar correlation experiments to quantify the peptide conformation. 
Third, we measured the helix orientations using unoriented membrane samples and found 
small differences between the apo and drug-bound peptide, as well as different tilt angles in 
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lipid bilayers of different thicknesses (20, 21). Fourth, the peptide dynamics were probed by 
2H quadrupole NMR and various dipolar coupling and chemical shift anisotropy 
measurements, and were found to be dramatically altered by drug binding (20). Finally, we 
measured interhelical distances at V27, A30, L38, and W41 using 19F-labeled M2TMP to 
constrain the helix packing in the tetrameric bundle (22, 23). These SSNMR results were 
obtained from M2TMP bound to hydrated and unoriented DLPC, DMPC or POPC 
membranes, which are more natural environments for membrane proteins than detergents.  
 In this work, we report the chemical shifts of Ser31, Val28 and Leu36, and propose a 
backbone structural model of M2TMP using all SSNMR constraints obtained so far. Ser31 has 
been postulated to be the main residue involved in amantadine binding. MD simulations 
suggested that the Ser31 hydroxyl group forms hydrogen bonds with the amantadine amine 
(24). This was supported by neutron diffraction experiments that showed amantadine to be 
positioned between Val27 and Ser31 (25). Mutation of Ser31 to Asn gives rise to the main drug-
resistant mutant in current influenza A viruses. Thus, knowledge of Ser31 conformation in 
M2TMP is important for understanding how amantadine blocks the channel. The availability 
of chemical shifts for a contiguous segment of the peptide allows us to deduce the (φ, ψ) 
torsion angles of the protein using the well established relation between protein conformation 
and NMR chemical shifts (26). From this chemical shift constrained monomer structure, we 
constructed a tetramer model of the transmembrane domain using several interhelical 
distances measured previously. We compare this MAS-NMR model with the solution NMR, 
X-ray, and 15N orientation-NMR structures, and suggest the binding site of amantadine.  
 
Results  
13C chemical shifts of VSL-M2TMP without and with amantadine 
 Figure 6.2 shows the lipid-suppressed 13C MAS spectra of V28, S31, L36-labeled 
M2TMP without (a, c) and with amantadine (b, d). The lipid background signals were 
suppressed by a 13C-13C DQ filter in (a, b) and a 15N-13C heteronuclear dipolar filter in (c, d). 
For the N-C filtered spectra, only the directly bonded Cα signals are selected due to the short 
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N-C recoupling time used. All spectra were measured at 243 K, in the gel phase of the 
membrane.  
 
 
Figure 6.2. 1D 13C spectra of VSL-M2TMP in DLPC bilayers at 243 K. (a) 13C DQF spectrum of the 
apo peptide. (b) 13C DQF spectrum of the amantadine-bound peptide. (c) 15N-filtered 13C spectrum of 
the apo peptide. (d) 15N-filtered 13C spectrum of the amantadine-bound peptide.  
 
The main 13C chemical shift difference caused by amantadine occurs at S31 Cα and 
Cβ: the two sites overlap completely in the apo-M2TMP spectrum (a) but become partly 
resolved in the amantadine-complexed spectrum (b). In addition, the 15N-13C filtered spectra 
in (c, d) show a narrower S31 Cα peak for the complexed peptide than the apo peptide. At 
low temperature where peptide motion is frozen, NMR linewidths reflect conformational 
distribution. Thus, the narrower Cα line of the complexed peptide indicates reduced 
conformational heterogeneity at S31 upon drug binding (see below).  
 Figure 6.3 shows the 2D 13C-13C DQF-COSY spectra to illustrate the unambiguous 
assignment of the 13C chemical shifts. The 2D spectra further illustrate the striking difference 
of S31 chemical shifts between the apo- and amantadine-complexed M2TMP: while the apo 
peptide does not resolve the S31 Cα and Cβ peaks near 61 ppm, the complexed peptide 
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shows clear off-diagonal intensities indicative of chemical shift separation between Cα and 
Cβ (b). On the other hand, the S31 Cα/CO cross peaks are unchanged by amantadine (c). 
Since protein secondary structures give opposite-signed secondary shifts between Cβ on one 
hand and Cα and CO on the other, the absence of opposite Cα and CO shift changes from the 
Cβ shift change suggests that the cause for the Cβ change is packing interaction with 
amantadine rather than (φ, ψ) angle changes of the S31 backbone.  
 
 
 
Figure 6.3. 2D 13C-13C DQF correlation spectra of VSL-M2TMP in DLPC bilayers at 243 K without 
(black) and with (red) amantadine. (a) Aliphatic region. (b) S31 and V28 region. (c) Carbonyl region.  
 
To confirm the S31 Cβ chemical shift, we carried out a 1D CH2-spectral editing 
experiment. The experiment selectively detects CH2 groups such as Ser Cβ while suppressing 
the signals of all CH groups such as backbone Cα’s. Figure 6.4 compares the CH2-edited 
spectra (b, d) with the 13C CP spectra (a, c) of the apo and complexed M2TMP. The 
unfiltered spectra contain all labeled peptide 13C signals as well as natural abundance lipid 
13C signals; thus they are less resolved than Figure 6.2. The CH2 filter suppressed the V28 
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and L36 Cα signals but retained S31 Cβ, L36 Cβ, and the main lipid CH2 peaks. The method 
does not completely suppress the mobile CH3 groups, however their chemical shifts do not 
overlap with Ser Cβ. The CH2-edited spectra of the apo and complexed peptide (b, d) 
confirm the 1.0 ppm upfield shift of the S31 Cβ peak upon amantadine binding.  
In addition to S31, V28 Cα and CO show significant chemical shift changes in the 2D 
spectra (Figure 6.3c). The CO frequency increased by 1.4 ppm while the Cα chemical shift 
increased by 0.7 ppm (Table 6.1). These downfield shift changes are consistent with a more 
ideal helical conformation in the presence of amantadine. Moreover, the CO chemical shift is 
sensitive to hydrogen bonding (27); thus the larger increase of the CO chemical shift over Cα 
suggests that amantadine may perturb the hydrogen-bond network around V28.  
 
 
 
Figure 6.4. Selective detection of S31 Cβ by CH2 editing. (a) 13C CP-MAS spectrum of apo-M2TMP. 
(b) CH2 edited spectrum of apo-M2TMP. (c) 13C CP-MAS spectrum of amantadine-bound M2TMP. 
(d) CH2 edited spectrum of bound M2TMP. Note the suppression of the Cα CH peaks in (b) and (d).  
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Table 6.1: 13C and 15N chemical shifts (ppm) of M2TMP in DLPC bilayers at 243 K without and with 
amantadine (Amt). Sites with chemical shift differences greater than 0.5 ppm are bolded. Letters s, m 
and w denote strong, medium and weak, respectively. The 13C and 15N shifts are referenced to TMS 
and liquid NH3, respectively.  
 
  N CO Cα  Cβ  Cγ  Cδ Cε 
L26 apo 117.7 176.6 55.5 39.1 25.2 23.8 21.2 
 Amt 117.5 176.3 55.7 39.4 25.2 23.3 20.9 
V27 Apo 120.4 177.8 63.8 29.7 21.2 19.3  
 Amt 119.9 178.1 63.9s 
62.0w 
30.0 20.8 19.5  
V28 Apo 122.8 175.9 64.8 29.7 20.7 19.5  
 Amt 125.9 177.0 65.4 29.7 20.8 19.0  
A29 Apo 120.9 176.7 53.5 16.6    
 Amt 121.7 176.8 53.5 16.3    
A30 Apo 118.0w 
119.4 
177.7 52.8 16.5    
 Amt 118.7 177.5 52.8 17.0    
S31 Apo 114.7 173.7 61.2 60.8    
 Amt 121.4 173.1 61.3 59.8    
I33 Apo 120.3 175.7 63.1 35.4 28.5 15.7 
14.9 
11.8 
 Amt 119.4 176.0 63.2 35.4 28.3 16.0 12.0 
G34 Apo 107.1 173.0 45.7     
 Amt1 
Amt2 
106.3 
109.7 
173.2 
175.0 
45.5 
45.0 
    
I35 Apo 122.3 175.5 63.9 35.7 28.1 15.7 11.7 
 Amt 124.6 175.4 63.8 35.8 27.3 15.6 11.6 
L36 Apo 119.9 175.8 56.0 39.4 24.9 24.2 21.2 
 Amt 119.6 175.3 55.8 39.5 24.7 23.8 21.2 
L38 apo 117.8 175.8 56.1 37.5w 
39.5s 
25.0 24.2 20.1 
 Amt 117.1 175.8 56.0 37.4m 
39.6s 
24.9 23.9 21.0 
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15N chemical shifts of VSL-M2TMP without and with amantadine 
 Low-temperature 1D 15N MAS spectra of the apo and complexed VSL-M2TMP are 
shown in Figure 6.5. The assignment of the 15N peaks is based on 2D 15N-13C correlation 
spectra shown in Figure 6.6 below. Both the 15N chemical shifts and 15N linewidths show 
dramatic changes upon amantadine binding. The V28 and S31 15N peaks move downfield, 
and all three sites are narrowed by a factor of two. The drug-complexed peptide has FWHM 
of 2.0 ppm for all three sites, while the apo peptide linewidths range from 3.5 – 5.3 ppm 
(Table 6.2).  
 2D 15N-13C correlation spectra are shown in Figure 6.6 to provide definitive evidence 
of structure perturbation by amantadine. Consistent with the 13C data, the most pronounced 
15N chemical shift change occurs at S31 (6.7 ppm), followed by V28, which has a more 
modest but still significant 15N shift increase of 3.1 ppm. Similar to the 13C data, L36 exhibits 
little change in its 15N chemical shift.  
 
 
 
Figure 6.5. 1D 15N CP-MAS spectra of VSL-M2TMP in DLPC bilayers at 243 K. (a) Without 
amantadine. (b) With amantadine.  
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Figure 6.6. (a) 2D 15N-13C 2D correlation spectrum of VSL-M2TMP in DLPC bilayers at 243 K. 
Black: without amantadine. Red: with amantadine. (b) S31 15N cross sections.  
 
 
Table 6.2. 13C and 15N apparent (Δ*) and intrinsic linewidths (Δ) of VSL-M2TMP at 243 K under 71 
kHz 1H decoupling. Significant linewidth changes between the apo and amantadine-bound samples 
are bolded.  
 
Residue site Δ*, apo 
(ppm) 
Δ, apo 
(ppm) 
Δ*, + Amt 
(ppm) 
Δ, + Amt 
(ppm) 
V28 N 5.3 - 2.0 - 
 Cα 1.4 0.60 1.3 0.60 
 Cβ 1.1 0.67 1.0 0.67 
 Cγ1 1.7 0.40 1.4 0.40 
 Cγ2 1.3 0.40 1.6 0.40 
S31 N 3.5 - 2.0 - 
 Cα 1.5 0.60 0.93 0.60 
 Cβ 2.8 0.57 1.6 0.57 
L36 N 4.0 - 2.0 - 
 Cα 1.0 0.47 0.9 0.47 
 Cβ 1.3 0.73 1.1 0.73 
 Cγ 1.1 0.57 1.0 0.57 
 Cδ1 1.9 0.40 1.7 0.40 
 Cδ2 1.4 0.40 1.4 0.40 
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Chemical shift perturbation at the M2TMP core  
Table 6.1 summarizes all 13C and 15N chemical shifts measured for eleven residues, 
including L26, V27, V28, A29, A30, S31, I33, G34, I35, L36, and L38. This table extends 
the one recently reported (13) by the addition of V28, S31 and L36 chemical shifts, the 
addition of carbonyl chemical shifts for all residues, and the more accurately measured 
sidechain methyl chemical shifts (13). Figure 6.7a plots the average chemical shift change 
per residue due to amantadine binding:  
€ 
chemical shift perturbation =  1n δapo,i − δamt,ii=1
n
∑ , 
where n is the number of chemical shift values available in each residue. Both the 13C and 15N 
chemical shifts are included, and the absolute value of the chemical shift difference is 
summed to avoid cancellation of positive and negative shift changes. Figure 6.7a shows three 
distinct local maxima of chemical shift perturbation: S31, G34 and V28, with average 
chemical shift changes of 2.1 ppm, 1.1 ppm, and 0.9 ppm, respectively.  
 
 
 
Figure 6.7. Amantadine-induced changes of M2TMP structure and dynamics in DLPC bilayers. (a) 
Average isotropic chemical shift changes for each residue, measured at low temperature. (b) Average 
13C T2 changes, measured at 303 K.  
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Conformational distributions at V28, S31 and L36 
 While isotropic chemical shifts report the average conformation, linewidths of frozen 
proteins indicate the conformational distribution. Apparent linewidths (Δ*) directly read off 
from the spectra are indicative of conformational heterogeneity, while homogeneous 
linewidths (Δ) result from T2 relaxation, which is induced by microsecond-timescale 
molecular motions that modulate the nuclear spin interactions. The homogeneous linewidths 
can be measured using spin echo experiments and are related to T2 by 
€ 
Δ =1 πT2 . We 
extracted the 15N and 13C apparent linewidths from 2D 13C-13C and 15N-13C correlation spectra 
where all signals are resolved. Low temperature spectra are used since they capture all 
conformations present in the fluid membrane. Table 6.2 shows that the apparent linewidths of 
most sites in V28, S31 and L36 are similar between the apo and complexed peptide, with the 
exception of all amide 15N sites and S31 Cα and Cβ.  
To obtain the 13C homogeneous linewidths, we measured the T2 relaxation times 
under a 1H decoupling field of 71 kHz. 1H-decoupled heteronuclear T2 is mainly sensitive to 
motions on the timescale of the inverse of the decoupling field, which is thus ~ 10 µs. Table 
6.2 shows that the 13C homogeneous linewidths are identical between the apo and complexed 
peptide within experimental uncertainty, indicating that all peptide motion is frozen at 243 K 
and does not cause different relaxation between the apo and complexed states. Thus, the 
narrower Δ* of S31 in the complexed peptide must be attributed to reduced conformational 
heterogeneity due to drug binding.  
 
Amantadine-induced changes of M2TMP dynamics 
 Complementing the low-temperature chemical shift and linewidth data, we measured 
the 13C spectra of M2TMP in the liquid-crystalline phase of the lipid bilayer to obtain 
information on the molecular motion of the protein. Previous data on eight other labeled 
residues found across-the-board line narrowing by amantadine at high temperature (13). This 
is now observed at V28, S31, and L36 as well. Figure 6.8 shows the 13C CP-MAS spectra of 
apo and complexed VSL-M2TMP in DLPC bilayers from 243 K to 313 K. At 243 K, the 
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spectra show strong intensities characteristic of immobilized molecules for both the apo and 
complexed M2TMP. When the temperature increased to 283 K, near the phase transition 
temperature of the DLPC bilayer, the peak intensities decrease significantly for both samples, 
indicating intermediate-timescale motion. Increasing the temperature to the near-
physiological 313 K partially recovered the intensities of both samples, but the amantadine-
complexed peptide exhibits stronger CP intensities than the apo-peptide, especially for 
methylene groups such as L36 Cβ and S31 Cβ.  
 
 
 
Figure 6.8. 1D 13C variable-temperature CP-MAS spectra of VSL-M2TMP bound to DLPC bilayers. 
(a) Without amantadine. (b) With amantadine. Temperatures from top to bottom are 313 K, 283 K 
and 243 K.  
 
To probe fluid-phase dynamics of M2TMP, we measured the 13C T2 of the peptide at 
303 K using the Hahn-echo experiment and compared them between the apo and complexed 
states. Table 6.3 shows that the 13C T2 values increase by 1.5 – 4.0 fold upon drug binding, 
consistent with what was observed at other residues (13). Plotting the fractional increase of 
the 13C T2 for the eleven residues as  
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€ 
fractional T2 change =  
1
n
T2,amti − T2,apoi
T2,amtii=1
n
∑ , 
we find two local maxima, V27 and S31 (Figure 6.7b).  
 
Table 6.3. 13C homogeneous T2 (ms) of VSL-M2TMP at 303 K with 71 kHz 1H decoupling.  
 
Residue site T2, apo T2 , +Amt 
V28 Cα 1.0 2.5 
 Cγ1  3.0 5.6 
 Cγ2 2.6 4.7 
S31 Cα 3.5 
 Cβ 1.1 3.8 
L36 Cα 1.0 3.6 
 Cβ 1.1 3.5 
 Cγ 2.6 7.9 
 Cδ1 6.0 11.6 
 Cδ2 6.0 - 
 
 
Dependence of M2 structural changes on amantadine concentration and specificity of the 
structure changes 
The above amantadine-induced chemical shift changes were measured on membrane 
samples prepared from buffers containing 10 mM amantadine. 1H solution NMR analysis of 
the supernatant after the membrane is pelleted showed that the amount of amantadine bound 
to the membrane typically corresponded to a M2 : amantadine molar ratio of ~1 : 10. This is 
well in excess of the expected stoichiometric M2 : amantadine ratio, which is either 4 : 1 
based on the crystal structure or 1: 1 based on the solution NMR structure. The use of excess 
amantadine is largely due to the concern that the lipophilic drug, which readily partitions into 
the lipid membrane from the aqueous solution (28-30), may not all end up in the channel. 
Nevertheless, the question arises as to whether the observed M2 chemical shift changes result 
from non-specific effects of amantadine on the lipid bilayer that then indirectly change the 
peptide structure, or whether it is due to direct amantadine-peptide interactions. To address 
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this question, we prepared a VSL-M2TMP sample in DLPC bilayers with a much lower M2 : 
amantadine molar ratio of 1 : 2, by directly titrating a quantitative amount of amantadine 
solution into the M2 membrane pellet. The resulting 2D spectrum (Figure 6.9c) shows that 
70% of the S31 15N-13Cα peak has shifted to the bound position. The 30% remaining 
unshifted signal can be attributed to channels without amantadine, implying that some 
amantadine is dispersed in the rest of the lipid bilayer. The observation of the same chemical 
shift perturbation at much lower amantadine levels confirm that the structural changes we 
detect at high concentration result from direct drug-protein interactions rather than non-
specific lipid-mediated effects, as shown in Figure 6.9.  
 
 
 
Figure 6.9. 2D 15N-13C correlation spectra of VSL-M2TMP in DLPC bilayers with different amounts 
of amantadine. The S31 15N-13Cα cross peak is used to indicate the degree of amantadine binding. 1D 
15N CP spectra are shown projected from the indirect dimension of each spectrum. (a) No amantadine. 
The S31 peak is completely in the unbound position. (b) Amantadine added at 10 mM in the buffer. 
The M2 : amantadine molar ratio in the final membrane is ~1 : 8. Almost all S31 intensities are at the 
bound position. (c) Amantadine directly titrated into the membrane pellet. The M2 : amantadine 
molar ratio in the final pellet is ~ 1 : 2. 70% of the S31 intensity is at the bound position.  
 
A related question is whether amantadine causes the M2 13C T2 relaxation time 
changes (Figure 6.7b) by indirect and non-specific changes of the membrane dynamics. To 
answer this question, we prepared two DLPC samples without the M2 peptide. One sample 
does not contain amantadine and the other contains 10 mM amantadine in the buffer during 
vesicle formation. The 13C T2 relaxation times of the two DLPC samples were measured at 
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313 K by direct polarization Hahn echo experiments, in which identical 1H decoupling field 
strengths (30 kHz) were used to ensure that the motion is probed on the same timescale. 
Figure 6.10 shows the fractional T2 changes for all resolved DLPC carbon sites. It can be 
seen that all sites except the headgroup Cβ experience negligible T2 changes of less than 
±10% upon amantadine binding. Moreover, most DLPC sites show a decrease of 13C T2, 
opposite to the trend for M2TMP. Thus, amantadine does not significantly impact the lipid 
dynamics, and the dynamic changes of M2TMP are specifically due to peptide-drug 
interactions.  
 
 
 
Figure 6.10. Fractional 13C T2 changes of DLPC lipid carbons upon amantadine binding at 313 K. No 
M2 peptide is present. The fractional change is calculated as 
€ 
T2,amt −T2,apo( ) T2,apo . 
 
Discussion 
 The goals of this study are two fold: obtain a chemical shift constrained backbone 
structure of M2TMP in the absence and presence of amantadine, and determine the size and 
nature of the drug-induced conformational change, particularly at Ser31. With the 
consolidation of the 13C and 15N chemical shifts for eleven consecutive residues in the core of 
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the peptide, we can now use the TALOS program to predict the backbone torsion angles of 
the M2 peptide in the lipid bilayer.  
Backbone structure of M2TMP monomer  
 The TALOS predicted (φ, ψ) torsion angles of M2TMP based on the 13C and 15N 
chemical shifts are shown in Figure 6.11 and tabulated in Table 6.S1 in Supplementary 
Materials. TALOS requires the chemical shifts of three consecutive residues to predict the 
torsion angles of the central residue. Since I32 and H37 have not been labeled in our studies 
but data for their neighboring residues are available, we used database ideal helical chemical 
shifts for these two residues as placeholders in order to extract the (φ, ψ) angles of their 
neighboring residues. The torsion angles of I32 and H37 are thus not entirely constrained 
(shaded points in Figure 6.11).  
 
 
 
Figure 6.11. TALOS predicted (φ, ψ) angles for residues 26-38 of apo (black) and amantadine-
complexed M2TMP (red). Filled and open red symbols denote the conformations of amt1 and amt2, 
which differ at G34. Residues 32 and 37 are shaded due to incomplete experimental data.  
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 The chemical shift changes listed in Table 6.1 indicate a number of (φ, ψ) changes, 
although none of them are large enough to alter the basic helical nature of the protein. The 
first region of change is V27-V28, and the second is A30-S31. Interestingly, while the 
chemical shifts of V27 and A30 themselves are not significantly perturbed, the larger 
chemical shift changes of their C-terminal residues, V28 and S31, translated into significant 
(φ, ψ) changes at V27 and A30. In particular, the large 15N chemical shift changes of S31 and 
V28 indicate that the ψ angle of A30 and V27, respectively, are significantly perturbed.  
 The G34-I35 pair is the third region of (φ, ψ) perturbation that merits attention. Not 
only do both residues show clear chemical shift perturbations, but also two sets of G34 15N 
and 13C chemical shifts are present in the complexed peptide (Table 6.1). We denote the set 
with an upfield 15N shift of 106.3 ppm as amt1, and the set with a downfield 15N chemical 
shift of 109.7 ppm as amt2. The amt1 chemical shifts are similar to the apo values, 
suggesting that a population of peptide either does not bind or only weakly binds amantadine. 
In contrast, the amt2 chemical shifts are significantly different from the apo values, and cause 
larger G34 φ and I35 ψ changes (Figure 6.11). Overall, the TALOS predicted (φ, ψ) angle 
differences between the apo- and amt2 forms of M2TMP are on average (1.8˚, 2.8˚).  
 Figure 6.12 shows the monomer structure of the M2TMP backbone based on the 
TALOS (φ, ψ) angles. The apo structure is shown in black and gray and the amt2 structure in 
blue and cyan. For residues 39 down to the end of the helix, where no experimental chemical 
shifts are available, we used the helical torsion angles of (-59˚, -44˚) for both the apo and 
complexed peptide. Figure 6.12 shows that both helices are relatively ideal. The side views 
of the two models are oriented such that the N-terminus half of the helix above G34 has a tilt 
angle of 35˚ for the apo peptide and 38˚ for the amantadine-bound peptide. These tilt angles 
were measured on hydrated vesicle samples by 15N NMR (13, 20, 21). When the N-terminal 
segments of the two helices are superimposed, it becomes apparent that the amt2 and apo 
helices diverge in the orientation of the segment C-terminal to G34. Comparing the helical 
axis for residues 27-33 with the helical axis for residues 35-41, we find a kink of 8˚ for the 
apo peptide and 5˚ for the amt2 helix. The helical axis orientations were calculated as the 
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average N-H vector orientation of each 7-residue segment, which approximately complete 
two turns of the helix.  
 
 
 
Figure 6.12. Chemical shift constrained backbone structure of the M2TMP monomer. Apo: black and 
gray ribbon. Amantadine-bound: blue and cyan ribbon. (a) Side view of the helix with tilt angles 
determined by SSNMR. (b) Top view of the apo monomer. (c) Top view of the amantadine-
complexed monomer. The apo peptide has a more noticeable kink. 
 
 15N chemical shift anisotropies and N-H dipolar couplings have been measured on 
M2TMP in glass-plate aligned DMPC/DMPG membranes using static NMR techniques. 
These data indicated a pronounced helix kink of 13˚ for the drug-complexed M2TMP (18). 
The site of the kink is G34, in good qualitative agreement with the current chemical shift data 
that indicate structure perturbation at G34-I35. However, the kink from the oriented-sample 
NMR data is much larger than deduced from the current unoriented MAS samples. While 
static 15N anisotropic couplings are very sensitive to helix orientations, it is possible that 
glass-plate samples may exert additional influences on the protein orientation through 
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mechanical stress and hydration. In comparison, the unoriented vesicle samples should place 
much less stress on membrane proteins and thus provide a useful check of the protein 
orientation. Moreover, the membrane thickness may affect the helical kink. The aligned 
membrane experiments were done in DMPC and DMPG lipids while the current experiments 
were conducted in the thinner DLPC bilayers.  
 The recent solution NMR (14) and X-ray structures (15) of drug-bound and detergent 
solubilized M2 peptide show different kinks of the helical backbone. Comparing the same 
segments of 27-33 and 35-41, the solution NMR structure (PDB: 2RLF) has a minor kink of 
4˚, while the refined crystal structure (PDB: 3C9J) has a larger kink of 12˚. Thus, the amt2 
kink of 5˚ measured by MAS-SSNMR falls within the range of reported by all methods.  
 Paradoxically, the structure of the apo M2 peptide is much less known than that of the 
drug-bound M2. Static 15N NMR data of the apo peptide suffered from broad linewidths due 
to unfavorable conformational dynamics of the protein (19, 31), which made it difficult to 
detect possible helix orientation differences between the N- and C-terminal segments of the 
helix. The MAS-NMR approach here bypasses this difficulty since its main structural 
constraints are isotropic chemical shifts, which can be measured at low temperature where 
motion is frozen. Based on the 13C and 15N isotropic chemical shifts, the helical backbone of 
the apo M2TMP is also not straight but has a kink of ~9˚, as shown in the top view in Figure 
6.12b. While the chemical shift constrained backbone conformation are only indirect 
constraints of the helix orientation, the data nevertheless suggests that the presence of Gly34 in 
the peptide may cause a small kink already in the apo protein. This would not be surprising 
since Gly is a helix breaker in globular proteins (32). In membrane proteins Gly adheres to 
more ideal helical torsion angles (33), as in the case of Gly34, but a small deviation from 
ideality is all that is required to cause a small kink of the helical axis. If confirmed, then the 
role of helix kink to the M2 channel activity would need to be considered. Since Gly34 is 
located roughly one turn away from His37, which is responsible for proton conduction, we 
speculate that the kink may be required for establishing the proper His37 sidechain 
conformation. The change in the helix kink after amantadine binding may thus be relevant 
for proton blockage.  
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Backbone structure of the M2 tetramer  
 Based on the chemical shift constrained monomer structure, we now construct a 
tetramer model of amantadine-bound M2TMP using the measured helix orientation and 
interhelical distances. Again, the helix tilt angle is set to be 35˚ for the apo peptide (20) and 
38˚ for the amantadine-bound peptide (13, 21) for the segment N-terminal to Gly34. We have 
previously measured two 19F-19F interhelical distances at Trp41 5-19F (23) and Phe30 4-19F (22, 
34) using 19F spin diffusion NMR (35) . By design, these experiments measure all three 
distances in the symmetric tetramer, including two nearest neighbor i – i±1 distances 
€ 
rnn  and 
the diagonal i – i+2 distance, 
€ 
2rnn . The tetrameric nature of the channel is directly 
confirmed in the experiment as an equilibrium value of 1/4. We found an 
€ 
rnn  of 11.8 Å for 
Trp41 5-19F and 8.5 Å at Phe30 4-19F. The former constrained the Trp41 sidechain rotamer to 
t90 (χ1=180˚, χ2=90˚), while the latter constrained the Phe30 rotamer to t (χ1=180˚). In 
addition to these two interhelical distances, we use a Gly34 Cα-Cα diagonal distance of 10.4 
Å (36) in building the tetramer model.  
 Figure 6.13 shows the tetramer model for the amt2 peptide where the three distance 
restraints are indicated. For clarity we show only the diagonal distances, which are 16.7 Å, 
12.5 Å, and 10.4 Å for Trp41 5-19F, Phe30 4-19F, and Gly34 Cα, respectively. For comparison, 
the tetramer structure solved by 15N static NMR (PDB: 2H95), solution NMR (PDB: 2RLF), 
and X-ray crystallography (PDB: 3C9J) are shown in Figure 6.14b-d. A number of 
differences can be seen. First, both the solution NMR structure in DHPC micelles and the 
static 15N NMR structure in DMPC bilayers give inter-helical Trp41 distances that are much 
shorter than the measured value. This discrepancy is mainly due to the different (χ1, χ2) 
angles in these models: t-90 in the solution NMR structure and (-95˚, 125˚) in the static 15N 
NMR model. The crystal structure has the t90 rotamer for Trp41 and thus gives consistent 
interhelical distances with the 19F MAS NMR result. Second, the MAS-SSNMR tetramer 
model is more open at the N-terminus than the solution NMR and crystal structures. At Val27, 
the Hγ - Hγ diagonal distances in our model are ~11 Å, but are 5 – 7 Å in the other models. 
The relatively large pore opening at Val27 in our model is a direct result of the helix 
orientation, and is consistent with the small chemical shift perturbation of Val27 and the 
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interhelical Phe30 distance constraint. This large opening may be necessary to allow the drug 
to bind at the N-terminus. The smaller Val27 constriction in the solution NMR and crystal 
structures is a direct result of smaller tilt angles, which may be influenced by the detergent 
matrix used. It is well documented that the orientation of the M2 transmembrane helix is 
relatively plastic, readily affected by the bilayer thickness (20, 37). In DLPC and DMPC 
bilayers, both MAS and static NMR experiments point to a large helical tilt angle of about 
35˚, while in POPC bilayers the tilt angle is only 26˚ (20).   
 In contrast to the openness of the channel at Val27, the MAS-derived structural model 
shows a tight Ser31 constriction, with a distance of 9.0 Å between the two opposing hydroxyl 
oxygens. This Ser31 constriction is similar to the crystal structure, but tighter than the static 
15N NMR model (11.9 Å) and the solution NMR structure (19.4 Å) (Figure 6.14). Overall, 
the small Ser31 constriction is consistent with the large chemical shift perturbation at this site 
(see next section). 
 
 
Figure 6.13. Tetramer model of M2TMP constrained by SSNMR chemical shifts, interhelical 
distances and helix orientations. (a) Trp41 5-19F distance between the two opposite helices is 16.7 Å 
(23). (b) Phe30 4-19F diagonal distance is 12.5 Å (22). (c) Side view of the tetramer, with a diagonal 
Gly34 Cα-Cα distance of 10.4 Å.  
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Figure 6.14. Comparison of the MAS NMR structure model with other recently published structures 
of drug-complexed M2. The Trp41 indole ring and the diagonal distance between its 5-19F or Hζ3 is 
indicated. (a) MAS-NMR model of amantadine-bound M2TMP. (b) 15N static SSNMR model of 
amantadine-bound M2TMP (PDB code: 2H95). (d) Solution NMR structure of rimantadine-bound 
M2(18-60) (PDB code: 2RLF). (d) Crystal structure of amantadine-bound M2TMP (PDB: 3C9J).  
 
 To compare the various M2 PDB structures with the current MAS-based model more 
quantitatively, we used the SHIFTX program (38) to calculate the 15N, 13CO, 13Cα and 13Cβ 
chemical shifts for the crystal structure (PDB: 3C9J), the solution NMR structure (PDB: 
2RLF), and the oriented solid-state NMR structure (PDB: 2H95). The root-mean-square 
(RMS) deviations of the predicted chemical shifts from the measured values for both the apo 
and amantadine-bound M2TMP are summarized in Table 6.S2 (Supplementary Material). 
Three observations can be made. First, with the exception of the 13CO shifts for the oriented 
NMR structure model, most 13C RMS shift differences are in the range of 0.8-1.3 ppm, which 
are comparable to the standard RMS errors of the SHIFTX program. This suggests that the 
deviations are mostly due to systematic uncertainties in the prediction protocol rather than 
large secondary structure differences. Second, the 15N chemical shifts differences are 
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comparable to the standard RMS error when the predicted values are compared to the 
measured apo chemical shifts, but the differences become almost two times larger when the 
predicted values are compared to the amantadine-bound chemical shifts. This further 
indicates the sensitivity of 15N chemical shifts to long-range electrostatic effects due to ligand 
binding and helix packing, which are not taken into account in such chemical shift prediction 
programs. Third, among the three PDB structures, the oriented SSNMR structure (2H95) has 
the largest 13C chemical shift deviations from the current data, but the smallest 15N chemical 
shift deviations. This is consistent with the sole use of 15N NMR inputs to constrain the 2H95 
model.  
 
Ser31 interaction with amantadine 
 The chemical shift perturbation plot (Figure 6.7a) indicates maximal drug-induced 
changes at Ser31 and Val28, which are mainly due to the large 15N chemical shift changes of 
these two residues. Many factors influence 15N chemical shielding: in addition to (φ, ψ, χ) 
torsion angles (39), solvation effects and electrostatic field effects can be significant. 
Hydrogen bonding of the NH group can cause a deshielding of as much as 13 ppm (40), and 
γ-gauche effect through the sidechain torsion angle also affects the 15N chemical shifts (39). 
However, database 15N secondary shifts show only small deviations of ~ 1 ppm for the 
helical conformation from the random coil values (41).  Thus, it is difficult to directly 
interpret the large 15N chemical shift perturbation of Ser31. Nevertheless, it is noteworthy that 
both the 15N and Cβ chemical shifts of Ser31 in the bound peptide (Table 6.1) are well beyond 
the typical values for α-helical Ser (41), which are 114.9 ppm and 61.2 ppm, respectively, 
while the apo peptide’s Ser31 chemical shifts are within the database range for α-helical Ser. 
This suggests that Ser31 is locally perturbed by amantadine through packing effects.  
 Early neutron diffraction (25) and MD simulations (24) both supported the N-
terminus of the helical bundle to be the amantadine binding site. However, the recently 
published high-resolution crystal structure (15) and solution NMR structure (14) of M2 gave 
contradictory results on the drug binding site. The former shows an N-terminus binding site 
deeper than Ser31, while the latter puts four rimantadine molecules per channel on the C-
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terminus side at helical interfaces. Since then, a functional study of the proton conductivity of 
M2 mutants has been carried out that supports the N-terminus region as the primary 
amantadine binding site with channel inhibition properties (42).  
 While the current data do not directly probe the drug binding site, several indirect 
pieces of structural evidence support an N-terminus location for amantadine. First, Ser31 is 
the only residue among the three studied here whose sidechain Cβ linewidth is reduced. This 
may reflect sidechain conformational ordering necessary to form the appropriate hydrogen 
bond with amantadine. Second, the chemical shift perturbation for the segment N-terminal to 
G34 is extensive (Figure 6.11), with only the lipid-facing A29 and the very upstream L26 
showing no torsion angles changes. Third, both V28 and L36 lie at lipid-facing positions (b 
and c) of the heptad repeat, but the chemical shift perturbation of the N-terminus V28 is 
much larger than that of the C-terminus L36.  
Assuming that amantadine indeed binds the N-terminus portion of the channel, we 
can model the distances of amantadine from Ser31 in the tetramer (Figure 6.15). Using the 
height of amantadine found in the crystal structure as a template, we found that if the amine 
points to the center of the membrane, then the RNO distances between Ser31 OH and 
amantadine NH2 are 7.5 – 8.0 Å, too long for hydrogen bonding. However, if the amine 
points to the membrane surface, then much shorter RNO distances of ~4.5 Å are found. This 
amine-up orientation is supported by a recent paramagnetic relaxation NMR and MD 
simulation study of the depth of insertion of amantadine in the absence of M2 (29). To 
decrease the RNO distance further to form hydrogen bonds of 2.5 – 3.5 Å, the Ser31 χ1 torsion 
angle would need to be changed. Due to the small sidechain, Ser does not have a single 
dominant χ1 rotamer. For α-helical backbones, the most popular rotamer of m (χ1= –65˚) is 
44% while the least popular rotamer t (χ1=-170˚) still has a significant presence of 22% (43). 
In our model (Figure 6.15), both the m and t rotamers give RNO distance of ~4.5 Å, but 
shorter distances of ~3.5 Å may be reached for less canonical χ1 angles. Ultimately, 
intermolecular distance experiments are necessary to test this Ser31 binding-site hypothesis 
and to determine the high-resolution structure of the amantadine binding pocket in the 
bilayer-bound M2.  
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Figure 6.15. MAS-NMR M2 tetramer model with the proposed amantadine-binding site. The height 
of amantadine is set to be similar to that of the crystal structure. Ser31 sidechain O distances to the 
amine are indicated. The top view looks down the helix axis from the N- to the C-terminus. 
 
Molecular dynamics of M2TMP 
The conformational plasticity of the M2 peptide in lipid membranes are now well 
documented (20, 31, 37). The low 13C CP intensities and short 13C T2 relaxation times for 
V28, S31 and L36 at high temperature all confirm the presence of intermediate-timescale 
conformational dynamics, which interfere with 1H decoupling and the 1H-13C cross 
polarization process. In the gel phase, the motion is largely frozen, thus the distribution of 
conformations sampled at high temperature is shown as isotropic chemical shift distributions. 
The larger low-temperature linewidths of the apo peptide compared to the complexed 
peptides, mostly at 15N sites, indicate larger conformational disorder of the apo peptide.  
The nature of the M2 motion is complex. We have shown that the whole helical 
bundle undergoes uniaxial rotation around the bilayer normal (20), which explains the 
observation that the short 13C T2 times are not local but occur throughout the peptide. The 
lengthening of the T2 upon amantadine binding (Table 6.3) can in principle result from either 
a decrease or increase of motional correlation times. Temperature-sensitive relaxation times 
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(unpublished data) indicate that the rate of motion is accelerated rather than slowed down by 
amantadine. Figure 6.7b indicates that most residues have similar amantadine-induced T2 
increases except for Ser31 and Val27, whose T2 increases are much larger. We hypothesize that 
the exceptionally long 13C T2 at this two sites may be caused by strong interaction with 
amantadine. However, the exact nature of the site-specific conformational dynamics or 
ordering will require further investigation.  
 In summary, the solid-state NMR chemical shifts and dynamic constraints measured 
here for Ser31 and other residues combine with previous data to allow the determination of a 
bilayer-bound structure of the transmembrane domain of this important influenza proton 
channel. We found that the apo and amantadine-complexed M2TMP differ in conformation 
mainly at three regions, V27-V28, A30-S31, and G34-I35. In particular, G34 is the site of a 
helical kink in both the apo and drug-bound peptide. Interhelical distances and helix 
orientations constrain the tetramer to be relatively open at the N-terminus, which allows the 
drug to enter, but tight at Ser31, which suggests hydrogen bonding between the hydroxyl 
group and the amantadine amine. At Trp41 the channel has an interhelical distance of ~16.7 Å 
between opposing helices. Among all residues, Ser31 shows the largest drug-induced 
perturbations of chemical shifts, conformational dynamics, and conformational disorder, 
strongly suggesting that this residue is the amantadine binding site.  
 
Material and Methods 
Peptides and lipids  
  Fmoc-protected uniformly 13C, 15N-labeled Val, Ser, and Leu were either prepared in-
house (44) or purchased from Sigma-Aldrich and Cambridge Isotope Laboratories. The M2 
transmembrane domain of the Udorn strain (residues 22-46) (45) was synthesized by 
PrimmBiotech (Cambridge, MA) and purified to >95% purity. The amino acid sequence is 
SSDPL VVAASII GILHLIL WILDRL. The main peptide used in this work includes labeled 
residues at V28, S31, and L36 and is denoted VSL-M2TMP. Two previously studied 
M2TMP samples were also re-examined for their chemical shift assignment. One peptide 
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contains labeled residues at L26, A29, G34 and I35, and the other peptide contains labeled 
sites at V27, A30, I33 and L38.  
 
Membrane sample preparation  
M2TMP was reconstituted into 1,2-dilauroyl-sn-glycero-3-phosphatidylcholine 
(DLPC) bilayers by detergent dialysis (23). DLPC was chosen because of the favorable 
dynamics of the protein in this membrane (20) and the similar phase transition temperature (-
2˚C) of this bilayer to biological cell membranes. The lipid vesicle solution was prepared by 
suspending dry DLPC powder (Avanti Polar Lipids) in 1 mL phosphate buffer (10 mM 
Na2HPO4/NaH2PO4, 1 mM EDTA, 0.1 mM NaN3) at pH 7.5, vortexing and freeze-thawing 6-
8 times to create uniform vesicles (46). M2TMP powder was codissolved with OG in 2 mL 
phosphate buffer to an OG concentration of 30 mg/mL. The M2TMP/OG solution was mixed 
with an equal volume of DLPC vesicles to halve the OG concentration to 15 mg/mL. The 
final peptide/lipid molar ratio (P/L) was 1:15. The mixture was vortexed for 1 hr, allowed to 
stand for 6-8 hrs at room temperature, then dialyzed with a 3.5 kDa cutoff against 1 L 
phosphate buffer at 4 °C for 3 days. The buffer was changed every 8-12 hrs to ensure 
complete removal of the detergent. The dialyzed M2TMP/DLPC solution was centrifuged at 
150,000 g for 3 hours at 10˚C, resulting in a pellet containing ~50 wt% water. For most 
amantadine-bound samples, 10 mM amantadine hydrochloride was added to the phosphate 
buffer either throughout the vesicle formation and peptide reconstitution processes or before 
ultracentrifugation. After ultracentrifugation the percent of amantadine left in the supernatant 
was quantified by 1H solution NMR and found to be roughly 60%. This gave a peptide : lipid 
: drug molar ratio of about 1 : 15 : 8. All membrane-bound M2 samples were thus studied at 
pH 7.5, corresponding to the closed state of the channel.  
 
Solid-state NMR spectroscopy  
 Most SSNMR experiments were carried out on a Bruker AVANCE-600 (14.1 Tesla) 
spectrometer (Karlsruhe, Germany) using a 4 mm triple-resonance MAS probe. 13C-13C and 
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15N-13C 2D correlation experiments were conducted at 243 K to freeze peptide motion. 13C T2 
relaxation times were measured at 303 K where the peptide is uniaxially mobile in the liquid-
crystalline DLPC bilayer. Typical rf pulse lengths were 5 µs for 13C and 3.5-4.0 µs for 1H. 1H 
TPPM (47) or SPINAL (48) decoupling field strengths of 60 – 70 kHz were applied. 13C 
chemical shifts were referenced to the α-Gly C’ signal at 176.49 ppm on the TMS scale, and 
15N chemical shifts were referenced to the 15N signal of N-acetyl-valine at 122.0 ppm on the 
liquid ammonia scale. 
 Three types of 2D 13C-13C correlation experiments were carried out to assign all regions 
of the 13C spectra. A double-quantum-filtered (DQF) COSY experiment was used to obtain 
lipid-free protein spectra. Double-quantum filtration was performed using the dipolar 
recoupling sequence SPC5 (49) with the sample spun at 7000 Hz. To better assign the 
carbonyl peaks, which are weak in the DQF-COSY spectrum due to their large chemical shift 
difference from the aliphatic carbons, a 2D 1H-driven 13C spin diffusion experiment with a 10 
ms DARR mixing period (50) was carried out under 5333 Hz MAS. Finally, to completely 
resolve the sidechain methyl 13C signals, a double-quantum single-quantum correlation 
experiment, INADEQUATE (51, 52), was used in which the SPC5 sequence was again used 
for double-quantum excitation and reconversion.  
 Heteronuclear 2D 15N-13C correlation experiments were carried out in an out-and-back 
fashion using the REDOR sequence (53) for 13C-15N coherence transfer (54). The C-N 
recoupling times varied between 0.7 and 2.1 ms to observe one-bond versus multiple-bond 
cross peaks.  
 To selectively detect the S31 Cβ signal that overlaps with its Cα, we carried out a 
methylene spectral editing experiment (55) at 233 K. The β pulse in the sequence that was 
responsible for clean suppression of the methine CH signals was optimized to be 40˚. For 
MREV-8 (56) 1H homonuclear decoupling, a 1H pulse flip angle of 94° was used.  
 
Structure Modeling 
 The M2TMP tetramer structure was modeled in Insight II (Accelrys, Inc. San Diego). 
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The central segment of residues 26-38 was constrained by the chemical shifts and interhelical 
distances except for residues I32 and H37. The final tetramer model used the wild-type 
residue Ala at position 30, after the mutation Phe30 was checked for interhelical distance 
restraint. The atomic coordinates of the tetrameric helical bundle have been deposited in the 
Protein Data Bank (accession number: 2kad). The SSNMR chemical shift restraints have 
been deposited in the Biological Magnetic Resonance Bank (accession number: 16020). 
These data will be released upon publication.  
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Supporting Information 
 
Table 6.S1. TALOS predicted (φ, ψ) angles (degrees) and their uncertainties for apo-M2TMP and 
amantadine-bound M2TMP (amt2 form). 13C and 15N chemical shifts measured under MAS on 
membrane-bound M2TMP were used as inputs.  
 
Residues Apo (φ, ψ) Apo (Δφ, Δψ) Amt2 (φ, ψ) Amt2 (Δφ, Δψ) 
L26 (-64.5, -39.1) (8.1, 12) (-64.7, -39.3) (8.3, 14) 
V27 (-62.7, -45.0) (6.6, 6.0) (-64.9, -39.1) (5.2, 10) 
V28 (-63.4, -44.9) (4.8, 2.6) (-65.3, -42.8) (6.1, 6.4) 
A29 (-59.9, -39.3) (2.1, 5.9) (-60.7, -38.3) (2.5, 6.5) 
A30 (-65.2, -38.7) (5.2, 7.0) (-68.8, -36.0) (6.1, 9.4) 
S31 (-62.9, -40.6) (4.0, 11) (-65.5, -40.3) (11, 6.6) 
I32 (-61.9, -41.8) (8.5, 4.8) (-61.3, -42.3) (5.8, 7.9) 
I33 (-63.0, -42.7) (3.3, 7.1) (-62.3, -45.3) (5.0, 6.0) 
G34 (-61.4, -39.3) (5.3, 5.5) (-59.3, -40.1) (5.6, 7.0) 
I35 (-64.9, -37.3) (4.3, 6.2) (-67.3, -43.5) (3.2, 9.5) 
L36 (-62.0, -41.1) (4.4, 3.9) (-63.1, -40.2) (5.0, 4.3) 
H37 (-63.0, -40.8) (3.6, 5.1) (-62.4, -40.4) (3.4, 5.6) 
L38 (-67.2, -39.4) (7.9, 7.9) (-67.1, -36.5) (7.9, 11) 
RMS error  (5.0˚, 6.2˚)  (5.8˚, 7.4˚) 
 
 
The TALOS (φ, ψ) uncertainties are larger than the torsion angle differences between the apo 
and amantadine-bound M2TMP, which are (1.8˚, 2.8˚) for (φ, ψ). This does not mean, 
however, that the structural difference between apo and amantadine-bound M2 is 
insignificant, since TALOS is based on the empirical correlation between database chemical 
shifts and protein structures, and thus has limited ability to distinguish torsion angles of 
perturbed protein states due to small-molecule binding.  
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Table 6.S2: RMS deviations (ppm) between SHIFTX-predicted chemical shifts for eleven residues of 
M2TMP and measured chemical shifts on bilayer samples by MAS NMR. The database standard 
RMS errors of SHIFTX prediction are given for comparison.  
 
Sites  X-ray 
(3C9J) 
Solution 
NMR (2RLF) 
Oriented 
NMR (2H95) 
Standard 
RMS error 
N, apo 2.73  2.48  2.08 
N, amt 4.56 4.04 3.78 
2.43  
CO, apo 1.10  1.18  2.33  
CO, amt 1.34 1.37 2.52 
1.16  
CA, apo 0.87 0.79  1.01  
CA, amt 0.97 0.80 1.13 
0.98  
CB, apo 0.85 1.03 1.34  
CB, amt 0.99 1.10 1.38 
1.10  
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Chapter 7 
 
Accurate Measurement of Methyl 13C Chemical Shifts by Solid-State NMR for the 
Determination of Protein Sidechain Conformation: the Influenza A M2 
Transmembrane Peptide as an Example 
A paper published in the Journal of the American Chemical Society 
2009, vol. 131 pp. 7806-7816 
Mei Hong, Tatiana V. Mishanina and Sarah D. Cady 
 
Abstract  
 The use of sidechain methyl 13C chemical shifts for the determination of the rotameric 
conformation of Val and Leu residues in proteins by solid-state NMR spectroscopy is 
described. Examination of the solution NMR stereospecifically assigned methyl groups 
shows significant correlation between the difference in the two methyl carbons’ chemical 
shifts and the sidechain conformation. It is found that α-helical and β-sheet backbones cause 
different sidechain methyl chemical shift trends. In α-helical Leu’s, a relatively large 
absolute methyl 13C shift difference of 2.89 ppm is found for the most populated mt rotamer 
(χ1=-60˚, χ2=180˚), while a much smaller value of 0.73 ppm is found for the next populated 
tp rotamer (χ1=180˚, χ2=60˚). For α-helical Val residues, the dominant t rotamer (χ1=180˚) 
has more downfield Cγ2 chemical shifts than Cγ1 by 1.71 ppm, while the next populated m 
rotamer (χ1=-60˚) shows the opposite trend of more downfield Cγ1 chemical shift by 1.23 
ppm. These significantly different methyl 13C chemical shifts exist despite the likelihood of 
partial rotameric averaging at ambient temperature. We show that these conformation-
dependent methyl 13C chemical shifts can be utilized for sidechain structure determination 
once the methyl 13C resonances are accurately measured by double-quantum (DQ) filtered 2D 
correlation experiments, most notably the dipolar DQ to single-quantum (SQ) correlation 
technique. The advantage of the DQ-SQ correlation experiment over simple 2D SQ – SQ 
correlation experiments is demonstrated on the transmembrane peptide of the influenza A M2 
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proton channel. The methyl chemical shifts led to predictions of the sidechain rotameric 
states for several Val and Leu residues in this tetrameric helical bundle. The predicted Val 
rotamers were further verified by dipolar correlation experiments that directly measure the χ1 
torsion angles. It was found that the chemical-shift predicted sidechain conformations are 
fully consistent with the direct torsion angle results; moreover, the methyl 13C chemical shifts 
are sensitive to ~5˚ changes in the χ1 torsion angle due to drug binding.  
 
Introduction 
 Recent advances in extensive 13C and 15N labeling, multidimensional correlation 
methods, and improved sample preparation protocols that produce well ordered solid 
proteins, have enabled atomic-level three-dimensional structure determination of proteins by 
solid-state NMR (1-5). Despite the tremendous progress, most studies have so far focused on 
the backbone conformation and fold, with considerably lower resolution structure for the 
sidechains (6). Sidechains are important for enzyme active site chemistry and interaction 
with small molecules. For ion channels in lipid membranes, the positions of sidechains, as 
manifested by their (χ1, χ2) angles, have important implications for ion conduction and 
transport. In principle, two NMR approaches are available for determining the protein 
sidechain conformation. The first measures the torsion angles by correlating the dipolar 
couplings along the two bonds sandwiching the torsional bond of interest. For the χ1 angle, a 
natural choice is to correlate the Cα-Hα and Cβ-Hβ dipolar couplings (7, 8). However, the 
dipolar-correlation based torsion angle experiments work best for β-branched residues (Val, 
Ile, Thr) with a single Hβ proton (9). For long-chain amino acids where methylene groups 
dominate, the torsion angle results are less easy to interpret, thus sidechain torsion angles 
farther away from the backbone are harder to measure. The second approach is to measure 
distances between sidechain carbons and backbone atoms such as the amide nitrogen (10). 
However, these experiments have limited sensitivity due to the need for long transverse 
mixing times, and as a result have been demonstrated only on well ordered microcrystalline 
proteins with long T2 relaxation times.  
 168 
 In principle, the chemical shifts of sidechain carbons should reflect the sidechain 
torsion angles χ1, χ2 and so on, analogous to the influence of (φ, ψ) torsion angles on 
backbone 13C chemical shifts (11, 12). Since chemical shifts are much easier to measure than 
torsion angles and distances, there is a considerable incentive to determine whether a 
correlation exists between the sidechain 13C chemical shifts and the rotameric conformation. 
Indeed, chemical shielding computation indicated that the χ1 torsion angle affects the Cγ 
shielding of Val (13): the χ1 =180˚ conformation has a more shielded (upfield) Cγ1 than Cγ2 
while the χ1=-60˚ conformation has a more deshielded (downfield) Cγ1 resonance. A more 
recent computation study found the Ile Cγ1 and Cγ2 chemical shift anisotropies are sensitive 
to both (χ1, χ2) angles (14). Very recently, an analysis of sidechain 13C chemical shifts of nine 
amino acids in five proteins showed a correlation between upfield shifts of the Cγ resonances 
and gauche conformations of the γ-substituents (15). Overall, however, efforts to predict and 
exploit the conformational dependence of sidechain 13C chemical shifts have been quite 
limited, mainly due to the concern that rotameric averaging may be too extensive for clear 
chemical shift differences to remain at ambient temperature. The second concern is aromatic 
ring current effects (16, 17), which can affect the sidechain chemical shifts significantly. 
Third, for double-methyl residues Val, Leu, and Ile, stereospecific assignment of the two 
methyl carbons is highly desirable if not absolutely necessary to establish a clear correlation 
between conformation and methyl chemical shifts.  
 Stereospecific assignment of the two methyl 13C chemical shifts of Val and Leu has 
been possible by solution NMR for a number of years. One approach uses fractional 13C 
labeling to create different labeling levels of the two methyl carbons due to their different 
stereoselective biosynthetic pathways (18). A second approach measures three-bond J-
couplings 
€ 
3JCγN  and 
€ 
3JCγC'  to give stereospecific assignment of Val residues once the 
Karplus equations are accurately parameterized (19-22). With these methods, an increasing 
database of proteins with known conformation and known methyl 13C chemical shifts has 
become available. More recently, analyses of sidechain C-H residual dipolar couplings 
(RDCs) in partially aligned media have allowed more precise determination of rotameric 
populations in proteins (23, 24). These scalar and dipolar coupling measurements showed 
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that many Val, Leu and Ile residues in globular proteins in solution adopt a single rotameric 
state with only small fluctuations around the mean, while those that show conformational 
equilibria between different canonical rotamers often retain one dominant (greater than 
~75%) conformation.  
 The 2D 1H-driven 13C spin diffusion experiment, due to its simplicity and robustness, 
has become the standard method of choice for 13C-based assignment of solid proteins. For 
well ordered proteins with narrow linewidths, these 2D spin-diffusion based correlation 
spectra, a variant of which is called DARR (25), contain surprisingly high levels of 
information and allow many spin systems to be resolved and assigned. However, the DARR 
experiment is less useful for membrane peptides and proteins, since the high natural 
abundance signals of the lipids tend to obscure cross peaks near the diagonal. Moreover, 
membrane proteins usually have broader lines than microcrystalline proteins or fibrous 
proteins due to conformational and dynamic disorder induced by the lipids. While alternative 
MAS techniques for 2D homonuclear correlation spectroscopy have been available, direct 
comparisons among these techniques have not been made, especially for sidechain resonance 
assignment of membrane proteins. Here, we compare the 2D DARR experiment with two 
double-quantum-filtered (DQF) 13C-13C correlation experiments that are equivalent to the 
solution NMR DQF-COSY experiment (26) and the INADEQUATE experiment (27, 28), for 
the purpose of accurately measuring methyl 13C chemical shifts to determine protein 
sidechain conformations.   
 We use the influenza A M2 transmembrane peptide (M2TMP) to demonstrate the 
accurate measurement of methyl 13C chemical shifts and to verify the correlation between 
these shifts and the sidechain conformation of Val. The M2 protein of influenza A virus 
forms a proton channel in the virus envelope that is essential for viral replication (29). 
Opening of the channel acidifies the viral core, which triggers the release of the viral 
ribonucleoprotein complex into the host cell (30). A number of high-resolution structural 
studies have been carried out on the transmembrane domain of the M2 protein, using X-ray 
crystallography (31), solution NMR (32), oriented solid-state NMR (SSNMR) (33, 34) and 
magic-angle spinning SSNMR (35, 36). Thus, a relatively large amount of structural 
information is available. Using the methyl 13C chemical shifts, we predict the dominant 
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rotameric states of five Val and Leu residues in M2TMP when bound to the lipid bilayer, and 
compare them with the PDB structures obtained from other methods.  
 
Materials and Methods 
M2TMP membrane sample preparation 
The M2 transmembrane peptide of the Udorn strain of influenza A virus was 
synthesized by PrimmBiotech (Cambridge, MA) and purified to >95% purity. The amino 
acid sequence is SSDPL VVAASII GILHLIL WILDRL. Two peptide samples with different 
sets of uniformly 13C, 15N-labeled residues were used in this study. The first sample contains 
13C, 15N-labeled residues at V28, S31 and L36 (VSL-M2TMP). The second sample contains 
13C, 15N-labels at V27, A30, I33 and L38 (VAIL-M2TMP). The peptide was reconstituted 
into DLPC lipid vesicles by detergent dialysis as described before (36, 37) with a 
peptide/lipid molar ratio of 1:15. A pH 7.5 phosphate buffer was used for the membrane 
sample preparation, thus the peptide studied here corresponds to the closed state of the proton 
channel. Both apo and amantadine-bound M2TMP were used. For the latter, amantadine was 
incorporated into the membrane by using buffer solutions containing 10 mM amantadine.  
 
Solid-state NMR experiments 
 SSNMR experiments were carried out on a Bruker AVANCE-600 (14.1 Tesla) 
spectrometer and a DSX-400 (9.4 Tesla) spectrometer (Karlsruhe, Germany). 4 mm triple-
resonance MAS probes were used and samples were spun between 5 kHz and 7 kHz. Typical 
rf pulse lengths were 5 µs for 13C and 3.5-4.0 µs for 1H. 1H TPPM (38) or SPINAL (39) 
decoupling fields of 60–70 kHz were applied. 13C chemical shifts were referenced to the α-
Gly C’ signal at 176.49 ppm on the TMS scale.  
 Three 2D 13C-13C correlation experiments were used to measure and assign the methyl 
13C chemical shifts in M2TMP. The 2D DARR spin diffusion experiment was carried out 
with a 10 ms mixing period (25) under 5.333 kHz MAS. The double-quantum (DQ) filtered 
SQ-SQ experiment was carried out under 7 kHz MAS. The 2D dipolar-mediated 
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INADEQUATE-type experiment (27, 28) was carried out under 7 kHz MAS. For the latter 
two experiments, 13C-13C dipolar recoupling was achieved using the SPC5 sequence (40). All 
spectra were measured at 243 K where the peptide motion is frozen.  
 
Statistical analysis of methyl chemical shifts and sidechain rotameric conformation 
 To identify any potential correlation between the methyl 13C chemical shifts and 
sidechain conformation of Val and Leu, we searched the Biological Magnetic Resonance 
Data Bank (BMRB) and first-hand literature reports for stereospecifically assigned methyl 
13C chemical shifts. Most residues (62 out of 73) in α-helices were stereospecifically 
assigned, with an ambiguity value of 1 in the BMRB. The exceptions are two residues from 
Dcp2, where no ambiguity value was given, five residues from chicken cytochrome c, and 
two residues each from cofilin and fasciclin, which were assigned an ambiguity value of 2 
(Table 7.2). The chemical shifts of these non-stereoassigned methyl groups fall within the 
general trend of each class, and therefore were included in the analysis. The structures of 
proteins with available methyl chemical shifts were downloaded from the RCSB Protein Data 
Bank (PDB) and visualized in Insight II (Accelrys, Inc. San Diego). A total of 19 protein 
structures were examined, 17 of which were solved by solution NMR and two structures 
(profilin IIa and yeast cytochrome c) were solved by X-ray crystallography. The sidechain χ1 
and χ2 angles were measured as N-Cα-Cβ-Cγ1 and Cα-Cβ-Cγ1-Cδ1, respectively, in Insight 
II.   
 The Val and Leu methyl 13C chemical shifts were grouped first according to the 
backbone conformation (helix or sheet), then according to the sidechain rotamer categories. 
For Val, the main rotamers are t (trans, χ1=180˚), m (minus, χ1=-60˚), and p (plus, χ1=+60˚) 
(Figure 7.1a) (41), using the nomenclature of the Penultimate Rotameric Library (42). For 
Leu, the main rotamers are mt (χ1 = -60˚, χ2=180˚), tp (χ1=180˚, χ2=60˚), and tt (χ1=χ2=180˚) 
(Figure 7.1b). Our analysis focuses on the difference between the two methyl 13C chemical 
shifts, which are not affected by possible inconsistencies in chemical shift calibration and are 
also less sensitive to ring current effects. The mean methyl chemical shift differences as well 
as the mean absolute shift differences are computed for each conformational category. The 
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standard deviation σ of each distribution is calculated as 
€ 
σ =
1
N −1 xi − x ( )
2
i=1
N
∑ , where x 
denotes the chemical shift difference. Chemical shift differences that fall beyond 2.6 times 
the standard deviations from the mean were discarded. This corresponds to a confidence level 
of 99% that these data points are anomalous or may be due to incorrect assignment. To 
obtain a measure of the uncertainty of the mean, we also computed the standard deviation of 
the mean 
€ 
σx   as 
€ 
σx = σ N .  
 
 
 
 
Figure 7.1. Definitions of the rotameric states of Val and Leu. (a) Val t, m, and p states. (b) Leu mt 
and tp states.  
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Results and Discussion 
Accurate measurement of the methyl 13C chemical shifts 
 We first compare the relative merits of three 2D 13C-13C correlation experiments for 
accurate measurement of the methyl 13C chemical shifts. The first experiment correlates SQ 
and SQ coherences and establishes the coherence transfer by 13C spin diffusion. This DARR 
experiment (25) is the solid-state analog of the solution NMR NOESY experiment. The 
second experiment correlates SQ coherences after passing them through a DQ filter, so that 
only 13C sites involved in coupled spin networks are detected. This DQ-filtered SQ-SQ 
experiment is the solid-state analog of the DQF-COSY experiment. The third experiment 
correlates the dipolar-generated DQ coherence with SQ coherence, thus is analogous to the 
INADEQUATE experiment (28). While all three solid-state MAS experiments are well 
known, for clarity and comparison we show their pulse sequences in Figure 7.2. The DQ 
excitation and reconversion periods are executed back-to-back between the evolution and 
detection periods of the DQ filtered SQ-SQ experiment, but are separated by the evolution 
period in the dipolar-INADEQUATE (DQ-SQ correlation) experiment. The 13C-13C dipolar 
couplings for exciting the DQ coherences were recoupled with the SPC5 sequence (40), one 
of many recoupling sequences available (43, 44).  
Figure 7.3 shows the three 2D correlation spectra of V28, S31, and L36-labeled 
M2TMP in DLPC bilayers at 243 K. The spin system connectivities are indicated in each 
spectrum. In the 2D DARR spectrum (a), the main resolved lipid signals along the diagonal 
are indicated with asterisks. It can be seen that while the Cα/Cβ cross peaks of the peptide 
are well resolved in the spectrum, the sidechain cross peaks, especially those involving 
methyl groups, cluster near and overlap significantly with the diagonal. They include the L36 
Cδ signal at 20.9 ppm and the V28 Cγ signal near 19.5 ppm (d). The homogeneous 
linewidths of the membrane sample at this temperature are actually relatively narrow, as seen 
by the width of the narrow part of the diagonal ridge. Thus, the broad bulges along the 
diagonal indicate cross peaks that are poorly resolved from the diagonal. In particular, the Ser 
Cα and Cβ chemical shifts are known to be similar in α-helices (45), thus the broad diagonal 
peak around 61 ppm is due to the diagonal Cα and Cβ peaks overlapping with the true 
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Cα/Cβ cross peaks (g). Moreover, in the 60-70 ppm region where the Ser signals resonate, 
there are various lipid signals such as the headgroup Cα (59.7 ppm), the glycerol G1 (63.2 
ppm) and G3 (63.9 ppm).  
 
 
 
Figure 7.2. Pulse sequences for 2D 13C-13C correlation spectroscopy. (a) SQ-SQ correlation by 
DARR mixing. (b) DQ filtered SQ-SQ correlation. (c) DQ-SQ correlation. The DQ excitation and 
reconversion are achieved by the SPC5 recoupling scheme (40).  
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Figure 7.3. 2D 13C-13C correlation spectra of amantadine-complexed VSL-M2TMP in DLPC bilayers 
at 243 K. (a) 2D DARR spectrum with a 10 ms mixing time. (b) 2D DQ filtered SQ-SQ correlation 
spectrum. (c) 2D DQ-SQ correlation spectrum. Two spectral regions are selected from each 2D 
spectrum and amplified in (d-i). Middle row (d-f): L36 methyl 13C region. Bottom row (g-i): S31 Cα 
and Cβ region.  
 
 The 2D DQ filtered SQ-SQ correlation experiment considerably simplifies the 
spectrum by removing all lipid natural abundance 13C signals along the diagonal (Figure 
7.3b). The Leu and Val methyl regions now show well resolved peaks, as seen in Figure 7.3e. 
The L36 Cγ signal at 24.9 ppm is well separated from one of the Cδ peaks at 21.3 ppm. 
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However, the second Leu methyl Cδ peak remains ambiguous. Based on the chemical shift 
databases, the second Leu methyl carbon may resonate close to the Cγ peak and thus may not 
be resolved from the diagonal. For the Ser Cα/Cβ cross peaks (Figure 7.3h), the DQ filtered 
SQ-SQ correlation spectrum shows a distinct cloverleaf pattern, which gives a relatively 
clear Cα-Cβ chemical shift separation of 1.7 ppm. Further verification that the upfield peak 
is Cβ while the downfield peak is Cα can be made by a CH2-filter experiment that suppresses 
all CH signals (thus Cα) while retaining all CH2 signals (thus Cβ) (36).  
 The remaining ambiguity of the methyl 13C chemical shifts is removed by the dipolar-
INADEQUATE experiment. Figure 7.3c shows the DQ-SQ correlation spectrum and the 
expanded Leu methyl region is shown in Figure 7.3f. Now two Leu Cγ-Cδ correlation slices 
can be observed, with the upfield Cδ2 peak appearing in the 45.6 ppm DQ slice while the 
downfield Cδ1 peak appearing in the 48.3 ppm DQ slice. The latter is close to the Cγ peak 
near the slope-2 diagonal of the spectrum. Importantly, since there are no un-partnered 
diagonal peaks in the DQ-SQ correlation spectra, two coupled resonances that have nearly 
identical chemical shifts simply resonate near the slope-2 line of the spectrum and can be 
assigned unambiguously. In the case of VSL-M2TMP, since the L36 Cγ resonance is clearly 
resolved in the 45.6 ppm DQ slice to be 24.7 ppm, its partner Cδ1 peak can be readily read 
off in the 48.3 ppm DQ slice as the difference between 48.3 ppm and 24.7 ppm, which is 
23.6 ppm. Thus, the Cδ1 peak is only 1.1 ppm from the Cγ peak, which explains the 
difficulty of resolving the two peaks in the SQ-SQ correlation spectra (Figure 7.3a, 7.3b).  
 Figure 7.4 shows the three 2D spectra of VAIL-M2TMP in gel-phase DLPC bilayers. 
This sample contains three double-methyl residues (V27, I33, and L38), thus making their 
chemical shift identification difficult in the DARR spectrum. Specifically, the Val Cβ and Ile 
Cγ1 chemical shifts are very similar near 30 ppm, thus the Ile Cβ/Cγ1 cross peak (35.6 ppm, 
28.4 ppm) is partly obscured by the Val Cβ peak and the lipid CH2 diagonal peak (Figure 
7.4d). Further, unless very long t1 evolution times are used, the lipid CH2 signal is often 
truncated, giving rise to truncation wiggles in the ω1 dimension that interfere with the precise 
measurement of near-diagonal cross peaks. The long t1 evolution times necessary for 
obtaining sharp lipid diagonal signals are usually excessive for the peptide signals, causing 
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sub-optimal use of the experimental time. The I33 Cγ1 signal at 28.4 ppm is also low and 
broad, which we attribute to the special spin dynamics of the Ile spin system. The two methyl 
groups of Ile have unequal distances from the backbone: the Cγ2 methyl group neighbors Cβ 
while the Cδ methyl neighbors Cγ1. The magnetization of Cγ1 between the two methyl 
groups appears to be disproportionally drawn to both methyl carbons, causing its low 
intensity in the 2D spectrum.   
The DQ filtered SQ-SQ correlation spectrum (Figure 7.4b, e) shows significantly 
simplified Ile Cβ/Cγ1 region: the cross peak, while still weak, can now be resolved from the 
diagonal since the lipid CH2 peak is suppressed. However, the strong Val Cβ diagonal signal 
still remains. The DQ-SQ correlation spectrum (Figure 7.4c, f) gives the highest resolution 
for the Ile spin system. The two Cβ/Cγ1 cross peaks are now of similar intensities and have 
well defined lineshapes and are well resolved from the Val Cα/Cβ and Cβ/Cγ peaks. In 
addition, the methyl region of the spectrum is also much better resolved, similar to Figure 
7.3.  
 Figure 7.4(g-i) demonstrates the ability of the dipolar INADEQUATE experiment to 
clearly identify conformational polymorphism. The L38 Cβ exhibits two chemical shifts that 
are 2.4 ppm apart. This is seen in all three 2D spectra, but is most clearly manifested in the 
dipolar INADEQUATE spectrum, since the presence of the two Cβ shifts is confirmed by the 
elongated shape of the Cα peak in the DQ dimension.  
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Figure 7.4. 2D 13C-13C correlation spectra of amantadine-complexed VAIL-M2TMP in DLPC 
bilayers at 243 K. (a) DARR spectrum with a 10 ms mixing time. (b) DQ filtered SQ-SQ correlation 
spectrum. (c) DQ-SQ correlation spectrum. Two spectral regions are selected from each 2D spectrum 
in (a-c) and amplified in (d-i). Middle row (d-f) I33 Cβ-Cγ1 region. Bottom row (g-i): L38 Cα-Cβ 
region. Note the presence of two Cβ peaks.  
 
  
 
 179 
 
Methyl chemical shift changes of M2TMP between the apo and amantadine-bound states 
 The influenza A M2 transmembrane domain (residues 22-46) contains two Val 
residues (V27, V28), five Ile residues, and six Leu residues. We have labeled both Val 
residues and three of the Leu residues (L26, L36, and L38). Since the two Ile methyl carbons 
have chemical shift differences of about 5 ppm, their spectral identification usually does not 
pose any difficulty, and will not be discussed further.  
 
 
Figure 7.5. Methyl 13C chemical shift changes of labeled Val and Leu residues in M2TMP in the 
absence (black) and presence (red) of amantadine. (a) V27 Cγ chemical shifts from 2D DARR 
spectra. (b) V28 Cγ chemical shifts from 2D DARR spectra. (c-e) Leu Cγ and Cδ chemical shifts 
from 2D DQ-SQ correlation spectra. (c) L26. (d) L36. (e) L38. Except for L36, all other residues 
show methyl 13C chemical shift perturbations by amantadine.  
 
 The binding of the M2 channel inhibitor amantadine has been recently shown to 
cause noticeable changes in the 13C chemical shifts of various residues (35, 36). Here we 
focus on the methyl 13C shift changes induced by the drug. Figure 7.5 compares the methyl 
regions of the five Val and Leu residues between the apo peptide and the amantadine-bound 
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peptide. The DQ-SQ correlation spectra of Leu residues and the DARR spectra of Val 
residues are shown, the latter because the Val Cβ/Cγ cross peaks are sufficiently separated 
from the diagonal. Figure 7.5 shows that four out of five residues show methyl chemical shift 
perturbations by amantadine. Between the two Val residues, the V27 Cγ1 intensity is 
weakened by amantadine binding, whereas the V28 Cγ2 intensity is increased by amantadine 
binding. Among the three Leu residues, L36 exhibited no chemical shift changes, whereas 
the L26 Cδ1 and L38 Cδ2 frequencies are shifted from their apo values. Since our methyl 13C 
assignments are not stereospecific, below we will use the absolute values of the methyl 13C 
chemical shift differences extracted from the protein databases to interpret the conformation 
of these M2 sidechains.  
 
Table 7.1. Experimental Val and Leu methyl 13C chemical shifts (ppm) 1 in apo and amantadine-
bound (amt) M2TMP in DLPC bilayers.  
Val  
€ 
δCγ2  
€ 
δCγ1  
€ 
δCγ2−δCγ1  Rotamer2 
V27 Apo 21.2 19.3 1.9 t 
 Amt 20.8 19.5 1.3 t/m 
 Soln NMR3 - - 1.6  
V28 Apo 20.7 19.5 1.2 t/m 
 Amt 20.8 19.0 1.8 t 
 Soln NMR3 - - 1.3  
Leu  
€ 
δCδ1  
€ 
δCδ2   
€ 
δCδ1−δCδ2  Rotamer2 
L26 Apo 23.8 21.2 2.6 mt 
 Amt 23.3 20.9 2.4 mt 
 Soln NMR3 - - 0.7  
L36 Apo 24.2 21.2 3.0 mt 
 Amt 23.8 21.2 2.6 mt 
 Soln NMR3 - - 1.5  
L38 Apo 24.2 20.1 4.1 mt 
 Amt 23.9 21.0 2.9 mt 
 Soln NMR3 - - 1.0  
 
1. The solid-state NMR 13C chemical shifts were not stereospecifically assigned and were measured at 
243 K. The chemical shift are referenced to TMS.  
2. Predicted rotameric states based on the 13C solid-state NMR chemical shifts.  
3. Solution NMR methyl 13C shift differences were measured on DHPC-micelle bound M2(18-60) at 
ambient temperature (32).  
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 Table 7.1 lists the methyl 13C chemical shifts of the five Val and Leu residues in the 
apo and amantadine-bound M2TMP in DLPC bilayers. Overall, amantadine causes 0.5 – 1.2 
ppm changes in the methyl 13C chemical shift difference. To interpret these 13C chemical shift 
changes, we turn to an analysis of the methyl chemical shift trends in protein NMR 
databases.  
 
Dependence of Val and Leu methyl 13C chemical shifts on protein sidechain conformation  
 Methyl 13C chemical shifts are sensitive to a number of factors, including the 
sidechain conformation, which can manifest through γ-gauche effects (46), and ring current 
effects. We hypothesize that when ring current effects are excluded by considering methyl 
13C shift differences in each residue, the sidechain conformation is the main determining 
factor for the methyl chemical shifts. Further, we wish to determine whether distinct trends of 
methyl 13C chemical shifts exist for different sidechain rotamers that are assigned by 
combinations of NOEs, RDCs, and scalar couplings. The existence of a significant 
correlation between the methyl chemical shifts and rotameric states would indicate that 
rotameric averaging, while present, is not too extensive to obliterate sidechain 
conformational differences. We examined the methyl 13C chemical shifts of 19 proteins in the 
RCSB Protein Data Bank, 17 of which are solution NMR structures and 2 are X-ray crystal 
structures. These proteins and their BMRB and PDB accession numbers are listed in Table 
7.2. The rotameric states and methyl 13C chemical shifts of the α-helical Val and Leu 
residues among these 19 proteins are listed in the Supporting Information Tables 7.S1 and 
7.S2. It is important to note from the beginning that since the conformational dependence is 
searched from solution NMR structures, any rotameric averaging necessarily reflects 
sidechain dynamics in medium to large globular proteins in solution at ambient temperature. 
The extent of this averaging depends on the percentage of surface-accessible residues. 
However, our systems of interest are membrane proteins in lipid bilayers at low 
temperatures, which have very little or no rotameric averaging, thus their methyl chemical 
shifts would correspond to purer conformational states.  
 182 
Table 7.2. Proteins that were examined for investigating the conformational dependence of methyl 
13C chemical shifts in proteins.  
Protein PDB ID BMRB ID 
Ubiquitin 1d3z 4375 
Calmodulin, N-terminus 1f70 4056 
Calmodulin, C-terminus 1f71 4056 
Cytochrome c, chicken 2frc 1404 
GB1 2gb1 7280 
Cofilin 1q8g 6004 
Profilin I 1pfl 4082 
Profilin IIa 2v8c 15452 
Fasciclin-like protein 1w7d 6312 
Talin C-terminal Domain 2jsw 15411 
Dcp2 decapping enzyme 2jvb 7325 
M2 (residues 23-60) 2rlf ref. (32) 
RNase T1 1ygw ref. (21) 
P22 c2 repressor 1adr ref. (18) 
Malate synthase G 2jqx ref. (22) 
Cytochrome c, yeast 2ycc ref. (14) 
Phosphohistidine 
phosphatase   2ai6 6625 
OmpX  1q9f ref. (54) 
Hsc-70 1ckr ref. (55) 
 
 
 The rotameric states of proteins depend on the backbone conformation. α-helical (H) 
and β-sheet (S) backbones have different populations of sidechain conformations for steric 
reasons (42). Thus, we first sort the methyl 13C chemical shifts by the backbone 
conformation. Within each backbone category, we binned the methyl 13C chemical shifts 
according to the canonical χ1 and χ2 angles. Since most solution NMR data we considered 
have stereospecifically assigned Val Cγ1/Cγ2 and Leu Cδ1/Cδ2 chemical shifts, we first 
analyzed the methyl 13C chemical shift difference with the sign. However, because 
stereospecific assignment is still not possible by solid-state NMR, we also need to investigate 
whether the absolute value of the methyl 13C chemical shift difference can serve to 
distinguish different rotamers. Thus Table 7.3 lists both the sign-sensitive and absolute 
methyl 13C shift differences of Val and Leu in α-helical and β-sheet secondary structures. 
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The standard deviations of the distributions are indicated, along with the standard deviations 
of the mean, which are reported as uncertainties (±) of the mean.  
Figure 7.6 plots the α-helical Val Cγ1 and Cγ2 chemical shifts in the t and m 
rotamers. The t rotamer (χ1 = 180˚) dominates (90%) in α-helical Val’s and thus has the 
largest number of data points. It can be seen that the Cγ2 chemical shift is more downfield 
(larger) than the Cγ1 shift in most cases, with an average difference of 1.71 ppm and a 
standard deviation of 0.52 ppm. Only two out of 21 data points in this class have upfield Cγ2 
chemical shifts than Cγ1. Because of the dominance of the t rotamer in Val and the generally 
downfield Cγ2 shifts, we calculate the methyl 13C shift difference for Val as 
€ 
δCγ2 − δCγ1
. When the absolute value of the methyl shift differences are considered, the average 
difference is 1.67 ppm. This trend agrees qualitatively with the recent finding of London and 
coworkers based on a smaller sample size of five proteins (15). 
 
 
Table 7.3. Statistics of Val and Leu methyl 13C chemical shift differences from protein databases.  
Valine       
Rotamer Population No. residues 
Mean 
€ 
δCγ2 − δCγ1 
(ppm) 
€ 
σδCγ2−δCγ1  
 (ppm)  
Mean 
€ 
δCγ2 − δCγ1   
(ppm) 
€ 
σ
δCγ2−δCγ1
 
(ppm) 
Helix, t 90% 21 1.71 ± 0.12 0.52 1.67 ± 0.11 0.51 
Helix, m 7% 6 -1.23 ± 0.41 1.00 1.23 ± 0.41 1.00 
Sheet, t 72% 24 -0.26 ± 0.29 1.41 1.25 ± 0.14 0.65 
Sheet, m 20% 2 -1.95 ± 0.65 0.92 1.95 ± 0.65 0.92 
Sheet, p 8% 5 0.28 ± 1.07 2.39 1.76 ± 0.62 1.39 
Leucine       
Rotamer Population No. residues 
Mean 
€ 
δCδ1 − δCδ2   
(ppm) 
€ 
σδCδ1−δCδ2
 
(ppm)   
Mean 
€ 
δCδ1 − δCδ2  
(ppm) 
€ 
σδCδ1−δCδ2
 
(ppm) 
Helix, mt 62% 15 2.89 ± 0.25 0.94 2.89 ± 0.25 1.13 
Helix, tp 30% 15 -0.10 ± 0.24 0.90 0.73 ± 0.13 0.50 
Helix, tt 1% 11 0.17 ± 0.35 1.15 0.90 ± 0.20 0.67 
Sheet, mt 46% 11 1.92 ± 0.32 1.01 2.12 ± 0.24 0.75 
Sheet, tp 36% 9 0.74 ± 0.77 2.30 2.14 ± 0.29 0.87 
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Figure 7.6. α-helical Val Cγ chemical shifts as a function of sidechain conformation from protein 
databases. (a) The t rotamer. (b) The m rotamer. Dashed lines in (a) indicate anomalous data points 
that are excluded in the statistical analysis in Table 7.3.  
 
 For the m rotamer of helical Val (7% abundant in proteins), the mean absolute 
Cγ2/Cγ1 shift difference is about 0.5 ppm smaller than the t  rotamer. More importantly, the 
sign of the chemical shift difference is reversed, with the Cγ1 chemical shifts now more 
downfield than Cγ2. Thus, new SSNMR techniques for stereospecific assignment of the Val 
methyl 13C chemical shifts should be able to distinguish the t and m rotamers simply based on 
the relative values of the Cγ1 and Cγ2 shifts. The upfield Cγ2 shift in the m rotamer can be 
well explained by the γ-gauche effect, as the Cγ2 carbon is gauche to both the N and C’ 
atoms of the backbone (Figure 7.1a) and experiences steric crowding (15, 46). For the p 
rotamer, due to its very low occurrence in proteins (2%) and the small chemical shift sample 
size (5 points) we found from databases, we do not consider its methyl chemical shift trend 
further.  
 Figure 7.7 shows the Cδ1 and Cδ2 chemical shifts of α-helical Leu residues. For the 
dominant mt rotamer (62%), the stereospecifically assigned Cδ1 chemical shifts are 
uniformly more downfield than Cδ2, with an average difference, 
€ 
δCδ1 − δCδ2 , of 2.89 ppm 
and a standard deviation of 0.94 ppm (Table 7.3). The upfield Cδ2 chemical shift in this 
rotamer can again be understood by the steric crowding of Cδ2 to Cα through the γ-gauche 
effect, as visualized in Figure 7.1b. In contrast, the 30% abundant tp rotamer has a much 
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smaller absolute methyl shift difference of 0.73 ppm, and has no clear trend in which methyl 
carbon has larger chemical shifts. Given the significant difference in the absolute methyl shift 
differences, these two most populated Leu rotamers can be readily distinguished even 
without stereospecific assignment.  
 
 
 
Figure 7.7. α-helical Leu Cδ methyl chemical shifts as a function of sidechain conformation from 
protein databases. (a) The mt rotamer. (b) The tp rotamer. (c) The tt rotamer. Dashed lines in (a) and 
(b) indicate anomalous data points that are not included in the statistical calculation in Table 7.3. 
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 For β-sheet backbones, the Val methyl shift differences are larger for the m rotamer 
than the t rotamer, contrary to the trend of the helical Val’s, although only a small dataset is 
available for the m rotamer. For β-sheet Leu’s, the tp rotamer has as many positive as 
negative methyl 13C shift differences, thus is ambiguous to distinguish from the mt rotamer.  
 The recent work of London and coworkers considered the sidechain 13C chemical 
shifts of not only the three double-methyl residues but also six other residues in five proteins 
(15). The main finding of the paper is that steric crowding by gauche conformations of Cγ 
substituents causes upfield shifts of the Cγ resonances. The paper reached qualitatively 
similar conclusions about the methyl 13C shift differences of Val and Leu as the present work. 
However, many quantitative details differ, mainly due to the fact that the previous work did 
not distinguish the α-helical and β-sheet backbone conformation, which are found here to 
give significantly different Cγ and Cδ shift differences. For example, while the Val t rotamer 
has much more upfield Cγ1 shifts than Cγ2 in α-helices (Table 7.3), the average difference is 
much smaller in β-sheets (–0.26 ppm) due to crossover of the Cγ2 and Cγ1 shifts. Another 
example is the Leu tp rotamer, which shows very different average Cδ shift differences 
between the helical and sheet conformations (Table 7.3). Thus, mixing of helical and sheet 
rotamers obscures some chemical shift trends. Expressed in terms of the chemical shift of a 
certain carbon in different rotamers, we find that the Leu Cδ1 average shift difference 
between the tp and mt rotamers in α-helices is 
€ 
δCδ1,tp − δCδ1,mt = −1.4  ppm , but has a much 
smaller value of –0.1 ppm in β-sheets. This suggests that steric crowding, which causes 
upfield shifts of the Cδ1 resonance, is stronger in α-helical tp rotamers than β-sheet tp 
rotamers. Secondly, the London work analyzed the χ1 dependence of chemical shifts 
separately from the χ2 dependence. For Leu, however, whose mt and tp rotamers are 
predominant and few other rotamers are populated, the combined χ1/χ2 analysis better 
reflects the conformational dependence of methyl chemical shifts.  
 How significant is the effect of rotameric averaging, which occurs more commonly in 
surface-accessible residues than interior residues in globular proteins, to the statistical methyl 
chemical shifts obtained here? To a first approximation, the fact that clear distinctions do 
exist between the methyl 13C shift differences of the Leu and Val rotamers indicates that 
 187 
sidechain conformational equilibria in globular proteins have sufficiently limited amplitudes 
or significantly skewed populations. Comparison of crystal structures with solution NMR 
structures showed that the solution-NMR derived dominant rotamers generally agree well 
with the crystal structure (21, 24). Earlier studies of structural and fibrous proteins such as 
collagen (47), keratin intermediate filaments (48), and the coat protein of filamentous 
bacteriophages (49) by 2H SSNMR found that Leu sidechains interconvert rapidly between 
the mt and tp rotamers with nearly equal populations. This extensive rotameric averaging was 
thought to have functional importance, one example being the distribution of mechanical 
stresses experienced by collagen fibrils in the organic-inorganic nanocomposites of bone. In 
membrane proteins, Val sidechain dynamics have been examined in bacteriorhodopsin (50) 
and gramicidin (51) by 2H SSNMR, with the former showing no χ1 dynamics at all while the 
latter showing χ1 averaging for some of the Val residues but with a dominant rotamer. While 
the literature of membrane protein sidechain dynamics is still limited, it is reasonable to 
hypothesize that small membrane peptides would exhibit more extensive sidechain 
conformational motion than large membrane proteins. Compared to fibrous and membrane 
proteins, large globular proteins have relatively small surface areas, thus near-equal 
populations of rapidly interconverting rotamers should be much less common, which 
explains the current statistical findings. In any case, since the methyl shift trends found here 
likely correspond to partially averaged conformational states, the true chemical shift 
differences between pure rotamers will be more pronounced than given here. Therefore, 
solid-state NMR methyl chemical shifts measured at low temperature, where most χ1 and χ2 
conformational dynamics are frozen, should show larger chemical shift differences between 
different rotamers.  
 
Verification of the χ1 dependence of Val methyl chemical shifts in M2TMP  
 Based on the above conformational dependence of methyl 13C chemical shifts and the 
measured M2TMP Val and Leu 13C chemical shifts, we can assign the rotameric states for the 
five Val and Leu residues. Table 7.1 shows that all three Leu residues should be assigned to 
the dominant mt rotamer, and amantadine binding, while changing the methyl shift 
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differences by as much as 1.2 ppm, does not change the assignment of the canonical rotamer. 
The particularly large methyl shift difference of L38 (4.1 ppm) in the apo state of M2TMP 
likely corresponds to a purer or more ideal mt conformation compared to L26 and L36.  
For the two Val residues, the apo V27 and amantadine-bound V28 can be readily 
assigned to the t rotamer. On the other hand, the amantadine-bound V27 and the apo V28 
have smaller methyl 13C shift differences of about 1.2 ppm that correlate better with the m 
rotamer (Table 7.3). However, because of the relatively small methyl shift difference 
between the m and t Val rotamers in the absence of sign information, such an assignment 
may not be definitive. Thus, we directly measured the χ1 torsion angle of Val using the 
HCCH dipolar correlation experiment. This serves to verify the correlation between the 
methyl 13C chemical shifts and rotameric states of Val. This direct measurement is possible 
for Val because its Cβ is a branched CH group with a single proton, so that correlation of the 
orientation-dependent Cα-Hα and Cβ-Hβ dipolar couplings gives the relative orientation of 
the two C-H bonds, which is the χ1 angle.  
 Figure 7.8a shows the pulse sequence of the HCCH experiment, which differs from 
the original experiment (7) in the choice of the DQ dipolar recoupling sequence and in the 
dipolar doubled nature of the C-H evolution period. We used the narrow-band HORROR 
recoupling scheme (52), where the 13C irradiation field ω1 is matched to half the spinning 
frequency ωr, to selectively recouple the Val Cα and Cβ signals. This eliminates possible 
contribution of the Val Cγ-Hγ dipolar coupling to the Hα-Cα-Cβ-Hβ dipolar correlation 
curve. Figure 7.8b shows the first slice of the V28 HCCH 2D spectrum, indicating the clean 
selection of the Cα and Cβ signals. The dipolar doubling during the t1 period is achieved by a 
constant time of one rotor period for homonuclear decoupling combined with moving 13C 
180˚ pulses to define the effective t1 time (53). This dipolar-doubled constant-time HCCH 
evolution both enhances the angular resolution of the χ1 technique and removes possible T2 
relaxation effects during t1. 
Panels (c) and (d) display the time evolution of the two Val residues under the dipolar 
couplings for the apo (black) and amantadine-bound (red) states. The unsymmetrized time 
domain data shows little intensity asymmetry for the V27 data and only minor asymmetry for 
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the V28 data, which is due to finite pulse length effects. For V27, the amantadine-bound 
peptide shows deeper dipolar dephasing than the apo state, indicating a smaller χ1 angle. 
Simulations yielded a best-fit χ1 angle of 164˚ for the apo peptide and 158˚ for the 
complexed peptide. Thus, amantadine binding shifts the χ1 angle by 6˚ away from the trans 
conformation. This is consistent with the direction of change predicted by the methyl 13C 
chemical shifts. For V28, the opposite is observed: the amantadine-bound peptide has 
shallower dipolar dephasing, giving a χ1 angle that is 6˚ larger, or closer to the trans 
conformation, compared to the apo peptide. 
 
 
 
Figure 7.8. Direct measurement of the χ1 torsion angles of V27 and V28 in M2TMP in the apo (open 
symbols) and amantadine-bound (filled symbols) states. (a) Double-quantum HCCH pulse sequence 
for correlating the Hα-Cα bond and Hβ-Cβ bond orientations to give the χ1H angle, which is equal to 
the χ1=N-Cα-Cβ-Cγ angle. (b) 13C chemical shift dimension of the HCCH spectra of V28-labeled 
M2TMP. Only the Val Cα and Cβ signals are selected. (c) Unsymmetrized V27 HCCH time-domain 
data for the apo peptide and the amantadine-complexed peptide. The best-fit χ1H angle is indicated. 
The bound peptide shows a 6˚ decrease of the χ1H angle, consistent with the direction of the chemical 
shift change. (d) Unsymmetrized V28 HCCH data. The bound peptide has a 6˚ higher χ1H angle than 
the apo peptide, consistent with the direction of the chemical shift change.  
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This difference is again consistent with the methyl chemical shift predictions. In addition to 
the consistent direction of change between the apo and Amt-bound samples for each Val 
residue, the HCCH data are in quantitative agreement with the methyl shift differences 
between V27 and V28. Namely, the V27 apo sample and V28 Amt-bound state, which have 
similar methyl shift differences of 1.9 ppm and 1.8 ppm, have the same HCCH-χ1 angle of 
164˚ . The V27 Amt-bound state and V28 apo state, which have similar methyl shift 
differences of 1.3 ppm and 1.2 ppm, also have the same HCCH-χ1 angle of 158˚. Thus, direct 
torsion angle experiments bear out the chemical-shift based prediction of the t and m 
rotamers in all four cases (Table 7.1).  
 Figure 7.9 shows the rotameric states of the five Val and Leu residues in amantadine-
bound M2TMP in top views of the helical bundle. All three Leu residues have the mt 
rotamer, while both Val residues have the t rotamer. Among these five residues, L36 has the 
most lipid-facing location, while L38 places its methyl groups closest to the channel lumen. 
L26 sidechain has a more interfacial position than V27 and V28. The two recent high-
resolution structures of M2TMP differed on the rotameric states of various Leu residues. For 
example, the solution NMR structure shows a L26 rotamer of tp (32), while the crystal 
structure shows a mixture of mt and tp states for L26 (31).  
 
 
Figure 7.9. Rotameric states of Val and Leu residues determined by methyl 13C chemical shifts and 
direct χ1 angle measurements in amantadine-bound M2TMP. The backbone structure is for the 
amantadine-bound peptide (36) (PDB accession code: 2kad).  
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The rotameric difference between the solution NMR structure and solid-state NMR structure 
appear to be real, as the solution NMR methyl 13C chemical shift differences of the three Leu 
residues are significantly smaller than found by solid-state NMR here (Table 7.1). This 
probably results from a combination of the higher temperature of the solution NMR 
experiments, which favor rotameric averaging, and the use of detergent micelles in the 
solution NMR experiments, which may lead to different sidechain conformations than in 
lipid bilayers.  
 
Conclusion 
We have shown that a significant statistical correlation exists between the methyl 13C 
chemical shift differences of Leu and Val and their sidechain conformations. For α-helical 
Val’s, the t rotamer has more upfield Cγ1 shifts than Cγ2, while the m rotamer has more 
upfield Cγ2 shifts than Cγ1. For α-helical Leu’s, the mt rotamer has a large methyl shift 
difference of 2.9 ppm while the tp rotamer only has an absolute methyl shift difference of 
0.73 ppm. Thus, accurate measurement of the methyl 13C chemical shifts in membrane 
proteins, by means of 2D DQ-SQ correlation experiments, can help to determine and refine 
the sidechain conformation of these proteins. Application to the influenza A M2 proton 
channel shows that two Val’s adopt the dominant t rotamer while three Leu residues exhibit 
the dominant mt rotamer. This work indicates that protein solid-state NMR can play an 
important role in understanding the conformational dependences of sidechain 13C chemical 
shifts due to the ability to suppress rotameric averaging at low temperature. The solid-state 
NMR measured sidechain chemical shifts can also serve as important benchmarks for further 
computational analysis of the conformation dependence of sidechain chemical shifts.  
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Table 7.S1: Val methyl Cγ chemical shifts in α-helical proteins.  
Protein Residue number Rotamer 
€ 
δCγ1  (ppm) 
€ 
δCγ2   (ppm) 
€ 
δCγ2 − δCγ1 
(ppm) 
Malate syn. 490 Ht 19.6 20.9 1.3 
Malate syn. 666 Ht 19.7 21.9 2.2 
Ubiq. 26 Ht 20 21 1.0 
Malate syn. 365 Ht 20.3 21.8 1.5 
P22 33 Ht 20.4 21.9 1.5 
Malate syn. 24 Ht 20.5 22.5 2.0 
Cal. N 35 Ht 20.6 23.2 2.6 
Cofilin 143 Ht 20.7 21.9 1.2 
Cal. C 108  Ht 20.8 23.6 2.8 
Malate syn. 166 Ht 21.1 22.7 1.6 
Cal. C 91  Ht 21.4 22.9 1.5 
Cal. C 142  Ht 21.4 23.2 1.8 
Malate syn. 20 Ht 21.5 23.9 2.4 
GB1 29 Ht 21.9 20.5 -1.4 
M2 27 Ht 21.3 22.9 1.6 
M2 28 Ht 21.4 22.7 1.3 
Dcp2 150 Ht 22.3 24.3 2.0 
Malate syn. 656 Ht 22.4 24.2 1.8 
Cal. C 121 Ht 22.5 23.5 1.0 
Cal. N 55 Ht 22.6 21.4 -1.2 
RNase T1 16 Ht 23.1 24.4 1.3 
Cyt. C 3 Hm 20.6 20.5 -0.1 
Malate syn. 701 Hm 21.4 19.7 -1.7 
Profilin I 60 Hm 21.5 21.2 -0.3 
Cofilin 29 Hm 22.7 21.2 -1.5 
Talin 2400 Hm 23.1 22.1 -1.0 
Malate syn. 553 Hm 22.9 20.1 -2.8 
Cofilin 14 Hp 22.4 24.9 2.4 
Malate syn. 608 Hp 20.7 21.9 1.2 
Cyt. C 11 Hp 21.3 19.7 -1.6 
Talin 2360 Hp 23 23.3 0.3 
Profilin I 40 Hp 22 19.4 -2.6 
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Table 7.S2. Leu methyl Cδ chemical shifts in α-helical proteins. 
 
Protein Residue number Rotamer 
€ 
δCδ1  
(ppm) 
€ 
δCδ2 (ppm) 
€ 
δCδ1 − δCδ2
 (ppm) 
Cyt. C 98 Hmt 24.3 21.6 2.7 
Dcp2 223 Hmt 24.3 21.8 2.5 
Cal. N 18 Hmt 25 24.7 0.3 
Cofilin 128 Hmt 25.3 21.8 3.5 
Cal. N 69 Hmt 25.4 24.7 0.7 
P22 17 Hmt 25.6 22 3.6 
Profilin IIa 134 Hmt 25.8 22.1 3.7 
Cal. N 48 Hmt 25.8 23.5 2.3 
Cal. C 112  Hmt 26.1 23.6 2.5 
Cal. N 39 Hmt 26.1 22.8 3.3 
Profilin I 134 Hmt 26.2 23.3 2.9 
P22 64 Hmt 26.4 22.3 4.1 
Malate syn. 696 Hmt 26.7 24.2 2.5 
Profilin IIa 123 Hmt 27.1 22.9 4.2 
Fasciclin 39 Htp 22.4 22 0.4 
Fasciclin 79 Htp 22.5 22.2 0.3 
Cal. N 32 Htp 22.9 26 -3.1 
Cyt. C 35 Htp 23.3 23.2 0.1 
Talin 2424 Htp 23.7 25.6 -1.9 
Dcp2 235 Htp 24.4 23.9 0.5 
P22 65 Htp 24.5 23.8 0.7 
Talin 2346 Htp 24.5 24.9 -0.4 
Talin 2393 Htp 24.7 25.2 -0.5 
Talin 2438 Htp 24.9 26.5 -1.6 
Malate syn. 291 Htp 25.3 26.3 -1.0 
Talin 2470 Htp 25.5 25.9 -0.4 
Talin 2407 Htp 25.8 25.1 0.7 
Cal. C 105  Htt 24.1 26 -1.9 
Malate syn. 285 Htt 24.6 23.6 1.0 
Malate syn. 576 Htt 24.9 24.7 0.2 
Malate syn. 128 Htt 25 24.3 0.7 
P22 53 Htt 25.2 25.3 -0.1 
Malate syn. 286 Htt 25.7 26.2 -0.5 
Dcp2 231 Htt 25.7 25 0.7 
Talin 2456 Htt 26.8 25.9 0.9 
Cyt. C 94 Htt 27.7 27.4 0.3 
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Chapter 8 
 
Effects of Amantadine on the Dynamics of Membrane-Bound Influenza A M2 
Transmembrane Peptide Studied by NMR Relaxation 
A paper to be published in the Journal of Biomolecular NMR 
In press 
Sarah D. Cady and Mei Hong 
 
Abstract 
 The molecular motions of membrane proteins in liquid-crystalline lipid bilayers lie at 
the interface between motions in isotropic liquids and in solids. Specifically, membrane 
proteins can undergo whole-body uniaxial diffusion on the microsecond time scale. In this 
work, we investigate the 1H rotating-frame spin-lattice relaxation (T1ρ) caused by the uniaxial 
diffusion of the influenza A M2 transmembrane peptide (M2TMP), which forms a tetrameric 
proton channel in lipid bilayers. This uniaxial diffusion was proved before by 2H, 15N and 13C 
NMR lineshapes of M2TMP in DLPC bilayers. When bound to an inhibitor, amantadine, the 
protein exhibits significantly narrower linewidths at physiological temperature. We now 
investigate the origin of this line narrowing through temperature-dependent 1H T1ρ relaxation 
times in the absence and presence of amantadine. Analysis of the temperature dependence 
indicates that amantadine decreases the correlation time of motion from 2.8 ± 0.9 µs for the 
apo peptide to 0.89 ± 0.41 µs for the bound peptide at 313 K. Thus the line narrowing of the 
bound peptide is due to better avoidance of the NMR time scale and suppression of 
intermediate time scale broadening. The faster diffusion of the bound peptide is due to the 
higher attempt rate of motion, suggesting that amantadine creates better-packed and more 
cohesive helical bundles. Analysis of the temperature dependence of 
€ 
ln T1ρ−1( )  indicates that 
the activation energy of motion increased from 14.0 ± 4.0 kJ/mol for the apo peptide to 23.3 
± 6.2 kJ/mol for the bound peptide. This higher activation energy indicates that excess 
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amantadine outside the protein channel in the lipid bilayer increases the membrane viscosity. 
Thus, the protein-bound amantadine speeds up the diffusion of the helical bundles while the 
excess amantadine in the bilayer increases the membrane viscosity.  
 
Introduction 
Nuclear magnetic resonance has long been used as a tool for measuring molecular 
dynamics over a broad range of time scales, from the fast picosecond – nanosecond regime 
(1), to the slow microsecond – millisecond regime (2-4), and to the ultra-slow supra-second 
regime (5, 6). Some of the most interesting applications are to biomolecules, where 
molecular dynamics has a particularly strong connection to function (7-9). In solution NMR 
studies of biomolecular dynamics, 15N relaxation NMR has been the method of choice and 
the Lipari-Szabo model-free formalism (10, 11) has provided a simple theoretical framework 
to separate the effects of internal anisotropic motions from whole-body isotropic motion and 
to extract the amplitudes and rates of internal motion.  
In the solid state, the lack of isotropic molecular tumbling considerably simplifies 
studies of internal motions by NMR. Many solid-state NMR techniques directly probe the 
amplitudes of internal motions, most notably 2H quadrupolar NMR (12), which has exquisite 
angular resolution but no chemical resolution, and 1H-X dipolar coupling techniques under 
magic-angle spinning (MAS), which have chemical site resolution (13-15). Nuclear spin 
relaxation times (T1, T2 and T1ρ) have also been used to determine the correlation times and 
activation energies of motional processes such as methyl three-site jumps and aromatic ring 
flips. Combined, these amplitude and rate measurements have provided detailed information 
on the dynamics of structural proteins such as collagen and silk (12, 16), enzymes (17), and 
lipid membranes (18, 19). Molecular motions of synthetic polymers (20-22) and small 
molecules (23) have also been investigated extensively using solid-state NMR.  
The dynamic environment of liquid-crystalline lipid bilayers lies at the interface 
between isotropic fluids and rigid solids and hence presents unique challenges to 
understanding membrane protein dynamics. While membrane protein sidechain motions have 
been studied by NMR for decades (24-27), whole-body uniaxial rotational diffusion of 
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membrane proteins has been less examined by NMR. As the symmetry axis of the lipid 
bilayer, the bilayer normal is the axis around which phospholipids undergo nanosecond 
rotational diffusion (28, 29). Membrane proteins can also undergo such rotational diffusion, 
because the same principle that underlies the phospholipid motion, which is Brownian 
diffusion in a two-dimensional fluid (30), also applies to membrane proteins. A number of 
examples of this uniaxial diffusion have now been reported for membrane peptides and 
proteins (31-38). Their NMR fingerprints include powder lineshapes with reduced anisotropy 
and an asymmetry parameter (η) of 0, vanishing intensity at the isotropic chemical shift of 
non-spinning cross polarization (CP) spectra, and narrow lines in macroscopically aligned 
samples whose alignment axis deviates from the static magnetic field (39-41).  
The influenza A M2 protein forms a proton channel in the virus envelope that is 
important for the virus life cycle (42, 43). Acidification of the virus interior uncoats the viral 
RNA and releases it into the host cell. Amantadine binds the M2 proton channel and prevents 
its opening, thus inhibiting viral replication (44, 45). The protein forms a tetrameric helical 
bundle in the membranes of both whole cells (46) and synthetic lipids (47). It undergoes 
uniaxial diffusion at a rate of ~
€ 
105 s−1 in DLPC bilayers based on 2H NMR spectra and the 
2D Brownian diffusion theory (48, 49). The motional axis is the bilayer normal, which is also 
the helical bundle axis. Since the TM helices have tilt angles of ~38˚ in DLPC bilayers (50), 
the rotational diffusion has large amplitudes. Combined with the fact that the motional rate is 
not orders of magnitude different from the 1H-13C and 1H-15N dipolar couplings, the motion 
strongly impacts the NMR spectra: the ambient-temperature 1H-decoupled 13C and 15N spectra 
of the protein in lipid bilayers are severely exchange-broadened under both MAS and static 
conditions (48, 51). Interestingly, upon amantadine binding, the resonances in both MAS and 
static solid-state NMR spectra of the protein sharpen considerably. This line narrowing was 
also observed in solution NMR spectra of M2(18-60) bound to DHPC micelles when an 
excess of the analogous rimantadine was added (52).  
Previously we have compared the 1H-decoupled 13C T2 relaxation times of the apo and 
bound M2TMP in DLPC bilayers to understand the amantadine-induced line narrowing. We 
found that the bound peptide has 30-150% longer 13C T2 than the apo state at 303 K (50, 53), 
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indicating that the line narrowing has a significant contribution from dynamic changes of the 
protein. However, the nature of this amantadine-induced relaxation time increase has not 
been elucidated.  
In this work, we have measured and analyzed temperature-dependent 1H T1ρ relaxation 
times of the apo and amantadine-bound M2TMP to better understand its motional properties. 
We quantify the rates and activation energies of the M2TMP microsecond motion in the 
absence and presence of amantadine. We find that amantadine increases the motional rates 
approximately three fold at 313 K by increasing the attempt rates, thus alleviating 
intermediate time scale broadening and narrowing the spectral lines. Further, excess 
amantadine in the bilayer increases the activation energy of the motion, whose physical 
origin will be discussed.  
 
Material and Methods 
Peptides and lipids  
  FMOC-protected uniformly 13C, 15N-labeled amino acids were either prepared in-
house (54) or purchased from Sigma-Aldrich and Cambridge Isotope Laboratories. The M2 
transmembrane domain (residues 22-46) of the Influenza A Udorn strain (55) was 
synthesized by PrimmBiotech (Cambridge, MA) and purified to >95% purity. The amino 
acid sequence is SSDPL VVAASII GILHLIL WILDRL. Three labeled peptides were used in 
this work, each with three to four uniformly 13C, 15N-labeled residues. They are LAGI (L26, 
A29, G34 and I35), VAIL (V27, A30, I33 and L38), and VSL (V28, S31 and L36).  
 
Membrane sample preparation  
M2TMP was reconstituted into 1,2-dilauroyl-sn-glycero-3-phosphatidylcholine 
(DLPC) bilayers by detergent dialysis (47). The lipid vesicle solution was prepared by 
suspending dry DLPC powder in 1 mL phosphate buffer (10 mM Na2HPO4/NaH2PO4, 1 mM 
EDTA, 0.1 mM NaN3) at pH 7.5, vortexing and freeze-thawing 6 times to create uniform 
vesicles (56). M2TMP was dissolved in octyl-β-D-glucopyranoside (OG) in 2 mL phosphate 
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buffer, then mixed with an equal volume of DLPC vesicles, and dialyzed against the 
phosphate buffer at 4 °C for 3 days. The final peptide/lipid molar ratio was 1:15. The 
dialyzed peptide-DLPC solution was centrifuged at 150,000 g to give a pellet containing ~50 
wt% water. For the amantadine-bound samples, 10 mM amantadine hydrochloride was added 
to the phosphate buffer. After pelleting, the amount of amantadine remaining in the 
supernatant was quantified by 1H solution NMR, and the bound fraction indicates a peptide : 
amantadine molar ratio of ~1 : 8 (53). All membrane-bound M2 samples were thus studied at 
pH 7.5, corresponding to the closed state of the channel.  
 
Solid-state NMR spectroscopy  
 NMR experiments were carried out on a Bruker AVANCE-600 (14.1 Tesla) 
spectrometer (Karlsruhe, Germany) using a 4 mm MAS probe. 1H T1ρ  measurements were 
carried out using a Lee-Goldburg (LG) spin lock sequence shown in Figure 8.1 (27). The 
initial two 90˚ and 35˚ 1H pulses prepare the 1H magnetization to be alternately parallel and 
antiparallel to the 1H spin lock axis, which lies at the magic angle 
€ 
cos−1 1 3( ) from the static 
magnetic field in the yz plane. The spin-lock effective field strength, 
€ 
ωe, was fixed at 2π x 
61.2 kHz in all experiments, since T1ρ depends on 
€ 
ωe (Equations 8.1-8.2). The samples were 
spun at 7000 Hz during all experiments. Six or seven spin lock time points τSL were measured 
between 0 and 8 ms to obtain the 1H T1ρ at each temperature, and six or seven temperatures 
were measured per peptide to provide a sufficient number of data points in the 
€ 
ln T1ρ−1( )  
versus inverse temperature plot (Figure 8.5) to extract the dynamic parameters. The NMR 
probe and samples were equilibrated for 30 minutes at each temperature before tuning and 
data acquisition. The 1H LG-CP period had the same field strength as the LG spin lock 
period, but had a constant contact time of 300 µs. Typical radiofrequency (rf) pulse lengths 
were 5 µs for 13C and 3.5-4.0 µs for 1H. 13C chemical shifts were referenced to the α-Gly 13C’ 
signal at 176.49 ppm on the TMS scale.  
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Figure 8.1. 13C-detected 1H Lee-Goldburg spin lock pulse sequence used to measure 1H T1ρ relaxation 
times. The 1H magnetization is spin-locked for a variable time τSL. The LG spin-lock and LG-CP have 
the same field strength.  
 
The 1H T1ρ’s were measured between 313 K and 243 K on six membrane samples with 
and without amantadine. The activation energy 
€ 
Ea , correlation time prefactor 
€ 
τ0, and 
correlation time 
€ 
τ  were extracted by least-square linear fits of the 
€ 
ln T1ρ−1( )  to 1000/T curves 
on the high temperature side using Equations 8.8-8.10. For the apo VAIL sample, artificially 
high T1ρ values were observed at 313 K, thus the apo and amantadine-bound VAIL-M2TMP 
data analysis did not include the 313 K data.  
C-H dipolar order parameters were measured at 313 K under 7000 Hz MAS using a 
dipolar-doubled DIPSHIFT experiment (57) where 1H homonuclear decoupling was achieved 
by the frequency-switched Lee-Goldburg sequence (58). The dipolar-doubled sequence 
suppresses the apparent T2 relaxation by making the total homonuclear decoupling time 
constant at one rotor period. The t1 evolution time was controlled by the position of a 13C π 
pulse in the rotor period.  
 
Theory 
 The membrane protein rotational diffusion of interest generally occurs on the 
microsecond time scale based on the 2D Brownian diffusion theory (30). Motions on this 
time scale can be probed by 1H-decoupled S-spin spin-spin relaxation times (T2) and rotating-
frame spin-lattice relaxation times (T1ρ). The T2 relaxation times of an S spin dipolar coupled 
to an I spin under conditions of random isotropic motion and I spin rf decoupling depends on 
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the spectral density at the decoupling field strength (23), which is typically 50-100 kHz. 
However, measurement of 13C T2 by the Hahn-echo experiment in uniformly 13C-labeled 
residues in proteins has the shortcoming that 13C-13C scalar coupling contributes to the time-
dependent intensity decay, unless a selective 13C π pulse is applied to remove the scalar 
interaction. Given the small chemical shift dispersion among the aliphatic carbons in 
proteins, very soft π pulses, which necessitate multiple experiments with shifted 13C offsets, 
would be required to obtain homonuclear and heteronuclear decoupled 13C T2’s of all sites. A 
simpler alternative, then, for probing microsecond time scale motion is to measure the T1ρ, 
since it is primarily sensitive to spectral densities at the frequency of the spin-lock field (2), 
which is also 50 – 100 kHz.  
 To obtain site-specific relaxation times, we measure the 1H T1ρ through the directly 
bonded 13C sites by transferring the 1H magnetization to 13C, and by using spin-diffusion-free 
Lee-Goldburg spin lock instead of transverse spin lock (59). The effective spin lock field is 
thus tilted at the magic angle, 
€ 
cos−1 1 3( ), from the static magnetic field. The 1H 
magnetization, prepared along the direction of the spin-lock field (Figure 8.1), can only 
undergo spin-lattice relaxation in the rotating frame.  
 The 1H T1ρ relaxation in 13C-labeled molecules is driven by fluctuating 1H-1H and 1H-
13C dipolar couplings due to random molecular motions. The orientation-dependent 
relaxation rate depends on spectral densities, 
€ 
J ω( ), at the spin lock field 
€ 
ωe, 
€ 
2ωe, Larmor 
frequencies 
€ 
ωH , 
€ 
ωC , and the sum and difference of 
€ 
ωH  and 
€ 
ωC  (27, 60). Since the Larmor 
frequencies are three to four orders of magnitude larger than 
€ 
ωe (
€ 
ωH  = 2π x 600 MHz, 
€ 
ωC  
= 2π x 150 MHz, and 
€ 
ωe = 2π x 61.2 kHz in our experiments), for motions in the tens to 
hundreds of kilohertz regime, one can safely ignore the spectral density terms at the Larmor 
frequencies. Taking into account magic-angle spinning at a frequency 
€ 
ωR , the powder 
averaged T1ρ for the rotating-frame relevant part is (61):  
 
 
€ 
T1ρ−1 = ΔM2 S,δCH ,δHH ,β( ) ⋅ J 2ωe + 2ωR( ) + J 2ωe − 2ωR( )[
                                                + J 2ωe +ωR( ) + J 2ωe −ωR( )]
 (8.1) 
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Here 
€ 
ΔM2  is the product of the dynamic portion of the dipolar second moment and 
orientational terms that transform spin interaction tensors from their molecule-fixed principal 
axis frames to the rotor frame (61). The dynamic portion of the dipolar second moment is 
approximately 
€ 
1− S2( ) times the rigid-limit dipolar second moment, where the order 
parameter S represents the orientation-invariant part of the interaction. In solid-state NMR, 
the order parameter can be independently measured by various dipolar chemical-shift 
correlation experiments (15, 27, 62). The dependence of 
€ 
ΔM2  on the C-H (
€ 
δCH ) and H-H (
€ 
δHH ) dipolar couplings in Equation 8.1 reflects the fact that the 13C-detected 1H T1ρ 
relaxation is driven by C-H and H-H dipolar couplings. β is the angle between B0 and the 
spin-lock field and is 
€ 
cos-1 1 3( )  in our experiments.  
 For motions with a single correlation time τ, the spectral density is given by (10): 
 
 
€ 
J(ω i) =
τ
1+ω i2τ 2
, (8.2) 
 
Explicitly writing the spectral density terms in Equation 8.1, we obtain  
 
 
€ 
T1ρ−1 = ΔM2 S,δCH ,δHH ,β( ) ⋅
τ
1+ 2ωe + 2ωR( )2 τ2
+
τ
1+ 2ωe − 2ωR( )2 τ2
⎡ 
⎣ 
⎢ 
⎢ 
                                               + τ
1+ 2ωe + ωR( )2 τ2
+
τ
1+ 2ωe −ωR( )2 τ2
⎤ 
⎦ 
⎥ 
⎥ 
 (8.3) 
 
 The dependence of T1ρ on correlation time τ can be considered in three regimes. In the 
long correlation time or strong collision limit where 
€ 
2ωeτ >>1, Equation 8.3 is 
approximated as:   
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€ 
T1ρ−1 ≈ ΔM2 S,δCH ,δHH ,β( ) ⋅
1
2ωe + 2ωR( )2
+
1
2ωe − 2ωR( )2
⎡ 
⎣ 
⎢ 
⎢ 
                 + 1
2ωe + ωR( )2
+
1
2ωe −ωR( )2
⎤ 
⎦ 
⎥ 
⎥ 
⋅
1
τ
,       2ωeτ >>1
 ,  (8.4) 
 
In the short correlation time or weak collision regime, Equation 8.3 is simplified to:  
 
 
€ 
T1ρ−1 ≈ 4ΔM2 S,δCH ,δHH ,β( ) ⋅ τ,       2ωeτ <<1 (8.5) 
 
In the intermediate motional regime where 
€ 
2ωeτ =1, for 
€ 
ωe >>ωR , the relaxation rate is the 
fastest, corresponding to a T1ρ minimum.:  
 
 
€ 
T1ρ−1 ≈ 2ΔM2 S,δCH ,δHH ,β( ) ⋅ τ,       2ωeτ =1 (8.6) 
 
For an activated motional process, the correlation time is given by the Arrhenius law:  
 
 
€ 
τ = τ0eEa / RT , (8.7) 
 
where 
€ 
Ea  is the activation energy and 
€ 
τ0 is the prefactor describing the attempt rate of 
motion. The larger the attempt rate, the smaller the 
€ 
τ0, and the shorter the correlation time τ. 
Substituting τ into Equation 8.5, we find that 
€ 
Ea  can be extracted from a plot of 
€ 
ln T1ρ−1( )  
versus 1000/T in the short τ limit:  
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€ 
ln T1ρ−1 = ln 4ΔM2τ0( ) +
Ea
1000R ⋅
1000
T ,   2ωeτ <<1 (8.8) 
 
Equation 8.8 indicates that the natural logarithm of relaxation rates is linear with 1000/T with 
a slope of 
€ 
Ea 1000R in the short correlation time regime. Moreover, the pre-exponential 
factor 
€ 
τ0 can be extracted from the intercept of the linear fit. For this purpose, we use the 
second moment expression from Mehring, which takes into account both C-H and H-H 
dipolar relaxation as well as the LG spin lock factor (27, 60):  
 
  
€ 
4ΔM2τ0 = 1− S2( ) 310 δHH
2 + 115 δCH
2⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ τ0,    2ωeτ <<1 (8.9) 
 
The motional correlation time is fully determined once the activation energy 
€ 
Ea  and 
the pre-exponential factor 
€ 
τ0 are obtained from the slope and the intercept, respectively.  
 In principle, an alternative method to determine the pre-exponential factor 
€ 
τ0 is to 
exploit the T1ρ minimum temperature, where 
€ 
2ωeτ =1. However, as we show below, the T1ρ 
minima observed for membrane-bound M2TMP result from the lipid phase transition, and 
are thus not the true minima of a single motional process. On the other hand, the lipid-
induced T1ρ minima should not affect the high-temperature slopes or intercepts, thus the 
activation energy 
€ 
Ea  and 
€ 
τ0 can still be extracted reliably from these features.  
 The T1ρ in the long correlation time limit can in principle also be used to extract 
€ 
Ea  
and τ. Equations 8.4 and 8.5 indicate that the slope of the 
€ 
ln T1ρ−1( )  plot with 1/T on the low 
temperature side has the same magnitude but the opposite sign from that of the high 
temperature side. But this scenario is true only if a single motional process with the same 
€ 
Ea  
persists throughout the temperature range. Thus, the lipid phase transition makes this 
assumption invalid. Since our purpose is to understand the physiological temperature 
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dynamics of M2TMP, below we will analyze only the high temperature regime of the T1ρ data 
to extract M2TMP motional parameters.  
 
Results 
 Site-specific 1H T1r relaxation times were measured on six membrane samples with 
three sets of labeled residues (LAGI, VAIL, and VSL) without and with amantadine. The 
eleven labeled residues are distributed from position 26 to 38 in the transmembrane domain, 
with I32 and H37 being the only residues not measured in this range.  
 Figure 8.2 shows representative 13C spectra of LAGI-M2TMP in the apo- and 
amantadine-bound states at 313 K, 273 K and 243 K. At 313 K, the amantadine-bound 
peptide has narrower linewidths than the apo peptide, whereas at 243 K the peptide signals of 
the two samples have similar intensities and linewidths, indicating immobilization of both 
states of the peptide. At 273 K, both the apo and bound peptide spectra exhibit significant 
exchange broadening with very low 13C intensities. This broadening coincides with the gel 
to liquid-crystalline phase transition temperature (271 K) of the DLPC membrane, indicating 
that the M2TMP motion responsible for the exchange broadening is intimately associated 
with the phase property of the lipid bilayer. The VAIL and VSL spectra exhibit similar 
temperature dependences and are given in the Supporting Information (Figures 8.S1, 8.S2). 
The fact that the amantadine-bound samples show narrower and higher backbone Ca signals 
than the apo samples at high temperature (50) indicates dynamic differences induced by 
amantadine, the nature of which are analyzed below.  
 1H T1r were measured at six to seven temperatures between 313 and 243 K. Figure 
8.3 displays representative T1r decay curves at 313 K, 273 K, and 243 K as a function of 
spin-lock time. The decay curves are well fit by single exponential functions, where the 
decay constants correspond to T1r. At 313 K, the T1r decays are slower for the amantadine-
bound peptide than for the apo peptide for all residues, indicating the bound peptide has 
longer T1r’s. At 273 K, the 1H T1r’s are significantly shorter than the high-temperature 
values for both the apo and bound peptides, and the bound peptide has marginally longer 
T1r’s than the apo peptide. At 243 K, the T1r values increase significantly over the high 
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temperature values, and there is no longer a consistent difference between the apo and bound 
peptide.  
 
Figure 8.2. 1D 13C CP-MAS spectra of LAGI M2TMP in DLPC bilayers at 313 K, 273 K, and 243 K. 
(a) With amantadine. (b) Without amantadine.  
 
Supporting information Table 8.S1-8.S3 lists all T1ρ values for backbone Hα, sidechain Hβ, 
and sidechain methyl protons in the apo and bound M2TMP at all temperatures.  
 Figure 8.4 shows the 1H T1ρ’s as a function of 1000/T (K-1) for representative 
backbone and sidechain sites. All curves have a V shape, indicative of passage through the 
fastest relaxing intermediate motional regime. Between the apo and bound peptides, the 
minimum T1ρ positions match well, with relatively similar T1ρ values as well as the transition 
temperature 
€ 
Tc . On the high temperature side of the minimum, the bound peptide has 
progressively longer T1ρ’s than the apo peptide with increasing temperature, indicating that 
M2TMP has shorter correlation times in the presence of amantadine (Equation 8.5). On the 
low temperature side, the apo and bound peptides have smaller T1ρ differences for the small 
number of temperatures measured. 
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Figure 8.3. Representative 1H T1ρ relaxation decays of M2TMP in DLPC bilayers at 313 K, 273 K, 
and 243 K. (a) L26 Cα, (b) I33 Cδ, (c) I35 Cα, and (d) I35 Cβ. The apo data are shown as open 
squares and fit by dashed lines. The amantadine-bound data are shown as filled squares and fit by 
solid lines. The decay constants are indicated for all sites.  
 
 To quantify the amantadine-induced dynamic differences of M2TMP, we convert the 
T1ρ plots to 
€ 
ln T1ρ−1( )  and extract the activation energy and correlation time prefactor
€ 
τ0 using 
Equations 8.8 and 8.9. Figure 8.5 shows 
€ 
ln T1ρ−1( )  as a function of 1000/T for a number of Hα 
sites. As expected, the shapes of the plots are roughly inverted from those of Figure 8.4, with 
the amantadine-bound peptide showing smaller relaxation rates than the apo peptide at 
physiological temperature. On the high temperature side of the T1ρ minimum, 
€ 
ln T1ρ−1( )  is 
roughly linear with inverse temperature for most sites, thus supporting the assumption that 
the rotational diffusion can be regarded as an activated process (vide infra). Moreover, the 
amantadine-bound peptide has more positive slopes than the apo peptide, indicating larger 
€ 
Ea . Least-square linear fits of the high-temperature side of the 
€ 
ln T1ρ−1( )  curves yielded the 
activation energies, listed in Table 8.1. The amantadine-bound peptide has an average 
€ 
Ea  of 
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23.3 kJ/mol, which is 66% larger than the average 
€ 
Ea  of 14.0 kJ/mol for the apo peptide. 
The average experimental uncertainty of the 
€ 
Ea  is 17%. The standard deviation of the 
€ 
Ea  
distributions is 6.2 kJ/mol for the bound peptide and 4.2 kJ/mol for the apo peptide. Figure 
8.6 compares the 
€ 
Ea  values of the apo and bound peptides for each Hα site. With the 
exception of G34, the 
€ 
Ea ’s are relatively uniform across all residues, given the experimental 
uncertainty. The small 
€ 
Ea  distribution is consistent with the approximation that the main 
motional process driving T1ρ relaxation is whole-body uniaxial diffusion rather than 
segmental motion. In addition, the 
€ 
Ea  ratio between the bound and apo peptides for each site 
is relatively uniform, with an average ratio of 1.73 and a standard deviation of 0.35.  
 
 
 
Figure 8.4. 1H T1ρ versus 1000/T for representative M2TMP Cα sites in the apo (open squares and 
dashed line) and amantadine-bound (closed squares and solid line) states in DLPC bilayers. (a) L26 
Cα, (b) S31 Cα, (c) G34 Cα, (d) L36, (e) V27 Cγ2, (f) I35 Cδ.   
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Figure 8.5. 
€ 
ln T1ρ−1( )  versus 1000/T curves for representative Cα sites of M2TMP. (a) L26. (b A30. (c) 
S31. (d) G34. (e) I35. (f) L36. The apo data are shown as open squares and fit by dashed lines, and 
the amantadine-bound data are shown as filled squares and fit by solid lines.  
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Figure 8.6. Activation energy 
€ 
Ea  (kJ/mol) extracted from the high-temperature slopes of the Hα 
€ 
ln T1ρ−1( ) versus 1000/T curves. The amantadine-bound M2TMP (filled bars) has larger activation 
energies than the apo peptide (open bars).  
 
To obtain the motional correlation times, we need the C-H order parameters and 
€ 
Ea  
(Equations 8.7 and 8.9). The Cα-Hα order parameters (Table 8.1) are found to be similar 
between the apo and bound peptides, indicating that the amantadine-induced spectral line 
narrowing is not due to amplitude changes but due to rate changes. Using the high-
temperature intercepts and SCH, we calculated 
€ 
τ0 and 
€ 
τ313 K  for the apo and amantadine-
bound M2TMP (Table 8.1). The bound peptide exhibits smaller 
€ 
τ0 values, indicating higher 
attempt rates. As a result, the average 
€ 
τ313 K  is shorter for the bound peptide (0.89 ± 0.41 
µs) than the apo peptide (2.8 ± 0.9 µs). The three-fold reduction of 
€ 
τ313 K  in the presence of 
amantadine is qualitatively consistent with the two-fold longer T1ρ, since 
€ 
T1ρ−1 is linear with τ 
in the short τ regime (Equation 8.5). The magnitude of 
€ 
τ313 K  is also reasonable, as it is 
similar to or shorter than the inverse of the spin lock field of 2.7 µs. In other words, the 
amantadine-bound M2TMP has a shorter correlation time than the characteristic time scale of 
the spin-lock field, thus alleviating exchange broadening, while the apo peptide correlation 
time is closer to the NMR time scale, thus giving rise to broader lines. Decreasing the 
temperature to 273 K increased the τ to 6.0 µs and 3.4 µs for the apo and bound peptides, 
respectively.   
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It is also interesting to examine the sidechain 1H T1ρ trends. Table 8.S3 shows that the 
methyl proton T1ρ’s are much longer than the backbone Hα T1ρ’s and are relatively similar 
between the apo and bound peptides at high temperatures. Figure 8.7 shows representative 
€ 
ln T1ρ−1( )  plots of two methyl groups and one methine Cβ site. The methyl protons have more 
similar high-temperature slopes between the apo and bound peptides, with an apparent 
activation energy difference of only 20% between the two states. The similarities can be 
attributed to three-site jumps of the methyl groups that are additional to the uniaxial 
diffusion, which reduce the dynamic difference between the apo and bound peptide. In 
comparison, the Cβ sites show more distinct activation energies between the apo and bound 
states, consistent with the Hα T1ρ behavior.  
 
Table 8.1. 
€ 
Ea , 
€ 
τ0, and 
€ 
τ313K  of M2TMP in DLPC bilayers in the absence and presence of 
amantadine extracted from Hα T1ρ’s. The 313 K T1ρ and SCH are also listed along with their 
uncertainties (superscript).  
Amantadine-bound peptide Apo peptide 
Residue 
€ 
Ea   
(kJ/mol) 
€ 
τ0 
(ns) 
€ 
τ313K   
(µs) 
€ 
T1ρ313K  
(ms) 
SCH 
€ 
Ea  
(kJ/mol
) 
€ 
τ0  
(ns) 
€ 
τ313K   
(µs) 
€ 
T1ρ313K  
(ms) 
SCH 
L26 20.91.3 0.25 0.76 3.10.1 0.420.02 13.51.3 10.3 1.9 1.30.1 0.440.02 
V27 25.17.8 0.03 0.40 4.00.3 0.330.04 17.1– 3.8 2.8 1.40.1 0.310.02 
V28 32.45.4 0.004 1.07 2.60.3 0.460.04 18.36.2 2.1 2.4 1.20.1 0.460.04 
A29 21.71.3 0.18 0.76 3.50.1 0.440.02 17.51.3 1.7 1.4 1.70.1 0.460.02 
A30 15.94.7 2.32 4.3 1.90.2 0.600.02 11.0 – 62.9 1.1 1.20.1 0.600.07 
S31 30.77.8 0.0086 1.1 2.30.3 0.500.02 13.67.2 15.0 2.8 0.90.1 0.400.02 
I33 25.11.8 0.027 0.40 4.00.3 0.460.02 17.1 – 4.4 3.2 1.40.1 0.310.02 
G34 12.10.4 17.5 1.8 1.70.1 0.600.02 5.40.9 514 4.1 0.90.1 0.690.09 
I35 22.21.3 0.16 0.79 3.10.1 0.420.02 12.01.3 18.0 1.9 1.30.1 0.420.02 
L36 30.22.1 0.010 1.1 2.20.2 0.480.04 18.68.1 1.8 2.3 1.20.1 0.440.02 
L38 20.69.9 0.18 0.48 2.90.2 0.350.02 9.6 – 96.6 3.8 1.30.1 0.330.07 
Mean 23.3 ±6.2  
0.89 
±0.41 
2.8 
±0.8  
14.0 
±4.2  
2.8 
±0.9 
1.3 
±0.2  
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Figure 8.7. (a-c) 
€ 
ln T1ρ−1( )  versus 1000/T curves for several M2TMP sidechains. (a) L26 methyl Cδ1/ 
Cδ2. (b) A30 Cβ and I33 Cγ2 methyl groups. (c) L36 Cβ. Apo data: open squares and dashed lines. 
Amantadine-bound data: filled squares and solid lines. (d) Activation energy (kJ/mol) of the methyl 
protons. The average 
€ 
Ea  difference between the apo and bound peptides is ~20%.  
 
Discussion  
M2TMP uniaxial diffusion is the main motion driving T1ρ relaxation  
 The motivation for this work is to quantify the motion of M2TMP that is responsible 
for exchange broadening of its NMR spectra in phosphocholine bilayers at physiological 
temperatures, and to understand the origin of amantadine-induced line narrowing. 
 The exchange broadening is due to microsecond motion of the peptide that interferes 
with 13C-1H and 15N-1H dipolar decoupling and cross polarization. We assign the motion to 
whole-body uniaxial rotational diffusion of the M2 helical bundle. The presence of this 
uniaxial diffusion has been previously shown based on the lineshapes of 2H quadrupolar 
spectra, 15N static powder spectra, and 15N-1H and 13C-1H dipolar couplings (48). Two lines of 
evidence support the assignment of the T1ρ relaxation mechanism to this uniaxial diffusion. 
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First, all eleven measured residues exhibit rapid T1ρ relaxation at high temperatures, and all 
T1ρ values are increased by amantadine. Such across-the-board effects can only result from a 
whole-body motion. Second, the two-dimensional Brownian diffusion theory of Saffman and 
Delbrück predicts a rate of 
€ 
105 s−1 for the uniaxial diffusion of the M2 helical bundle, which 
agrees well with the time scale probed by the T1ρ experiments.  
 The presence of whole-body motion does not exclude additional internal motions. 
Sidechain motions are certainly present, although they do not interfere with the extraction of 
the rates and activation energy of uniaxial diffusion from the backbone Hα T1ρ data. The 
clearest manifestation of sidechain motions is the fact that the methyl protons have longer 
T1ρ’s than the backbone protons, and the methyl 1H T1ρ’s are similar between the apo and 
bound peptides at high temperatures (Table 8.S3). These observations are not surprising, 
since the fast methyl rotation on the nanosecond time scale pre-averages the dipolar second 
moment, and thus reduce the relaxation rates (Equation 8.1). The local nature of the methyl 
rotation also makes the motion less sensitive to amantadine binding. The full T1ρ dependence 
includes spectral densities at the 1H and 13C Larmor frequencies, which are more relevant 
time scales for the methyl rotation. Thus, Equation 8.1 does not apply fully to methyl groups. 
Since the main purpose of this study is to understand the motion that causes exchange 
broadening of the NMR spectra, but sidechain methyl 13C signals do not suffer from 
exchange broadening, we do not consider the combined motion of three-site jumps and 
uniaxial diffusion experienced by the methyl groups further. Another manifestation of 
possible segmental motions is the distribution of 
€ 
Ea . Specifically, the G34 
€ 
Ea  is two 
standard deviations lower than the average, suggesting the local motion at this residue (vide 
infra).  
 
Correlation time of M2TMP diffusion and origin of spectral line narrowing by amantadine 
 The three-fold shorter correlation time of the amantadine-bound M2TMP (Table 8.1) 
explains the amantadine-induced line narrowing of the peptide spectra. The faster motional 
rates better avoid the intermediate time scale condition, thus alleviating line broadening. The 
faster diffusion rates result from the one to two orders of magnitude reduction of the 
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prefactor 
€ 
τ0, as obtained from the high-temperature intercepts of the 
€ 
ln T1ρ−1( )  curves. The 
intercept depends both on 
€ 
τ0 and the dipolar second moment (Equation 8.9), whose exact 
magnitude differs somewhat between different theories, depending on how many spin 
interactions are included and whether the MAS or the static condition is operative (27, 60, 
61). However, the ratio of the intercepts between the apo and bound peptide depends only on 
€ 
τ0. Thus, the relative size of 
€ 
τ0 between the apo peptide (long 
€ 
τ0) and the bound peptide 
(short 
€ 
τ0) is unambiguous.   
 The shorter 
€ 
τ0 of the amantadine-bound M2TMP indicates higher attempt rates of 
motion, which suggest that the M2 helices form better-packed tetramers in the presence of 
amantadine. Amantadine may interact with all four helices of the tetramer, thus serving as a 
non-covalent linker that brings the four helices together to form a more cohesive tetrameric 
bundle. A more cohesive helical bundle can diffuse faster, and would also have structurally 
and dynamically more homogeneous individual helices. This interpretation is consistent with 
the relative lack of correlation time distribution for the bound peptide (vide infra), as 
manifested by the sharpness of the T1ρ minima, and is also consistent with disulfide cross 
linking data that indicate increased tetramer association in the presence of amantadine (63). 
Thus, the reduced 
€ 
τ0 of the bound M2TMP suggests that amantadine is centrally located in 
the pore of the channel, shared by all four helices, consistent with the binding site seen in a 
recent crystal structure (64). In comparison, a solution NMR study (52) found four 
rimantadine molecules at the lipid-facing surface of each channel. It is difficult to imagine 
how this surface binding motif would homogenize the peptide conformation and speed up its 
motion.  
 A question that is beyond the scope of the current study is the correlation time 
distribution of apo M2TMP, which is manifested by the broad T1ρ minima of the apo peptide. 
The τ distribution suggests that without amantadine, the M2 helical bundles are floppier, with 
more internal degrees of freedom, and may exhibit dynamic heterogeneities between 
different tetramers. Such dynamic heterogeneity may be functionally relevant, as it may 
allow the apo peptide to adopt appropriate conformations to achieve its many functions, 
including channel activation, gating, and inhibition.  
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The activation energy of M2TMP uniaxial diffusion is related to membrane viscosity 
 A basic assumption in our dynamic analysis is that the rotational diffusion of a 
membrane protein in lipid bilayers can be considered an activated process that follows an 
Arrhenius law (Equation 8.7). The linearity of the observed 
€ 
ln T1ρ−1( )  with respect to 1000/T 
at high temperatures (Figure 8.5) validates this assumption, but it is of interest to consider the 
physical basis for the activated diffusion. Membrane protein diffusion in lipid bilayers 
requires the availability of free volume in the vicinity of the protein, which is achieved by 
discrete hopping of the lipid molecules. Thus, activated lateral and rotational diffusion of 
membrane proteins has its molecular origin in the free volume theory of liquids (65, 66). 
Considered in this light, the activation energy essentially reflects the macroscopic viscosity 
of the membrane. Higher activation energies indicate higher viscosities. Thus, the higher 
€ 
Ea  
of the amantadine-bound peptide indicates that excess amantadine increases the membrane 
viscosity. If this is true, then the lipid 1H T1ρ values should be affected by the excess 
amantadine outside the channel in the bilayer, in the same manner as the protein.  
 Examination of several resolved lipid 13C signals confirms that there is indeed an 
amantadine-induced increase of the lipid 
€ 
Ea . Figure 8.8 shows the 
€ 
ln T1ρ−1( )  curves of the 
lipid glycerol G3 and the acyl chain C2 signals. The excess-amantadine-containing 
membrane clearly has larger slopes than the amantadine-free membrane, similar to the 
peptide T1ρ behavior. The amantadine-bound samples in our experiments contain 8-fold molar 
excess of amantadine to the peptide, or 32-fold excess amantadine to the channel. The excess 
amantadine partitions into the bilayer (67, 68). Paramagnetic relaxation enhancement NMR 
data indicate that amantadine is located at the interfacial region of the DMPC bilayer with the 
amine group pointing to the surface (69). This depth and orientation are consistent with the 
amphipathic nature of amantadine, with its hydrophobic adamantane cage close the 
hydrocarbon core and its polar ammonium moiety pointing to the polar region of the bilayer.  
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Figure 8.8. 
€ 
ln T1ρ−1( )  versus 1000/T curves for several lipid 13C signals in M2TMP-containing DLPC 
bilayers. (a) Glycerol backbone G3. (b) Acyl chain C2. Apo data: open squares and dashed lines; 
Amantadine-bound data: filled squares and solid lines.  
 
 Our recently measured lipid 13C T2 relaxation times at 313 K in peptide-free DLPC 
bilayers showed no discernible difference between amantadine-containing and amantadine-
free bilayers (53), in contrast to the current lipid 1H T1ρ data. This discrepancy is likely due to 
the presence of the peptide in the current measurements but the lack of the peptide in the 
previous T2 experiments. Membrane viscosity is a function of molecular crowding: peptide-
containing bilayers have much smaller free volumes for amantadine than pure lipid bilayers, 
thus amantadine may cause detectable fluidity changes only in M2-containing bilayers.  
 The viscosity origin of the activation energy of M2TMP diffusion also explains the 
asymmetric slope of the 
€ 
ln T1ρ−1( )  curves on the two sides of the T1ρ minimum. Both the apo 
and bound peptides have steeper slopes or larger apparent activation energies on the low 
temperature side. Since this T1ρ minimum is associated with phase transition of the DLPC 
bilayer, the slope increase at low temperature is caused by the significant viscosity increase 
of the gel-phase membrane compared to the liquid-crystalline phase. Thus, the M2TMP 
rotational diffusion is not a single motional process above and below the lipid phase 
transition temperature, in contrast to most other motions that have been characterized by 
NMR (23, 70).  
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 The viscosity origin of the activation energy may also partly explain the 
€ 
Ea  
distribution among the residues. Since a perfectly rigid-body motion should have a single 
€ 
Ea
, the observed 
€ 
Ea  distribution beyond the experimental uncertainty must reflect additional 
motions, which may result from varying membrane viscosity across the bilayer thickness. 
The abnormally low 
€ 
Ea  of G34 may then be partly due to the location of G34 at the center of 
the TM helix and thus at the center of the bilayer, which has the lowest viscosity due to 
large-amplitude motions of the lipid chain ends. While the exact nature of the local G34 
motion is unknown, the conclusion of increased conformational flexibility is consistent with 
a large number of NMR parameters for this site: its 15N anisotropic chemical shifts, N-H 
dipolar coupling (71), and 15N isotropic chemical shifts were all found to change with drug 
binding (53, 72) and membrane composition (73).  
 The lipid-mediated influences of excess amantadine on the diffusion dynamics of 
M2TMP do not change the previous conclusion that the protein-bound amantadine causes 
site-specific conformational changes through direct amantadine-protein interactions. The 
structural changes are manifested as chemical shift perturbations that are highly site specific, 
with residues S31, G34, and V28 exhibiting large chemical shift perturbations while other 
residues showing little changes (50, 53).  
 
Conclusion  
 The temperature-dependent 1H T1ρ relaxation times shown here indicate that the 
uniaxial diffusion of the M2TMP in liquid-crystalline DLPC bilayers causes efficient 1H T1ρ 
relaxation, and the diffusion rates are increased by amantadine through an increase in the 
attempt frequencies. The average motional correlation time at 313 K is 0.89 µs for the bound 
peptide and 2.8 µs for the apo peptide. The faster diffusion of the bound peptide suggests that 
amantadine induces more homogeneous and better-packed M2TMP tetramers by 
coordinating with all four helices. Thus, the well documented amantadine-induced NMR line 
narrowing is due to suppression of the intermediate time scale broadening.   
 From the linear relation of 
€ 
ln T1ρ−1( )  with 1/T at high temperature, we extracted the 
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activation energy of the M2 uniaxial diffusion. The average 
€ 
Ea  is 23.3 kJ/mol for the bound 
peptide and 14.0 kJ/mol for the apo peptide. The higher 
€ 
Ea  of the bound peptide is attributed 
to larger membrane viscosity by excess amantadine, which is confirmed by the lipid T1ρ data.
 Similar exchange broadening of the apo protein and line narrowing of the bound 
protein have also been reported for solution NMR spectra of M2(18-60) in DHPC micelles 
(52). There, the exchange broadening of the apo protein spectra was alleviated by the 
addition of 40 mM rimantadine. At 53-fold molar excess to the protein (0.75 mM), the excess 
rimantadine is expected to significantly increase the viscosity of the micelle interior, which 
may affect the dynamics of the micelle-bound rimantadine in a way that facilitates the 
observation of its NOEs with the protein.  
 The present study illustrates the rich information that can be obtained from 
temperature-dependent relaxation studies of membrane proteins. Compared to most 
relaxation NMR studies so far, which were targeted to either small molecules with a single 
motion (23) or macromolecules with a well-defined local motion (74), the present study 
examines the rates and energetics of the global motion of a membrane protein (75). It gives a 
glimpse into the energetic driving force behind membrane protein uniaxial diffusion, which 
is not easily obtained by other biophysical techniques (28).  
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Supporting Information 
 
 
 
Figure 8.S1. 1D 13C CP-MAS spectra of VAIL-M2TMP in DLPC bilayers at 313 K, 273 K, and 243 
K. (a) With amantadine. (b) Without amantadine.  
 
 
 
  
Figure 8.S2. 1D 13C CP-MAS spectra of VSL-M2TMP in DLPC bilayers at 313 K, 273 K, and 243 
K. (a) With amantadine. (b) Without amantadine.  
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Table 8.S1. Hα T1ρ’s (ms) of M2TMP in the apo and amantadine (Amt) bound states in DLPC 
bilayers at various temperatures.  
 
Site  313 K 303 K 293 K 283 K 273 K 263 K 253 K 243 K 
L26 Apo 1.3 1.1  0.71 0.63 0.71 0.76 5.6 
 Amt 3.1 2.2  1.6 0.87 0.66 1.3 5.2 
V27 Apo 1.4 0.6  0.39 0.46 0.78 3.4 6.6 
 Amt 4.0 3.2  2.6 1.6 0.66 3.4 7.1 
V28 Apo 1.2  0.5  0.42 1.9 6.6 7.1 
 Amt 2.6  0.8  0.41 1.5 6.9 5.8 
A29 Apo 1.7 1.5  0.87 0.63 0.71 0.85 9.4 
 Amt 3.5 2.3  1.3 0.93 0.69 1.7 8.8 
A30 Apo 1.2 0.60  0.44 0.51 0.90 4.3 11.1 
 Amt 1.9 1.9  1.7 1.2 0.72 4.1 9.9 
S31 Apo 0.92  0.45  0.42 1.8 6.4 6.3 
 Amt 2.3  0.95  0.41 1.0 8.6 7.0 
I33 Apo 1.4 0.63  0.39 0.46 0.78 3.4 6.6 
 Amt 4.0 3.2  2.6 1.6 0.66 3.4 7.1 
G34 Apo 0.88 0.89  0.72 0.67 0.73 0.82 8.7 
 Amt 1.7 1.5  1.0 0.88 0.69 1.7 6.5 
I35 Apo 1.3 1.1  0.75 0.68 0.66 0.66 7.1 
 Amt 3.1 2.4  1.1 0.90 0.63 1.2 6.5 
L36 Apo 1.2  0.50  0.42 1.8 8.7 10.3 
 Amt 2.2  1.1  0.41 0.95 8.6 7.2 
L38 Apo 1.3 0.5  0.39 0.49 0.75 3.9 10.4 
 Amt 2.9 2.8  2.9 2.0 0.74 3.7 8.1 
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Table 8.S2. Hβ T1ρ’s (ms) of M2TMP in the apo and amantadine-bound states in DLPC bilayers at 
various temperatures.  
 
Site  313 K 303 K 293 K 283 K 273 K 263 K 253 K 243 K 
L26 Apo 1.9 1.5  0.81 0.70 0.74 0.76 8.7 
 Amt 4.3 3.5  1.5 1.2 0.80 1.1 3.2 
V27 Apo       2.9 4.8 
 Amt       3.4 5.0 
V28 Apo 0.83  0.41  1.1 2.0 6.5 6.0 
 Amt 1.5  0.31   1.4 6.3 5.4 
A29 Apo 2.9 2.5  1.4 1.8 1.3 1.3 7.0 
 Amt 6.3 4.8  2.3 2.0 1.3 1.6 7.8 
A30 Apo 2.7 1.4  1.1 1.0 1.4 4.3 8.3 
 Amt 3.6 2.9  1.7 1.2 1.1 3.7 7.3 
S31 Apo 0.92  0.46  0.42 1.8 6.8 5.9 
 Amt 3.2  0.94   1.0 7.6 5.9 
I33 Apo 1.6 0.74  0.39 0.50 0.78 2.5 3.9 
 Amt 2.5 2.8  1.6 1.3 0.82 4.3 3.8 
I35 Apo 1.7 1.3  0.73 0.64 0.69 0.73 5.1 
 Amt 3.4 2.6  1.3 1.0 0.70 1.6 5.6 
L36 Apo 1.3  0.74  0.47 1.3 5.9 8.1 
 Amt 4.7  1.6  0.51 0.91 6.3 5.8 
L38 Apo 1.4 0.71  0.39 0.42 0.55 3.0 6.8 
 Amt 1.6 1.3  0.80 0.60 0.49 1.8 6.7 
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Table 8.S3. Methyl 1H T1ρ’s (ms) in M2TMP in the apo and amantadine-bound states in DLPC 
bilayers at various temperatures.  
 
Site  313 K 303 K 293 K 283 K 273 K 263 K 253 K 243 K 
L26 Cδ Apo 4.8 4.5  2.3 1.9 2.0 1.8 4.5 
 Amt 7.5 7.0  4.6 3.5 2.3 1.9 4.7 
V27 Cγ Apo 4.9 1.9  1.2 0.82 1.2 3.8 7.0 
 Amt 6.3 4.6  2.5 1.5 1.1 4.1 6.3 
V28 Cγ Apo 1.9    1.4 2.5 8.0 7.1 
 Amt 3.6    0.98 1.9 6.8 6.1 
A29 Cβ Apo 2.9 2.5  1.4 1.8 1.3 1.3 7.0 
 Amt 6.3 4.8  2.3 2.0 1.3 1.6 7.8 
A30 Cβ Apo 2.7 1.4  1.2 1.0 1.4 4.3 8.3 
 Amt 3.6 2.9  1.7 1.2 1.1 3.7 7.3 
I33 Cγ2 Apo 5.2 2.1  1.3 1.1 1.3 3.1 7.2 
 Amt 3.6 2.9  1.7 1.2 1.1 3.7 7.3 
I33 Cδ Apo 5.2 2.1  1.3 1.1 1.3 3.1 7.2 
 Amt 7.0 5.0  2.5 1.6 1.4 3.2 5.4 
sI35 
Cγ2 
Apo 
2.9 2.5  1.4 1.8 1.3 1.3 7.0 
 Amt 6.3 4.8  2.3 2.0 1.3 1.6 7.8 
I35 Cδ  Apo 3.4 3.2  1.8 1.6 1.8 1.8 6.3 
 Amt 7.3 5.3  3.1 2.4 1.7 1.9 7.0 
L36 Cδ Apo 5.7    1.8 2.5 8.3 8.5 
 Amt 4.9    1.3 2.5 8.1 6.5 
L38 Cδ Apo 4.4 2.4  1.4 1.1 1.4 3.1 5.9 
 Amt 6.8 4.5  2.4 1.4 1.2 3.6 5.1 
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Appendix A 
 
Synthesis of 15N Labeled Amantadine 
 
Introduction 
 The following synthesis of 15N labeled amanatdine is adapted from Stetter, H., J. 
Mayer, M. Schwarz, and K. Wulff. 1960. Über Verbindungen mit Urotropin-Struktur. 16. 
Beiträge zur Chemie der Adamantyl-(1)-Derivate. Chemische Berichte-Recueil. 93: 226–230. 
The original manuscript is written in German the procedure was kindly translated by 
Professor Klaus Schmidt-Rohr. The original synthesis was not for 15N labeled product, so the 
reagents and glassware required for the procedure have been scaled accordingly. I will note 
where significant changes have been made from the original synthesis to improve 
experimental yield in order to make the most of the 15N-labeled acetonitrile. As with any 
isotopically labeled synthesis, a practice run with unlabeled materials is strongly encouraged. 
Product numbers listed are accurate as of 2009.  
 The synthesis proceeds in two basic steps: the formation of a carbocation from the 
bromoadamantane to form the adamantyl amide, and the subsequent saponification of the 
amide to form the amine. The final step is acidification of the free amine to form a water-
soluble salt. (Scheme A.1) The formation of the amide produces a product of high yield and 
purity, with experimental yields of 60-95% depending on the protocol used (see Part I). 
However, the saponification step and subsequent purification is somewhat low yield, with a 
final amantadineHCl product yield of around 6%. A full ampule of CH3C15N should yield 
approximately 20 mg of 15N amantadineHCl, which is more than sufficient for several NMR 
samples.   
 
Scheme A.1. Synthesis of 1-aminoadamantane, or amantadine, from bromoadamantane. For the 15N 
labeled product, CH3C15N is used as a starting material. 
high 
yield 
low 
yield 
low 
yield 
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Experimental Procedure 
Part I Reactants: synthesis of adamantyl amide from 1-bromoadamantane. 
 
Apparatus: 
• Stir plate 
• Round bottom flask, 5 mL (larger if needed) 
• Micro stir bar, ~0.5 cm (Fisher Scientific) 
• Plastic syringe for H2SO4 addition 
o Sigma-Aldrich Part # Z230723-1PAK (100/Pak)  
o Green, 1 mL, graduated in 0.1 mL increments. 
• Micropippette, 1 mL tip size 
• 100 mL beaker  
• Small Büchner funnel and vacuum apparatus 
• Filter paper to fit Büchner funnel 
• 20 mL scintillation vial for final product 
 
Reactants: 
• 0.621 mL (500 mg ampule) of 15N acetonitrile  
o Cambridge Isotopes Product # NLM-175-0.5 
Other reactants scale as follows: 
• 320 mg 1-bromoadamantane  
o Sigma-Aldrich Product # 109223 
• 0.48 mL concentrated H2SO4 
• 8.0 mL of chilled H2O  
Reactants for purification: 
• 5.0 M NaOH as needed, for neutralization 
• 5% solution (by weight) of sodium thiosulfate, as needed to remove remaining yellow 
bromine residue 
 
NOTE: In the original procedure, the limiting reagent is 1-bromoadamantane. Obviously we 
want the limiting reagent to be the more expensive 15N-acetonitrile, which also serves as the 
solvent. Although the Stetter, et al. protocol calls for only ~80mg of 1-bromoadamantane at 
this scale (for 500 mg of 15N acetonitrile), this amount in this list of reagents is adjusted to 
use more of the 15N label in the acetonitrile (320 mg of 1-bromoadamantane is listed above). 
Additional condition scanning can be conducted with unlabeled materials, but in my 
experience 6 times the published amount of bromoadamantane did not dissolve adequately in 
acetonitrile solution, but 4 times the amount dissolved adequately and gave significantly 
higher amounts of the amide. Note that if the reaction is scaled up in this manner, product 
yields for the first step will be 50-80% compared to 90-95% for the original protocol (relative 
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to 1-bromoadamantane).  However, it is possible to make more than three times as much of 
the amide as would have been made in the original protocol despite the lower relative yields.  
The final solution in the morning may have solid stuck to the side that did not react, this will 
go away upon purification.  The final solution will also be significantly more viscous than if 
only 80 mg bromoadamantane is used.  
 
Part I Procedure: synthesis of adamantyl amide from 1-bromoadamantane.  
1-bromoadamantane is measured out directly in the 5 mL round-bottom flask (RBF), 
which also contains the 0.5 cm stir bar.  15N acetonitrile is added directly from the ampule 
with stirring until some solid dissolves. It is not necessary to completely dissolve the solid 
before addition of the acid.  0.48 mL of concentrated H2SO4 is added dropwise over 3-5 
minutes using the 1 mL graduated syringe.  After approximately 75% of the H2SO4 has been 
added, bubbles and white precipitate form in the vial.  The solution will warm slightly, but 
not approaching boiling.  Approximately 30-45 minutes after the addition of H2SO4, small 
amounts of bromine gas will begin to evolve, as evidenced by a brown/red residue on the rim 
of the vial.  Loosely cap with a septa overnight.  At this point, the solution is slightly yellow 
and precipitate remains. 
In the morning, the solution is red/brown and translucent (Figure A.1).  Stop the 
reaction 20-24 hours after the H2SO4 was added. Pouring the red/brown solution into chilled 
H2O stops the reaction. White precipitate immediately forms.  (NOTE: It is not 
recommended to use a glass pipette to extract the red solution out of the flask, because the 
final solution is very viscous and will stick to the glass pipette.  If water is used to wash out 
the pipette, precipitate will form on the inside of the glass and it is very difficult to remove.) 
If the red solution is sticking to the sides of the RBF, it will be necessary to add cold water to 
the RBF and attempt to extract the solid with a glass pipette or spatula.  
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Figure A.1: Synthesis of adamantyl amide from 1-bromo-adamantane. The solution is red-orange in color and 
translucent after an overnight reaction with concentrated H2SO4.   
 
 
Neutralize the solution with 5.0 M NaOH, and test with pH paper to ensure a pH of 
7.0 – 9.0. Filter the solution with the filter paper and Büchner funnel, connected to a vacuum 
apparatus to remove most of the water. Transfer the solid to a 20 mL scintillation vial and dry 
overnight in a lyophilizer or an oven. If using the lyophilizer, freeze the sample in liquid 
nitrogen before putting under vacuum. If some yellow bromine residue remains, the product 
can be washed with a 5% solution (by weight) of sodium thiosulfate to remove residual the 
bromine. 
 
 
 
Part II Reactants: saponification of adamantyl amide by NaOH in diethylene glycol.  
Apparatus: 
• Hot plate 
• Sand 
• A small open dish for the sand bath (less than 4” in diameter) 
• Thermometer rated to at least 200 °C 
• 10 mL round bottom flask with 14/20 neck 
• Small condenser with 14/20 neck 
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• Chilled water supply and tubing to connect condenser 
• Plastic micropipette, 1 mL tip size 
• 14/20 septa 
• Large gauge disposable needle, size 18G 1 ½” (Pink label #305196) 
• Ring stand and small clamp 
• 20 mL scintillation vials (several) 
 
Reactants: 
• X g of product (adamantyl amide) from first step 
• 2X g of NaOH, crushed 
• 20X mL of diethylene glycol 
 
Part II Procedure: saponification of adamantyl amide by NaOH in diethylene glycol. 
Directly weigh out the crushed NaOH into the 10 mL round bottom flask. Add the 
appropriate amount of diethylene glycol (digol) to the flask using the 1 mL micropipette tip 
and swirl slightly to distribute the NaOH throughout the solvent.  At this time, also weigh out 
an appropriate amount of adamantyl amide into a small vial.  Place the thermometer in the 
sand bath next to the round bottom flask, and place the flask in the sand so that half of it is 
covered. Gently heat the NaOH solution in the sand bath at ~70 °C to try and get some of the 
solid to dissolve.  After about an hour, or when a slight yellow tinge appears in the solution, 
add the premeasured adamantyl amide. The solids are not highly soluble in the digol at this 
temperature.  Bury the flask back in the sand bath, clamp the condenser apparatus to the ring 
stand, and insert into the round bottom flask. Wrap a small amount of Teflon tape around the 
joint to prevent leakage.  Plug the top of the condenser with a 14/20 septa and insert a large 
gauge needle into it for venting.  Attach the tubes to the condenser, start the chilled water and 
turn the hot plate to the appropriate setting (for the FisherSci hot plate, the setting is between 
150-180 on the temperature dial).  Reflux the solution with the sand at 130-140 °C for 12-18 
hours.  If specks of solid remain, reflux for another few hours.  It will turn yellow after a 
short time and then brown after a few hours. 
When the solution is done refluxing, turn off the hot plate and remove the flask from 
the sand, allowing it to cool completely.  Dilute the digol solution with room temperature 
water until it is thin enough to be pipetted out of the flask.  Using a glass pipette, transfer the 
digol solution into a 20 mL scintillation vial, using as much water as needed to rinse out the 
flask completely.  Also rinse off the condenser apparatus with water or ether directly into the 
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10 mL RBF or the extraction vial.  If this is not done, white product will be seen on the 
condenser after it is allowed to cool and dry off.  
 
 
Part III Reactants: acidification and purification of amantadine. 
Apparatus: 
• Ring stand and small clap 
• 20 mL scintillation vials (several) 
• Funnel 
• Filter paper 
• Pasteur pipettes and bulbs 
• 6” hypodermic needle and glass syringe 
• Balloon filled with N2 gas attached to a syringe with a small gauge needle  
 
Reactants: 
• Diethyl ether 
• Magnesium sulfate 
• 2M HCl in ether 
o Sigma-Aldrich Product # 455180 
• Water  
• Methylene chloride 
• 0.1 M HCl, aqueous 
 
 
Part III Procedure: acidification and purification of amantadine. 
The digol solution will be extracted in the 20mL scintillation vial or a larger vial or a 
small separatory funnel if needed.  For the 20 mL scintillation vial scale: using ~10-15mL of 
ether each time, extract the digol solution 3-4 times, shaking and venting the vial to ensure 
complete extraction.  The layers will separate into organic and aqueous layers – we will be 
keeping the organic layer, which contains the amine (aminoadamantane/amantadine at this 
point) free base. With the scintillation vial this extraction involves siphoning the digol layer 
out of the vial with a Pasteur pipette, and transferring to a separate vial.  The final ether/free 
amine solution will be quite yellow with brown bubbles of digol coming in and out of 
solution when it is shaken.  Dry the ether/free amine solution over magnesium sulfate for ~30 
minutes and filter through a filter paper and funnel into a clean vial.   
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In order to prevent spillage, fasten the final vial containing ether/free amine to a ring 
stand with a clamp.  The ether/free amine solution will be acidified using neat HCl in ether 
solution or by bubbling HCl gas through the solution.  For the neat HCl in ether, insert the N2 
filled balloon/needle into the septa sealed lid of the ether container.  This is to ensure that the 
headspace remains inert after removing liquid. Insert the 6” hypodermic needle carefully into 
the septa, being sure to hold in the plunger as the pressure from the HCl/ether gas may cause 
it to rise.  Carefully extract 2mL of the ether solution and inject it into the vial containing the 
ether/free amine solution.  A white precipitate will form immediately.  If needed, inject more 
HCl/ether into the ether/free amine vial to ensure complete acidification.  After a few 
moments, brown greasy digol will begin to crash out on the sides.  
Dry down the ether/amantadineHCl solution under a stream of N2 gas. The final 
product will be quite impure at this point.  Once almost all of the ether has been removed, 
bring the product back up in ~10 mL water and shake to rinse the sides. Finally, add ~10mL 
of methylene chloride and shake to mix, venting the vial after shaking.  Most of the brown 
impurity will go into the MeCl2 layer, while small white amtHCl precipitate remains in the 
water layer.  After a few moments, the amtHCl will dissolve into the water layer.  Using the 
same procedure as before, siphon off the MeCl2, and keep the layer in a separate vial.  
Extract a few more times until the MeCl2 does not absorb any more color.  Back-extract the 
MeCl2 with 0.1 M HCl (aqueous) to ensure no free amine remains in the organic layer.  
Combine the water layers and wait a few minutes until any remaining MeCl2 falls to the 
bottom, and remove the small amount via Pasteur pipette. Freeze and lyophilize the final 
product.  A small amount of greasy brown residue may remain, but continue lyophilizing 
until all of the digol evaporates.  Some brown residue may remain after lyophilization, but it 
should be pure enough by NMR (~95%) for the final use with protein samples. If necessary, 
the final product can be extracted with MeCl2 a few more times or recrystalized.   
To recrystalize, add a few drops of ethanol to the final dried product. This will be 
enough to solubilize the entire amount of product and impurity.  Fill the rest of the 20mL 
scintillation vial with ether, and place in the 4 °C fridge or freezer overnight.  Small 
brownish crystals will crash out and eventually sink to the bottom.  After a day or two, 
remove most of the ether and transfer it to another vial to continue recrystallizing any 
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remaining product, although the amount will be small.  Lyophilize the crystals that have 
collected at the bottom and bring back up in D2O for analysis.  Or, the crystals can be 
brought up directly in water and lyophilized, producing a very fluffy white powder 
resembling lyophilized lipids.  These crystals will be very pure. Final purity of 15N amtHCl  
is confirmed through 1H solution NMR and 15N solid-state NMR.  
 
 
 
  
Figure A.2: Recrystalization of amtHCl in ethyl ether and ethanol.  
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Experimental Results and NMR Spectra 
• Adamantyl amide from Step I: 250-270 mg, 40-80% yield relative to 
bromoadamantane depending on amount of bromoadamantane used.  
• AmtHCl after recrystallization: 6-9 mg, 5-6% yield relative to adamantyl amide.  
(8.5 mg amtHCl from 215.6 mg adamantyl amide.) 
• AmtHCl purity before recrytallization: 46 %. After recrystallization: 92 %.  
 
 
 
Figure A.3: 1H solution NMR spectra of (a) adamantyl amide in CH3Cl, (b) commercial unlabeled 
amtHCl (Fluka) in D2O/EtOD and (c) recrystallized 15N amtHCl in D2O.  
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Figure A.4: Full 1H solution NMR spectra of (a) adamantyl amide in CH3Cl, (b) commercial 
unlabeled amtHCl (Fluka) in D2O/EtOD and (c) recrystallized 15N amtHCl in D2O. ~3.5 ppm peak in 
(c) is residual diethylene glycol, an ~8% impurity in this sample after recrystallization. 
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Appendix B 
 
Temperature calibration of 4 mm MAS probes using 207Pb chemical shift 
 
 
Introduction 
 In solid-state NMR, accurate knowledge of sample temperature is often an important 
consideration. When a sample is subjected to magic angle spinning (MAS), the various 
airflows involved, the physical rotation of the sample at a high rate, the high magnetic field, 
and multiple radiofrequency pulses (1) can all lead to changes of the sample temperature 
inside the MAS rotor. Most NMR probes are designed with the sample thermocouple in the 
stator, but it is difficult to measure the sample heating or temperature gradients that may be 
occurring inside the rotor. The purpose of this study is to determine the effects of high versus 
low airflow from the variable temperature unit, especially at low temperature, in order to 
have accurate temperature reporting for the variable temperature T1ρ data shown in Chapter 8.  
The 207Pb chemical shift of lead nitrate, Pb(NO3)2, has been shown to be linearly 
sensitive to temperature changes over the range of 143 K to 423 K (2). This temperature 
range also provides desirable 207Pb linewidths under MAS.  At ambient temperatures, the 
chemical shift change that occurs with a 0.5 K temperature change is equal to the spectral 
linewidth of the Pb(NO3)2 peak. Previous studies (2) have shown that temperature changes as 
small as 0.1 K can be observed through 207Pb chemical shift changes given enough signal to 
noise. Thus, Pb(NO3)2 can be used as a probe to measure the effects of variable temperature 
air flow  and sample temperature gradients within the rotor. 207Pb chemical shift varies 
linearly with temperature, and it has been shown experimentally (2) that the chemical shift 
changes at the rate of 0.753 ppm/K. By conducting a series of experiments at several 
temperatures, we are able to observe the relationship between the variable temperature air 
flow and sample temperature. 
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Sample Packing and Data Acquisition  
 The Pb(NO3)2 powder was obtained from Dr. Sam Houk’s laboratory at Iowa State 
University. Two samples with different types of sample packing were prepared for this study. 
The first sample packing, shown in Figure B.1a, contains a 4 mm PTFE spacer at the bottom 
of the rotor, with approximately 120 mg of Pb(NO3)2 packed on top of the spacer. In this 
sample, the Pb(NO3)2 is not constrained to a uniform density, so there may be a gradient of 
sample concentration throughout the rotor as the lead nitrate is a loose powder. This sample 
also contained a large amount of material, which was intended to fill the majority of the rotor 
for observation of sample temperature gradients. The second sample packing, shown in 
Figure B.1b, contains a 4 mm PTFE spacer at the bottom of the rotor, and a 2 mm PTFE 
spacer on top of the sample powder. Approximately 40 mg of Pb(NO3)2 powder is 
sandwiched tightly between the spacers in order to produce a compact sample that cannot 
shift in the rotor, and should not experience much of a temperature gradient. 
 
Figure B.1. Rotor packing of Pb(NO3)2 for variable-temperature air flow calibration. (a) Non-center 
packed sample contains a 4 mm PTFE spacer at the bottom of rotor and approximately 120 mg of 
Pb(NO3)2. (b) Center packed sample contains approximately 40 mg of Pb(NO3)2, sandwiched between 
a 4 mm PTFE spacer at the bottom of rotor and a 2 mm spacer at the top of the rotor.  
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NMR experiments were carried out on a Bruker AVANCE-600 (14.1 Tesla) 
spectrometer (Karlsruhe, Germany) using a 4 mm MAS probe. The spinning speed was 7 
kHz for all experiments in order to simulate conditions used for most membrane protein 
samples on this machine. Spectra were obtained with a single pulse experiment in four scans 
with an acquisition time of 51 ms. Although the Pb(NO3)2 peak was not calibrated to 
tetramethyl lead (3), the spectrometer reference value was calculated such that at 273 K the 
chemical shift of Pb(NO3)2 was near -3810 ppm. Bielecki, et al. arbitrarily calibrated the 273 
K peak to be 0 ppm since the absolute chemical shift is unimportant, only the relative 
chemical shift change with temperature is of interest.  
 
Flow Calibration and Variable Temperature Data 
 As mentioned above, the goal of this study was to determine how different flow rates 
from the variable temperature unit affect the sample temperature, and whether or not the 
stator thermocouple gives an accurate temperature reading when the VT air is at a high flow 
rate. Not only can the flow rate be adjusted in the EDTE window in Topspin or XWinNMR, 
there is also a manual flow control knob inside the Variable Temperature Unit in the 
spectrometer cabinet. When the top of the case is removed, a small black knob can be found 
on the upper right-hand corner when facing the case. When adjusting the airflow in this 
fashion, the VT air hose should be connected to a flow meter, and the airflow in the EDTE 
window should be at the maximum value of 2000 L/h. To adjust the airflow, pull the knob 
towards the left-hand side of the case, and turn until the desired flow is obtained.  
The flow meter used to calibrate these experiments consisted of three flow meters 
attached to one hose, each reading a maximum value of 10 L/min. The resultant flow is read 
as a combination of the three flow meters, for example 10/10/9 equals 10 L/min, 10 L/min 
and 9 L/min respectively, for a total flow of 29 L/min. The reading was taken when the 
EDTE window flow rate was set at 2000 L/h, and the airflow knob was manually adjusted to 
obtain the appropriate flow readings. When the flow meters read 10/10/9 (“high flow”) this 
corresponds to a total flow rate of approximately 1740 L/h, which is close to the EDTE value 
of 2000 L/h. When the flow meters read 6/6/7 (“low flow”) this corresponds to a total flow 
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rate of approximately 1140 L/h. Thus the EDTE window flow rate does not necessarily equal 
the actual flow out of the VT air hose, and care must be taken to ensure appropriate flow. 
The resultant spectra are shown in Figure B.2. The temperatures reported for each set 
of spectra are the EDTE window readings, however it will be shown that this reading may 
not be completely accurate. For the non-center packed sample, only the “high flow” base 
value of 10/10/9 was used, and at each temperature the EDTE flow rate was set to be the 
minimum flow required to stabilize the sample temperature. These spectra are show in red in 
Figure B.2. For the center packed sample, the same procedure was followed for the blue 
spectra shown in Figure B.2. Additionally, at low temperatures, a higher flow rate was used 
to demonstrate that excessive VT airflow causes the temperature inside the sample to be 
lower than the thermocouple is reporting. These spectra are shown in green. For the center 
packed sample, a series of spectra at the “low flow” setting of 6/6/7 was also acquired, which 
are shown in black in Figure B.2.  
For the non-center packed sample, the 207Pb spectra at most temperatures show an 
obvious distribution of chemical shifts due to the loose packing of the Pb(NO3)2 powder and 
a temperature gradient within the sample. The high flow spectra for the center packed sample 
also show a downfield shift relative to the low flow spectra at 313 K, indicating the 
temperature inside the sample is actually higher than that measured by the thermocouple. At 
low temperature, the sample also shows a large distribution of temperatures. These are fit 
separately in Figure B.3 to demonstrate the difference in slope.   
Figure B.3 shows the 207Pb chemical shift as a function of temperature for (a) the non-
center packed sample, (b) the center packed sample at high flow and the (c) the center packed 
sample at low flow. For the non-center packed sample (Figure B.3a), the slope of 0.81 
ppm/K deviates significantly from the theoretical value of 0.753 ppm/K. This indicates that 
the sample temperature is significantly different from the stator thermocouple reading. 
Additionally, at the lowest temperatures (263 -243 K), a second peak can be plotted and fit. 
The slope for the second peak is 1.28 ppm/K, indicating that a portion of the non-
centerpacked sample is at a much lower temperature than the thermocouple is reading. The 
temperature distribution of the non-center packed sample at 243 K is greater than 7 K.  
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Figure B.2. Variable temperature 207Pb solid-state NMR spectra of Pb(NO3)2 at 7 kHz spinning speed. 
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Figure B.3. Variable temperature Pb(NO3)2 chemical shift as a function of apparent temperature.  
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This temperature distribution is calculated by taking the difference in chemical shift of the 
most upfield and most downfield points of the spectrum, and may be slightly larger 
depending on the chemical shift values.  
Both high and low flow temperature series for the center packed sample (Figures 
B.3b and c) show a slope of 0.74 ppm/K, which is close to the theoretical value of 0.753 
ppm/K. This indicates that the thermocouple in the stator is reading a temperature very close 
to the actual temperature inside the rotor. Our slope measurement of 0.74 ppm/K means that 
the temperature reading over 100 K range may vary up to 1.3 K from the actual sample 
temperature. Since we typically measure samples within a 70 K range, this effect is minimal. 
When a higher flow rate for the VT air is used for the center packed sample, the internal 
sample temperature is lower than the thermocouple reading, by about 1.9 K at the lowest 
temperature of 243 K.  Thus it is important to use the minimum flow require to reach the 
desired sample temperature.  
 
Conclusion 
 This study has attempted to measure the reliability of the stator thermocouple 
temperature reading versus the actual temperature inside the sample rotor. We have shown 
through a series of 207Pb NMR spectra, that a center packed sample shows good temperature 
homogeneity throughout the rotor. We have also shown that using a high flow of VT air can 
cause temperature gradients throughout the sample. When very high flows are used, we 
measure up to 1.9 K deviation from the thermocouple reading. Thus, it is important to take 
these factors into consideration when conducting a series of variable temperature 
experiments, especially when relaxation data is extracted from the temperature series.  
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Appendix C 
 
Sample Dialysis and Transfer of Hydrated Lipid Gels via Centrifugation 
 
 
Introduction 
 This appendix will summarize the preparation, ultracentrifugation and transfer of 
hydrated liposome pellets containing hydrophobic peptides for solid-state NMR experiments. 
The focus of this work has been the M2 transmembrane peptide (M2TMP) of the influenza A 
virus, thus the preparation method detailed here is geared towards the incorporation of 
hydrophobic transmembrane peptides into lipid vesicles.  
 
Buffer Preparation 
All samples prepared for the work included in this dissertation have been studied at a 
neutral pH of 7.0-7.5. The preparation included here will produce a buffer in this range. If the 
pH is to be much above or below this range, change the buffer precursors accordingly to 
obtain proper pH and buffering capacity. 
This buffer recipe will produce 100 mM phosphate buffer with 10 mM EDTA and 0.1 
mM NaN3. This buffer is ten times the concentration used in dialysis. To prepare the final 
buffer, use 100 mL of the concentrated buffer and dilute to 1 L with distilled/deionized 
water. Finally, adjust the pH of the dilute buffer with a small amount (generally 2-5 mL) of 1 
M NaOH or HCl to obtain the desired pH. 
The phopsphate ions serve as the buffering medium, whereas EDTA is a water 
softener to prevent heavy metals from binding to the sample, and NaN3 is used as a protease 
killer to ensure the sample is not contaminated with bacteria from the air or other surfaces. 
Weigh out all buffer reagents and add directly to a 1 L bottle, and add 1 L of 
distilled/deionized water and mix or shake until all reagents are dissolved. 
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Buffer Reagents: 
Na2HPO4, sodium hydrogen phosphate, approximately 11.9 g 
NaH2PO4, sodium dihydrogen phosphate, approximately 4.1 g 
EDTA, ethylenediaminetetraacetic acid, approximately 3.7 g 
NaN3, sodium azide, approximately 0.065 g 
 
Sample Preparation and Dialysis 
 All samples prepared for the work included in this dissertation include only a single 
lipid such as DLPC, POPC or DMPC. Other preparations, including the viral membrane 
mixing, are covered elsewhere (1). Most samples were prepared with a molar ratio of 1 
peptide to 15 lipids. The detergent dialysis protocol is covered in the group literature (2), but 
will be expanded upon here with additional notes and pictures. 
The lipid vesicle solution is prepared by suspending dry lipid powder in 1 mL 
phosphate buffer (10 mM Na2HPO4/NaH2PO4, 1 mM EDTA, 0.01 mM NaN3) at pH 7.5, 
vortexing and freeze-thawing 6 times to create uniform vesicles (3). M2TMP is dissolved in 
octyl-β-D-glucopyranoside (OG) in 2 mL phosphate buffer, and then mixed with an equal 
volume of lipid vesicles. Typically 30 mg of OG is used to solvate 5-6 mg of M2TMP.  The 
final solution of lipid, peptide and detergent is vortexed for 1 hr and allowed to stand for 6-8 
hrs at room temperature. At this point, a length of dialysis tubing should be prepared by 
soaking 4-5” of tube in the dialysis buffer. After the bag has been hydrated, use a tube clip to 
close one of the ends (Figure C.1). The sample mixture can now be added to the dialysis 
tubing using the 1 mL micropipette. Ensure that the tip of the micropipette is inside of the 
bag before releasing the solution. This transfer is usually conducted with a large weigh boat 
set under the dialysis tube to catch any spillage. Rinse the vial 2-3 times with small aliquots 
of buffer to ensure complete transfer. If possible, the final solution volume should be 
approximately 3-3.5 mL so that the entire volume can be contained in one ultracentrifuge 
tube.  Clip the other end of the dialysis tube, leaving some air space in the tube.  The solution 
is dialyzed with a 3.5 kDa cutoff against 1 L phosphate buffer at 4 °C for 3 days with buffer 
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changes every 8-12 hrs to ensure complete removal of the detergent. After dialysis, the 
sample is transferred again with the 1 mL micropipette directly to a 4 mL ultracentrifuge 
tube. Rinse the dialysis bag with 2-3 small aliquots of clean buffer, and fill any remaining 
headspace in the ultracentrifuge tube with buffer until only 2-3 mm remain at the top of the 
tube. The dialyzed peptide-lipid solution is centrifuged at 150,000 g (55,000 rpm) and 4 °C 
to give a pellet containing ~50 wt% water. 
 
 
Figure C.1. Dialysis tube filled with a solution, and clipped on both ends with tube clips (4).  
 
Sample Transfer via Ultracentrifugation 
  Previously, hydrated liposome samples were packed into the rotor by scraping the 
pellet out of the ultracentrifuge tube. However, this transfer method could be inconvenient 
and lossy at times. The ultracentrifugation method was originally developed to transfer 
microcrystalline proteins. Advantages of this method are that there is less sample stuck to 
centrifuge tube walls and packing tools. Transfer can be difficult if the sample is too dry, as it 
will stick to the sides of pipette tips, or if the sample is too wet it can overspill the rotor. In 
previous experience, this transfer method does not work well for viral membrane samples. 
Additionally, if KEL-F rotor insert is being used, one can only have 35-40 mg total size 
sample. 
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Figure C.2: Equipment required from left to right: 15 mL centrifuge tube, 5 mL pipette tip, 4 mL 
ultracentrifuge tube (with pellet sample at bottom), 200 uL flame-sealed pipette tip, 1.5 mL 
Eppendorf tube, rotor-holding funnel, rotor or rotor insert (not pictured). 
 
Figure C.2 displays the equipment required for the centrifugation sample transfer. 
The Iowa State University Machine Shop manufactured the funnel pictured at far right 
especially for our group. Also, the 200 µL pipette tip has been flame-sealed by briefly 
dragging the pipette tip across a Bunsen burner flame.  
 
 
Figure C.3: Eppendorf tube with cap clipped, 5 mL pipette tip cut to approximately 2” in length and 
ultracentrifuge tube cut to approximately 1”.  
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 Figure C.3 shows how to trim the Eppendorf tube, the 5 mL pipette tip and 
ultracentrifuge tube so that the pieces will fit into the 15 mL orange cap centrifuge tube.  
Figure C.4 shows the final assembly: the clipped ultracentrifuge tube fits into the 5 mL 
pipette tip, which fits into the 200 µL flame-sealed pipette tip. The entire assembly is inserted 
into the black funnel and rests in the clipped Eppendorf tube. It is important to clip the 5 mL 
pipette tip and the ultracentrifuge tube such that the final assembly is not too tall to fit into 
the orange cap tube. Weigh the sealed pipette tip before transfer 
 
 
Figure C.4: Sample transfer assembly. (a) Clipped ultracentrifuge tube fits into clipped 5 mL pipette 
tip, which rests in 200 µL flame-sealed pipette tip and black funnel. The entire assembly rests in the 
Eppendorf tube with cap removed. (b) The assembly needs to fit inside a 15 mL orange cap tube.  
 
 The final assembly pictured in figure C.4b is then centrifuged for 2-3 minutes, or until 
the pellet has transferred into the sealed pipette tip. At this point, weigh the pipette tip to 
ensure that most of the sample has been transferred, and calculate sample transfer efficiency. 
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If the pellet is too heavy for packing, the sample can be dried slightly through lyophilization 
or in the dessicator. Drug can also be added to the peptide sample at this point. 
 
 
 
Figure C.5: Liposome sample that has been transferred to a sealed pipette tip.  
 
 At this point, the 5 mL pipette tip and ultracentrifuge tube can be discarded if the 
entire sample has been spun down. Weigh a rotor with insert (if using). The black funnel is 
engineered such that the pipette tip will fit at the top, and the rotor can be inserted in the 
bottom. The rotor can be placed at the bottom of the Eppendorf tube and the pipette tip can 
be clipped and placed back in the black funnel and slipped over the rotor. Spin down the 
sample for another 2-3 minutes to transfer into the rotor. Weigh the rotor and calculate 
transfer efficiency. Typically 85-90% of the sample is transferred.  
 
Troubleshooting 
• Occasionally the pellet will be too dry after ultracentrifugation. A uniform and well-
hydrated pellet is much easier to transfer.  Clip the ultracentrifuge tube to 1” and add 
5-10 µL of H2O to the pellet. Wrap in Parafilm and allow to sit in the incubator at 30-
35 °C for 12-24 hours. 
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• If the rotor gets too full, it may prevent the entire sample from spinning out of the 
clipped pipette tip. If this happens, wrap the pipette tip with a thin layer of Parafilm 
near the top where it rests in the black funnel. This should elevate the tip enough 
such that the sample will be able to spin into the rotor.  
• If residual sample is stuck to the sides of any of the transfer tubes, the residue can be 
washed into an Eppendorf tube or sealed pipette tip and lyophilized to dryness. The 
resultant powder can be rehydrated and added to the rotor.  
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